query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
LOKIASV2_1517_ESMFold_hypothetical_protein	7txi-assembly1.cif.gz_A-1	LOKIASV2_1517_ESMFold_hypothetical_protein	7txi-assembly1.cif.gz_A-1 Cryo-EM of A. pernix flagellum	0.251	194	139	22	207	2	195	1.606E-10	318
LOKIASV2_1517_ESMFold_hypothetical_protein	7ofq-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7ofq-assembly1.cif.gz_A The archaellum of Methanocaldococcus villosus	0.193	207	150	22	208	3	209	1.149E-10	315
LOKIASV2_1517_ESMFold_hypothetical_protein	5ya6-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5ya6-assembly1.cif.gz_A Crystal structure of archaeal flagellin FlaB1 from Methanocaldococcus jannaschii	0.206	155	110	69	207	4	158	8.923E-09	295
LOKIASV2_1517_ESMFold_hypothetical_protein	5tfy-assembly1.cif.gz_I	LOKIASV2_1517_ESMFold_hypothetical_protein	5tfy-assembly1.cif.gz_I The archaeal flagellum of Methanospirillum hungatei strain JF1.	0.226	187	125	22	208	3	164	2.473E-09	291
LOKIASV2_1517_ESMFold_hypothetical_protein	5z1l-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5z1l-assembly1.cif.gz_A Cryo-EM structure of Methanoccus maripaludis archaellum	0.216	197	146	22	208	3	199	5.795E-10	289
LOKIASV2_1517_ESMFold_hypothetical_protein	7ofq-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7ofq-assembly1.cif.gz_B The archaellum of Methanocaldococcus villosus	0.207	211	147	22	208	3	213	2.923E-09	274
LOKIASV2_1517_ESMFold_hypothetical_protein	5o4u-assembly1.cif.gz_O	LOKIASV2_1517_ESMFold_hypothetical_protein	5o4u-assembly1.cif.gz_O The flagellin of Pyrococcus furiosus	0.189	204	149	22	206	3	206	1.920E-07	222
LOKIASV2_1517_ESMFold_hypothetical_protein	8cwm-assembly1.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	8cwm-assembly1.cif.gz_F Cryo-EM structure of the supercoiled S. islandicus REY15A archaeal flagellar filament	0.148	276	149	22	197	3	278	2.538E-07	205
LOKIASV2_1517_ESMFold_hypothetical_protein	5tuh-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5tuh-assembly2.cif.gz_B Archaellum periplasmic stator protein FlaG from Sulfolobus acidocaldarius	0.142	125	84	69	193	4	102	4.814E-05	169
LOKIASV2_1517_ESMFold_hypothetical_protein	5tug-assembly1.cif.gz_C-2	LOKIASV2_1517_ESMFold_hypothetical_protein	5tug-assembly1.cif.gz_C-2 Archaellum periplasmic stator protein complex FlaF and FlaG from Sulfolobus acidocaldarius	0.157	126	83	68	193	15	114	1.390E-04	159
LOKIASV2_1517_ESMFold_hypothetical_protein	4zbh-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4zbh-assembly1.cif.gz_A THE CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF SULFOLOBUS ACIDOCALDARIUS FLAF	0.097	125	98	69	193	8	116	2.428E-04	144
LOKIASV2_1517_ESMFold_hypothetical_protein	6pbk-assembly1.cif.gz_C-3	LOKIASV2_1517_ESMFold_hypothetical_protein	6pbk-assembly1.cif.gz_C-3 Archaellum periplasmic stator protein complex FlaF and FlaG from Sulfolobus acidocaldarius	0.141	126	85	68	193	15	114	1.737E-04	140
LOKIASV2_1517_ESMFold_hypothetical_protein	5tug-assembly1.cif.gz_D-3	LOKIASV2_1517_ESMFold_hypothetical_protein	5tug-assembly1.cif.gz_D-3 Archaellum periplasmic stator protein complex FlaF and FlaG from Sulfolobus acidocaldarius	0.100	139	112	55	193	3	127	2.428E-04	136
LOKIASV2_1517_ESMFold_hypothetical_protein	8fk7-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	8fk7-assembly1.cif.gz_A Structure of the Pyrobaculum calidifontis flagellar-like archaeal type IV pilus	0.143	176	115	22	197	2	136	2.675E-03	98
LOKIASV2_1517_ESMFold_hypothetical_protein	7y1b-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7y1b-assembly1.cif.gz_A 3.2 angstrom cryo-EM structure of extracellular region of mouse Basigin-2 in complex with the Fab fragment of antibody 6E7F1	0.111	129	89	69	197	7	107	7.723E-03	74
LOKIASV2_1517_ESMFold_hypothetical_protein	7dre-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7dre-assembly1.cif.gz_B Cryo-EM structure of DfgA-B at 2.54 angstrom resolution	0.121	129	97	68	196	5	115	2.947E-02	72
LOKIASV2_1517_ESMFold_hypothetical_protein	8oxx-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	8oxx-assembly1.cif.gz_A Transglutaminase 3 in complex with inhibitor Z-don and DH patient-derived Fab DH63-B02	0.133	141	114	68	208	2	133	2.263E-03	72
LOKIASV2_1517_ESMFold_hypothetical_protein	5bxg-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5bxg-assembly1.cif.gz_A Crystal structure of an uncharacterized beta-sandwich protein (CD630_09570) from Clostridium difficile 630 at 1.90 A resolution	0.143	125	106	69	193	25	149	1.207E-02	68
LOKIASV2_1517_ESMFold_hypothetical_protein	7o85-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7o85-assembly1.cif.gz_B Anthrax toxin prepore in complex with the neutralizing Fab cAb29	0.117	128	87	68	195	3	102	3.895E-02	63
LOKIASV2_1517_ESMFold_hypothetical_protein	7xy8-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7xy8-assembly2.cif.gz_B Crystal structure of antibody Fab fragment in complex with CD147(EMMPIRIN)	0.060	129	88	69	197	5	99	5.444E-02	62
LOKIASV2_1517_ESMFold_hypothetical_protein	7wp6-assembly1.cif.gz_I	LOKIASV2_1517_ESMFold_hypothetical_protein	7wp6-assembly1.cif.gz_I Cryo-EM structure of SARS-CoV-2 recombinant spike protein STFK in complex with three neutralizing antibodies	0.098	133	98	69	201	4	113	2.493E-02	61
LOKIASV2_1517_ESMFold_hypothetical_protein	1nud-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	1nud-assembly2.cif.gz_B Role of Calcium Ions in the Activation and Activity of the Transglutaminase 3 Enzyme (3 calciums, active form)	0.116	121	86	88	208	36	133	1.687E-02	61
LOKIASV2_1517_ESMFold_hypothetical_protein	1l9m-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	1l9m-assembly1.cif.gz_B Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions change structure for activation	0.138	141	113	68	208	2	133	1.595E-02	60
LOKIASV2_1517_ESMFold_hypothetical_protein	8q95-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	8q95-assembly1.cif.gz_C Crystal structure of the SARS-CoV-2 BA.1 RBD with neutralizing-VHHs Ma16B06 and Ma3F05	0.107	129	101	69	197	2	115	5.149E-02	59
LOKIASV2_1517_ESMFold_hypothetical_protein	5dfk-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5dfk-assembly1.cif.gz_A Crystal Structure of the Escherichia coli Common Pilus Chaperone, EcpB	0.124	130	94	69	198	2	109	4.119E-02	59
LOKIASV2_1517_ESMFold_hypothetical_protein	4m9o-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4m9o-assembly1.cif.gz_A Crystal Structure of monomeric zebrafish beta-2-microglobulin	0.069	128	82	69	196	7	95	1.486E-01	58
LOKIASV2_1517_ESMFold_hypothetical_protein	3f62-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	3f62-assembly1.cif.gz_A Crystal Structure of Human IL-18 in complex with Ectromelia virus IL-18 Binding Protein	0.097	128	88	69	196	11	108	3.895E-02	58
LOKIASV2_1517_ESMFold_hypothetical_protein	3oq3-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	3oq3-assembly1.cif.gz_B Structural Basis of Type-I Interferon Sequestration by a Poxvirus Decoy Receptor	0.060	131	91	69	199	232	329	5.444E-02	58
LOKIASV2_1517_ESMFold_hypothetical_protein	8oxv-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	8oxv-assembly1.cif.gz_A Transglutaminase 3 zymogen in complex with DH patient-derived Fab DH63-B02	0.133	141	114	68	208	3	134	2.230E-02	58
LOKIASV2_1517_ESMFold_hypothetical_protein	6tqu-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6tqu-assembly2.cif.gz_B The crystal structure of the MSP domain of human MOSPD2 in complex with the Phospho-FFAT motif of STARD3.	0.108	126	100	68	193	5	117	4.355E-02	57
LOKIASV2_1517_ESMFold_hypothetical_protein	1nug-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	1nug-assembly2.cif.gz_B Role of Calcium Ions in the Activation and Activity of the Transglutaminase 3 Enzyme (2 calciums, 1 Mg, inactive form)	0.133	141	114	68	208	2	133	2.636E-02	57
LOKIASV2_1517_ESMFold_hypothetical_protein	6eg0-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6eg0-assembly1.cif.gz_B Crystal structure of Dpr4 Ig1-Ig2 in complex with DIP-Eta Ig1-Ig3	0.076	129	85	69	197	208	300	4.605E-02	56
LOKIASV2_1517_ESMFold_hypothetical_protein	1im3-assembly2.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	1im3-assembly2.cif.gz_H Crystal Structure of the human cytomegalovirus protein US2 bound to the MHC class I molecule HLA-A2/tax	0.097	129	81	69	197	3	93	2.597E-01	55
LOKIASV2_1517_ESMFold_hypothetical_protein	1bx2-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	1bx2-assembly1.cif.gz_B CRYSTAL STRUCTURE OF HLA-DR2 (DRA*0101,DRB1*1501) COMPLEXED WITH A PEPTIDE FROM HUMAN MYELIN BASIC PROTEIN	0.074	131	85	69	199	99	191	9.512E-02	55
LOKIASV2_1517_ESMFold_hypothetical_protein	1eba-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1eba-assembly1.cif.gz_A COMPLEX BETWEEN THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP] AND AN INACTIVE PEPTIDE [EMP33] CONTAINS 3,5-DIBROMOTYROSINE IN POSITION 4 (DENOTED DBY)	0.062	127	86	70	196	14	106	2.197E-01	55
LOKIASV2_1517_ESMFold_hypothetical_protein	1w8n-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1w8n-assembly1.cif.gz_A Contribution of the Active Site Aspartic Acid to Catalysis in the Bacterial Neuraminidase from Micromonospora viridifaciens.	0.135	107	65	87	193	375	450	3.895E-02	54
LOKIASV2_1517_ESMFold_hypothetical_protein	3dj9-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	3dj9-assembly1.cif.gz_A Crystal Structure of an isolated, unglycosylated antibody CH2 domain	0.104	128	90	68	195	2	102	3.070E-01	53
LOKIASV2_1517_ESMFold_hypothetical_protein	5m95-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	5m95-assembly2.cif.gz_D STAPHYLOCOCCUS CAPITIS DIVALENT METAL ION TRANSPORTER (DMT) IN COMPLEX WITH MANGANESE	0.113	131	103	69	199	3	119	8.046E-02	53
LOKIASV2_1517_ESMFold_hypothetical_protein	6pzy-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	6pzy-assembly1.cif.gz_D CryoEM derived model of NA-73 Fab in complex with N9 Shanghai2	0.072	131	98	69	199	2	108	1.257E-01	52
LOKIASV2_1517_ESMFold_hypothetical_protein	5mwn-assembly1.cif.gz_N	LOKIASV2_1517_ESMFold_hypothetical_protein	5mwn-assembly1.cif.gz_N Structure of the EAEC T6SS component TssK N-terminal domain in complex with llama nanobodies nbK18 and nbK27	0.090	125	97	69	193	2	109	2.787E-02	52
LOKIASV2_1517_ESMFold_hypothetical_protein	1iu1-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1iu1-assembly1.cif.gz_A Crystal structure of human gamma1-adaptin ear domain	0.105	126	86	68	193	12	108	3.484E-02	52
LOKIASV2_1517_ESMFold_hypothetical_protein	5xf0-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5xf0-assembly1.cif.gz_A Solution structure of the IgI domain of CD147	0.060	129	88	69	197	10	104	1.662E-01	51
LOKIASV2_1517_ESMFold_hypothetical_protein	2r39-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	2r39-assembly1.cif.gz_A Crystal structure of FixG-related protein from Vibrio parahaemolyticus	0.114	130	92	68	197	3	107	4.119E-02	51
LOKIASV2_1517_ESMFold_hypothetical_protein	4eee-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	4eee-assembly1.cif.gz_C Crystal Structure of YLDV 14L IL-18 Binding Protein in Complex with Human IL-18	0.059	127	92	69	195	9	107	6.087E-02	51
LOKIASV2_1517_ESMFold_hypothetical_protein	1gyv-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1gyv-assembly1.cif.gz_A Gamma-adaptin appendage domain from clathrin adaptor AP1, L762E mutant	0.112	126	85	68	193	12	108	1.276E-02	51
LOKIASV2_1517_ESMFold_hypothetical_protein	6a8p-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6a8p-assembly1.cif.gz_A Transglutaminase 2 mutant G224V in complex with GTP	0.093	121	91	88	208	38	138	1.064E-01	51
LOKIASV2_1517_ESMFold_hypothetical_protein	4llm-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4llm-assembly1.cif.gz_B Structure of redesigned IgG1 first constant and lambda domains (CH1:Clambda constant redesign 1, CRD1) at 1.75A	0.073	128	88	68	195	5	100	4.291E-01	50
LOKIASV2_1517_ESMFold_hypothetical_protein	8tea-assembly1.cif.gz_G	LOKIASV2_1517_ESMFold_hypothetical_protein	8tea-assembly1.cif.gz_G HCMV Pentamer in complex with CS2pt1p2_A10L Fab and CS3pt1p4_C1L Fab	0.061	110	85	88	197	16	107	1.189E-01	50
LOKIASV2_1517_ESMFold_hypothetical_protein	2cry-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	2cry-assembly1.cif.gz_A Solution structure of the fifth ig-like domain of human kin of IRRE like 3	0.094	132	87	69	200	15	111	1.406E-01	50
LOKIASV2_1517_ESMFold_hypothetical_protein	7z50-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7z50-assembly1.cif.gz_B Structure of the highly diabetogenic 4.1-T cell receptor targeting a hybrid insulin peptide bound to I-Ag7.	0.062	121	82	75	195	89	176	1.064E-01	50
LOKIASV2_1517_ESMFold_hypothetical_protein	7xad-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7xad-assembly1.cif.gz_A Crystal strucutre of PD-L1 and DBL2_02 designed protein binder	0.068	129	84	69	197	120	210	2.904E-01	50
LOKIASV2_1517_ESMFold_hypothetical_protein	6kn9-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6kn9-assembly2.cif.gz_B Crystal structure of human interleukin 18 receptor beta extracellular domain in complex with an antagonistic scFv	0.035	127	104	70	196	112	220	4.605E-02	50
LOKIASV2_1517_ESMFold_hypothetical_protein	4edq-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4edq-assembly2.cif.gz_B MBP-fusion protein of myosin-binding protein c residues 149-269	0.103	110	75	88	197	388	472	4.355E-02	50
LOKIASV2_1517_ESMFold_hypothetical_protein	1wcq-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	1wcq-assembly2.cif.gz_B Mutagenesis of the Nucleophilic Tyrosine in a Bacterial Sialidase to Phenylalanine.	0.154	107	63	87	193	375	450	1.006E-01	50
LOKIASV2_1517_ESMFold_hypothetical_protein	6a3w-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6a3w-assembly1.cif.gz_B Complex structure of 4-1BB and utomilumab	0.052	110	84	88	197	15	104	1.257E-01	49
LOKIASV2_1517_ESMFold_hypothetical_protein	7m6g-assembly1.cif.gz_S	LOKIASV2_1517_ESMFold_hypothetical_protein	7m6g-assembly1.cif.gz_S Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15	0.074	128	97	70	197	1	106	1.572E-01	49
LOKIASV2_1517_ESMFold_hypothetical_protein	6x04-assembly1.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	6x04-assembly1.cif.gz_F Nup133 (aa55-481) from S. cerevisiae bound by VHH-SAN5	0.104	125	93	69	193	3	107	1.064E-01	49
LOKIASV2_1517_ESMFold_hypothetical_protein	1eba-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	1eba-assembly1.cif.gz_B COMPLEX BETWEEN THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP] AND AN INACTIVE PEPTIDE [EMP33] CONTAINS 3,5-DIBROMOTYROSINE IN POSITION 4 (DENOTED DBY)	0.062	127	86	70	196	14	106	4.538E-01	49
LOKIASV2_1517_ESMFold_hypothetical_protein	8a0y-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	8a0y-assembly1.cif.gz_A Crystal structure of mouse contactin 2 immunoglobulin domains	0.111	130	84	68	197	476	571	1.330E-01	49
LOKIASV2_1517_ESMFold_hypothetical_protein	3s3s-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	3s3s-assembly1.cif.gz_A Transglutaminase 2 in complex with a novel inhibitor	0.093	121	91	88	208	38	138	1.572E-01	49
LOKIASV2_1517_ESMFold_hypothetical_protein	2dav-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	2dav-assembly1.cif.gz_A Solution structure of the first ig-like domain of Myosin-binding protein C, slow-type	0.087	126	93	72	197	6	108	1.330E-01	48
LOKIASV2_1517_ESMFold_hypothetical_protein	1gyw-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1gyw-assembly1.cif.gz_A Gamma-adaptin appendage domain from clathrin adaptor AP1 A753D mutant	0.105	126	86	68	193	18	114	5.757E-02	48
LOKIASV2_1517_ESMFold_hypothetical_protein	7dce-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7dce-assembly1.cif.gz_B Cryo-EM structure of human XKR8-basigin complex bound to Fab fragment	0.059	131	90	69	199	5	101	1.965E-01	48
LOKIASV2_1517_ESMFold_hypothetical_protein	5muh-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5muh-assembly1.cif.gz_B Crystal structure of an amyloidogenic light chain dimer H7	0.073	128	88	68	195	85	180	2.746E-01	48
LOKIASV2_1517_ESMFold_hypothetical_protein	7yxb-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	7yxb-assembly2.cif.gz_D MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange	0.074	131	85	69	199	100	192	2.323E-01	48
LOKIASV2_1517_ESMFold_hypothetical_protein	6moj-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6moj-assembly1.cif.gz_B Dimeric DARPin A_angle_R5 complex with EpoR	0.055	125	88	72	196	17	110	5.365E-01	48
LOKIASV2_1517_ESMFold_hypothetical_protein	7zcf-assembly1.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	7zcf-assembly1.cif.gz_E SARS-CoV-2 Spike RBD in complex with the single chain fragment scFv76 (Focused Refinement)	0.089	131	95	69	199	121	225	1.757E-01	48
LOKIASV2_1517_ESMFold_hypothetical_protein	7sqc-assembly1.cif.gz_2A	LOKIASV2_1517_ESMFold_hypothetical_protein	7sqc-assembly1.cif.gz_2A Ciliary C1 central pair apparatus isolated from Chlamydomonas reinhardtii	0.095	126	86	68	193	125	220	8.046E-02	48
LOKIASV2_1517_ESMFold_hypothetical_protein	3cx2-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	3cx2-assembly1.cif.gz_A Crystal structure of the C1 domain of cardiac isoform of myosin binding protein-C at 1.3A	0.098	106	71	88	193	21	100	6.437E-02	47
LOKIASV2_1517_ESMFold_hypothetical_protein	7wp2-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7wp2-assembly1.cif.gz_L Cryo-EM structure of SARS-CoV-2 C.1.2 S6P trimer in complex with neutralizing antibody VacW-209 (local refinement)	0.088	121	94	77	197	4	107	7.609E-02	47
LOKIASV2_1517_ESMFold_hypothetical_protein	3zy7-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	3zy7-assembly1.cif.gz_B Crystal structure of computationally redesigned gamma-adaptin appendage domain forming a symmetric homodimer	0.114	126	82	68	193	12	104	4.869E-02	47
LOKIASV2_1517_ESMFold_hypothetical_protein	6obe-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6obe-assembly1.cif.gz_B Ricin A chain bound to VHH antibody V6H8	0.142	125	91	69	193	3	109	8.508E-02	47
LOKIASV2_1517_ESMFold_hypothetical_protein	8oxy-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	8oxy-assembly1.cif.gz_C Transglutaminase 3 without calcium in complex with DH patient-derived Fab DH63-B02	0.067	128	89	68	195	116	211	4.058E-01	47
LOKIASV2_1517_ESMFold_hypothetical_protein	7jqe-assembly1.cif.gz_A-2	LOKIASV2_1517_ESMFold_hypothetical_protein	7jqe-assembly1.cif.gz_A-2 Structure of an extracellular fragment of EsaA from Streptococcus gallolyticus	0.088	119	82	80	198	165	255	1.125E-01	47
LOKIASV2_1517_ESMFold_hypothetical_protein	1eut-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1eut-assembly1.cif.gz_A SIALIDASE, LARGE 68KD FORM, COMPLEXED WITH GALACTOSE	0.128	128	79	69	196	362	453	1.330E-01	47
LOKIASV2_1517_ESMFold_hypothetical_protein	5mo9-assembly1.cif.gz_X	LOKIASV2_1517_ESMFold_hypothetical_protein	5mo9-assembly1.cif.gz_X Structure of human TrkB receptor ligand binding domain in complex with the Fab frgment of antibody AB20	0.053	126	82	68	193	4	91	3.838E-01	46
LOKIASV2_1517_ESMFold_hypothetical_protein	7ul3-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	7ul3-assembly1.cif.gz_C CryoEM Structure of Inactive H2R Bound to Famotidine, Nb6M, and NabFab	0.113	125	92	69	193	3	107	1.006E-01	46
LOKIASV2_1517_ESMFold_hypothetical_protein	6dnv-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6dnv-assembly2.cif.gz_B Crystal Structure of Neisseria meningitidis DsbD n-terminal domain in the reduced form	0.069	144	108	65	208	9	125	1.757E-01	46
LOKIASV2_1517_ESMFold_hypothetical_protein	5dk2-assembly2.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	5dk2-assembly2.cif.gz_E Fc Heterodimer E356K/D399K + K392D/K409D	0.099	128	88	68	195	2	100	3.433E-01	46
LOKIASV2_1517_ESMFold_hypothetical_protein	3c5j-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	3c5j-assembly1.cif.gz_B Crystal structure of HLA DR52c	0.100	127	78	69	195	94	181	2.746E-01	46
LOKIASV2_1517_ESMFold_hypothetical_protein	3pv7-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	3pv7-assembly1.cif.gz_A Crystal structure of NKp30 ligand B7-H6	0.098	109	75	88	196	129	212	3.838E-01	46
LOKIASV2_1517_ESMFold_hypothetical_protein	1f42-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1f42-assembly1.cif.gz_A THE P40 DOMAIN OF HUMAN INTERLEUKIN-12	0.104	131	97	68	198	94	202	2.746E-01	46
LOKIASV2_1517_ESMFold_hypothetical_protein	3duh-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	3duh-assembly1.cif.gz_A Structure of Interleukin-23	0.077	131	98	68	198	95	201	1.406E-01	46
LOKIASV2_1517_ESMFold_hypothetical_protein	4ekx-assembly2.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	4ekx-assembly2.cif.gz_C Crystal Structure of YLDV 14L IL-18 Binding Protein in Complex with Human IL-18	0.047	125	83	69	193	4	91	1.572E-01	45
LOKIASV2_1517_ESMFold_hypothetical_protein	7al7-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7al7-assembly1.cif.gz_A The Crystal Structure of Human IL-18 in Complex With Human IL-18 Binding Protein	0.108	126	86	68	193	4	100	3.070E-01	45
LOKIASV2_1517_ESMFold_hypothetical_protein	7x94-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7x94-assembly1.cif.gz_L The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab712	0.051	114	81	78	191	15	100	1.486E-01	45
LOKIASV2_1517_ESMFold_hypothetical_protein	7ymj-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	7ymj-assembly1.cif.gz_D Cryo-EM structure of alpha1AAR-Nb6 complex bound to tamsulosin	0.126	131	98	69	199	4	116	2.746E-01	45
LOKIASV2_1517_ESMFold_hypothetical_protein	5xsy-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5xsy-assembly1.cif.gz_B Structure of the Nav1.4-beta1 complex from electric eel	0.095	114	100	88	201	16	127	7.196E-02	45
LOKIASV2_1517_ESMFold_hypothetical_protein	1fyt-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	1fyt-assembly1.cif.gz_B CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR1	0.072	107	69	89	195	104	178	3.838E-01	45
LOKIASV2_1517_ESMFold_hypothetical_protein	4gbx-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4gbx-assembly2.cif.gz_B Crystal structure of an immune complex at pH 6.5	0.076	127	79	69	195	103	188	3.838E-01	45
LOKIASV2_1517_ESMFold_hypothetical_protein	4p57-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4p57-assembly1.cif.gz_B MHC TCR peptide complex	0.062	126	82	70	195	108	195	3.070E-01	45
LOKIASV2_1517_ESMFold_hypothetical_protein	2r15-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	2r15-assembly1.cif.gz_B Crystal structure of the myomesin domains 12 and 13	0.164	154	92	48	201	96	206	1.257E-01	45
LOKIASV2_1517_ESMFold_hypothetical_protein	8g19-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	8g19-assembly1.cif.gz_L Crystal structure of monoreactive 4C05 human Fab	0.057	128	90	69	196	113	208	3.838E-01	45
LOKIASV2_1517_ESMFold_hypothetical_protein	7xad-assembly4.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	7xad-assembly4.cif.gz_H Crystal strucutre of PD-L1 and DBL2_02 designed protein binder	0.061	129	83	69	197	120	208	4.058E-01	45
LOKIASV2_1517_ESMFold_hypothetical_protein	6yjp-assembly3.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	6yjp-assembly3.cif.gz_E Crystal structure of a complex between glycosylated NKp30 and its deglycosylated tumour ligand B7-H6	0.096	126	82	68	193	120	211	1.662E-01	45
LOKIASV2_1517_ESMFold_hypothetical_protein	5v4e-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5v4e-assembly1.cif.gz_A Engineered human IgG Fc domain glyco801 (Fc801)	0.133	130	87	68	197	11	111	2.597E-01	45
LOKIASV2_1517_ESMFold_hypothetical_protein	6uib-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6uib-assembly1.cif.gz_B Crystal structure of IL23 bound to peptide 23-652	0.078	133	90	66	198	82	180	9.512E-02	45
LOKIASV2_1517_ESMFold_hypothetical_protein	6wdq-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6wdq-assembly1.cif.gz_A IL23/IL23R/IL12Rb1 signaling complex	0.081	131	104	68	198	96	209	1.662E-01	45
LOKIASV2_1517_ESMFold_hypothetical_protein	5l7v-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5l7v-assembly1.cif.gz_B Crystal Structure of BvGH123 with bond transition state analog Galthiazoline.	0.082	162	118	69	197	27	188	5.444E-02	45
LOKIASV2_1517_ESMFold_hypothetical_protein	1gyu-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1gyu-assembly1.cif.gz_A Gamma-adaptin appendage domain from clathrin adaptor AP1	0.112	126	85	68	193	12	108	6.437E-02	44
LOKIASV2_1517_ESMFold_hypothetical_protein	7w9m-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7w9m-assembly1.cif.gz_B Cryo-EM structure of human Nav1.7(E406K) in complex with auxiliary beta subunits, ProTx-II and tetrodotoxin (S6IV pi helix conformer)	0.107	118	104	87	203	15	132	1.125E-01	44
LOKIASV2_1517_ESMFold_hypothetical_protein	4j12-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4j12-assembly1.cif.gz_A monomeric Fc	0.097	132	94	68	199	2	106	7.091E-01	44
LOKIASV2_1517_ESMFold_hypothetical_protein	6wyt-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6wyt-assembly1.cif.gz_L Crystal structure of anti-Muscle Specific Kinase (MuSK) Fab, MuSK1B	0.079	128	87	68	195	111	206	3.838E-01	44
LOKIASV2_1517_ESMFold_hypothetical_protein	5grj-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5grj-assembly1.cif.gz_A Crystal structure of human PD-L1 with monoclonal antibody avelumab	0.136	129	93	69	197	4	112	2.078E-01	44
LOKIASV2_1517_ESMFold_hypothetical_protein	6vbv-assembly1.cif.gz_1	LOKIASV2_1517_ESMFold_hypothetical_protein	6vbv-assembly1.cif.gz_1 Structure of the bovine BBSome:ARL6:GTP complex	0.102	197	140	1	197	327	483	8.996E-02	44
LOKIASV2_1517_ESMFold_hypothetical_protein	6vnw-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	6vnw-assembly1.cif.gz_D Cryo-EM structure of apo-BBSome	0.102	197	140	1	197	369	525	8.996E-02	44
LOKIASV2_1517_ESMFold_hypothetical_protein	8dhv-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	8dhv-assembly1.cif.gz_B Treponema lecithinolyticum beta-glucuronidase	0.092	122	74	75	196	198	279	3.247E-01	44
LOKIASV2_1517_ESMFold_hypothetical_protein	2bzd-assembly3.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	2bzd-assembly3.cif.gz_C Galactose recognition by the carbohydrate-binding module of a bacterial sialidase.	0.144	106	65	88	193	373	449	1.257E-01	44
LOKIASV2_1517_ESMFold_hypothetical_protein	6igw-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6igw-assembly1.cif.gz_A MPZL1 mutant - S86G, V145G, Q146K,P147T,G148S	0.078	122	98	79	200	11	117	4.291E-01	43
LOKIASV2_1517_ESMFold_hypothetical_protein	6igo-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	6igo-assembly2.cif.gz_D Crystal structure of myelin protein zero-like protein 1 (MPZL1)	0.052	123	103	79	201	11	120	2.746E-01	43
LOKIASV2_1517_ESMFold_hypothetical_protein	5feb-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5feb-assembly1.cif.gz_A Crystal structure of the Voltage-gated Sodium Channel Beta 2 subunit extracellular domain	0.089	130	106	68	197	3	119	4.058E-01	43
LOKIASV2_1517_ESMFold_hypothetical_protein	6w5v-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	6w5v-assembly1.cif.gz_D NPC1-NPC2 complex structure at pH 5.5	0.097	131	107	63	193	7	125	4.538E-01	43
LOKIASV2_1517_ESMFold_hypothetical_protein	5ksu-assembly2.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	5ksu-assembly2.cif.gz_E Crystal structure of HLA-DQ2.5-CLIP1 at 2.73 resolution	0.100	125	74	69	193	95	177	4.798E-01	43
LOKIASV2_1517_ESMFold_hypothetical_protein	6uqc-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	6uqc-assembly2.cif.gz_D Mouse IgG2a Bispecific Fc	0.104	131	92	69	199	2	105	5.998E-01	43
LOKIASV2_1517_ESMFold_hypothetical_protein	5f6h-assembly2.cif.gz_J	LOKIASV2_1517_ESMFold_hypothetical_protein	5f6h-assembly2.cif.gz_J Crystal Structure of Tier 2 Neutralizing Antibody DH427 from a Rhesus Macaque	0.076	123	96	75	197	3	107	2.197E-01	43
LOKIASV2_1517_ESMFold_hypothetical_protein	4zso-assembly2.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	4zso-assembly2.cif.gz_F Crystal structure of a complex between B7-H6, a tumor cell ligand for natural cytotoxicity receptor NKp30, and an inhibitory antibody	0.103	112	80	85	196	124	213	5.672E-01	43
LOKIASV2_1517_ESMFold_hypothetical_protein	7rp2-assembly1.cif.gz_I	LOKIASV2_1517_ESMFold_hypothetical_protein	7rp2-assembly1.cif.gz_I Crystal structure of Kas G12C in complex with 2H11 CLAMP	0.080	131	98	68	198	2	108	4.291E-01	43
LOKIASV2_1517_ESMFold_hypothetical_protein	6was-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6was-assembly2.cif.gz_B Structure of D19.PA8 Fab in complex with 1FD6 16055 V1V2 scaffold	0.096	130	99	70	199	1	111	2.597E-01	43
LOKIASV2_1517_ESMFold_hypothetical_protein	5mho-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5mho-assembly1.cif.gz_A FXIIIa in complex with the inhibitor ZED2369	0.106	105	81	88	192	67	158	3.247E-01	43
LOKIASV2_1517_ESMFold_hypothetical_protein	4ekx-assembly3.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4ekx-assembly3.cif.gz_A Crystal Structure of YLDV 14L IL-18 Binding Protein in Complex with Human IL-18	0.046	125	84	69	193	4	92	3.070E-01	42
LOKIASV2_1517_ESMFold_hypothetical_protein	2mkl-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	2mkl-assembly1.cif.gz_C Solution structure of the fourth constant immunoglobulin domain of nurse shark IgNAR	0.064	126	91	68	193	4	101	6.706E-01	42
LOKIASV2_1517_ESMFold_hypothetical_protein	8bgg-assembly1.cif.gz_Y	LOKIASV2_1517_ESMFold_hypothetical_protein	8bgg-assembly1.cif.gz_Y Cryo-EM structure of SARS-CoV-2 spike (Omicron BA.1 variant) in complex with nanobody W25 (map 5, focus refinement on RBD, W25 and adjacent NTD)	0.102	125	94	69	193	2	107	1.406E-01	42
LOKIASV2_1517_ESMFold_hypothetical_protein	8epa-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	8epa-assembly1.cif.gz_H Structure of interleukin receptor common gamma chain (IL2Rgamma) in complex with two antibodies	0.107	117	92	77	193	7	110	6.806E-02	42
LOKIASV2_1517_ESMFold_hypothetical_protein	7xm9-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	7xm9-assembly1.cif.gz_C Cryo-EM structure of human NaV1.7/beta1/beta2-XEN907	0.075	129	106	69	197	2	117	4.058E-01	42
LOKIASV2_1517_ESMFold_hypothetical_protein	3q48-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	3q48-assembly2.cif.gz_B Crystal structure of Pseudomonas aeruginosa CupB2 chaperone	0.067	129	95	70	198	1	103	1.257E-01	42
LOKIASV2_1517_ESMFold_hypothetical_protein	6moh-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	6moh-assembly1.cif.gz_C Dimeric DARPin C_R3 complex with EpoR	0.054	106	75	87	192	28	107	4.538E-01	42
LOKIASV2_1517_ESMFold_hypothetical_protein	1ern-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	1ern-assembly1.cif.gz_B NATIVE STRUCTURE OF THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP]	0.063	124	83	75	198	14	103	7.498E-01	42
LOKIASV2_1517_ESMFold_hypothetical_protein	1eer-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	1eer-assembly1.cif.gz_B CRYSTAL STRUCTURE OF HUMAN ERYTHROPOIETIN COMPLEXED TO ITS RECEPTOR AT 1.9 ANGSTROMS	0.056	122	84	75	196	19	108	1.465E+00	42
LOKIASV2_1517_ESMFold_hypothetical_protein	4kte-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4kte-assembly1.cif.gz_L Fab fragment of HIV vaccine-elicited CD4bs-directed antibody, GE148, from non-human primate	0.071	128	88	68	195	121	216	4.798E-01	42
LOKIASV2_1517_ESMFold_hypothetical_protein	1f45-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1f45-assembly1.cif.gz_A HUMAN INTERLEUKIN-12	0.078	122	84	77	198	102	193	1.662E-01	42
LOKIASV2_1517_ESMFold_hypothetical_protein	8dhw-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	8dhw-assembly1.cif.gz_B Treponema lecithinolyticum beta-glucuronidase in complex with a UNC4917-glucuronide conjugate	0.085	122	74	75	196	190	271	3.630E-01	42
LOKIASV2_1517_ESMFold_hypothetical_protein	1ggy-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1ggy-assembly1.cif.gz_A HUMAN FACTOR XIII WITH YTTERBIUM BOUND IN THE ION SITE	0.098	129	97	69	197	497	605	2.197E-01	42
LOKIASV2_1517_ESMFold_hypothetical_protein	8dyt-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	8dyt-assembly1.cif.gz_L Cryo-EM structure of 227 Fab in complex with (NPNA)8 peptide	0.076	123	98	75	197	1	107	4.291E-01	41
LOKIASV2_1517_ESMFold_hypothetical_protein	2aw2-assembly3.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	2aw2-assembly3.cif.gz_A Crystal structure of the human BTLA-HVEM complex	0.071	132	92	69	200	3	102	7.928E-01	41
LOKIASV2_1517_ESMFold_hypothetical_protein	7dv4-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7dv4-assembly1.cif.gz_A Crystal structure of anti-CTLA-4 VH domain in complex with human CTLA-4	0.094	126	94	68	193	1	105	1.662E-01	41
LOKIASV2_1517_ESMFold_hypothetical_protein	5mwn-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	5mwn-assembly1.cif.gz_D Structure of the EAEC T6SS component TssK N-terminal domain in complex with llama nanobodies nbK18 and nbK27	0.108	125	95	69	193	2	109	1.189E-01	41
LOKIASV2_1517_ESMFold_hypothetical_protein	2yd7-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	2yd7-assembly2.cif.gz_B Crystal structure of the N-terminal Ig1-2 module of Human Receptor Protein Tyrosine Phosphatase Delta	0.060	129	85	69	197	4	94	3.630E-01	41
LOKIASV2_1517_ESMFold_hypothetical_protein	7tyv-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	7tyv-assembly1.cif.gz_H Structure of Lassa Virus glycoprotein (Josiah) bound to Fab 25.10C	0.084	124	96	69	192	2	107	2.078E-01	41
LOKIASV2_1517_ESMFold_hypothetical_protein	7cho-assembly2.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	7cho-assembly2.cif.gz_C Crystal structure of SARS-CoV-2 antibody P5A-1D2 with RBD	0.094	131	94	68	198	2	106	5.365E-01	41
LOKIASV2_1517_ESMFold_hypothetical_protein	5cgy-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	5cgy-assembly2.cif.gz_D Fab fragment of Chikungunya virus neutralizing human monoclonal antibody 4J21	0.092	132	98	68	199	2	110	2.746E-01	41
LOKIASV2_1517_ESMFold_hypothetical_protein	6nfn-assembly8.cif.gz_N	LOKIASV2_1517_ESMFold_hypothetical_protein	6nfn-assembly8.cif.gz_N Fab fragment of anti-cocaine antibody h2E2 bound to benzoylecgonine	0.076	112	90	88	199	17	114	7.498E-01	41
LOKIASV2_1517_ESMFold_hypothetical_protein	6iek-assembly2.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	6iek-assembly2.cif.gz_F Structure of RVFV Gn and human monoclonal antibody R12	0.079	128	87	68	195	120	215	4.798E-01	41
LOKIASV2_1517_ESMFold_hypothetical_protein	6cr1-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	6cr1-assembly1.cif.gz_H adalimumab EFab	0.073	128	89	68	195	126	222	4.058E-01	41
LOKIASV2_1517_ESMFold_hypothetical_protein	6kn9-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6kn9-assembly1.cif.gz_A Crystal structure of human interleukin 18 receptor beta extracellular domain in complex with an antagonistic scFv	0.044	124	100	74	197	153	258	4.538E-01	41
LOKIASV2_1517_ESMFold_hypothetical_protein	5l7u-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5l7u-assembly1.cif.gz_A Crystal structure of BvGH123 with bound GalNAc	0.085	152	116	69	196	28	179	4.355E-02	41
LOKIASV2_1517_ESMFold_hypothetical_protein	6kzb-assembly1.cif.gz_A-2	LOKIASV2_1517_ESMFold_hypothetical_protein	6kzb-assembly1.cif.gz_A-2 Transglutaminase2 complexed with calcium	0.087	106	83	88	193	37	128	5.073E-01	41
LOKIASV2_1517_ESMFold_hypothetical_protein	4crp-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4crp-assembly1.cif.gz_A Solution structure of a TrkAIg2 domain construct for use in drug discovery	0.059	132	87	68	199	11	103	8.864E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	7xw7-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7xw7-assembly1.cif.gz_B TSHR-K1-70 complex	0.080	117	90	75	191	2	100	2.746E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	6p65-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6p65-assembly1.cif.gz_L HIV Env 16055 NFL TD 2CC+ in complex with antibody 1C2 fragment antigen binding	0.092	125	89	69	193	3	101	3.070E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	7we9-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7we9-assembly1.cif.gz_L SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv289	0.060	126	94	68	193	2	102	1.572E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	3s36-assembly1.cif.gz_X	LOKIASV2_1517_ESMFold_hypothetical_protein	3s36-assembly1.cif.gz_X Structural basis for the function of two anti-VEGF receptor antibodies	0.100	132	95	70	201	4	109	3.838E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	5mvg-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5mvg-assembly1.cif.gz_A Crystal structure of non-amyloidogenic light chain dimer M7	0.079	128	87	68	195	80	175	2.456E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	6fy3-assembly1.cif.gz_Y	LOKIASV2_1517_ESMFold_hypothetical_protein	6fy3-assembly1.cif.gz_Y Crystal structure of a V2-directed, RV144 vaccine-like antibody from HIV-1 infection, CAP228-3D, bound to a heterologous V2 peptide	0.060	126	78	68	193	118	201	4.291E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	4y5x-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	4y5x-assembly1.cif.gz_C Diabody 305 complex with EpoR	0.054	109	70	88	196	25	99	1.239E+00	40
LOKIASV2_1517_ESMFold_hypothetical_protein	5mtl-assembly2.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	5mtl-assembly2.cif.gz_C Crystal structure of an amyloidogenic light chain	0.079	128	87	68	195	110	205	6.706E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	5cey-assembly2.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	5cey-assembly2.cif.gz_C Crystal Structure of Fab 9H+3L, a putative precursor of the PGT121 family of potent HIV-1 antibodies	0.079	128	87	68	195	110	205	2.746E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	7xsa-assembly2.cif.gz_I	LOKIASV2_1517_ESMFold_hypothetical_protein	7xsa-assembly2.cif.gz_I Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P2S-2E9 Fab	0.084	136	99	68	203	1	109	4.798E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	5y32-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5y32-assembly1.cif.gz_A Crystal structure of PTP delta Ig1-Ig2 in complex with IL1RAPL1	0.070	133	95	69	201	106	208	3.433E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	6cr1-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6cr1-assembly1.cif.gz_L adalimumab EFab	0.072	128	89	68	195	112	208	4.538E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	6moh-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	6moh-assembly1.cif.gz_D Dimeric DARPin C_R3 complex with EpoR	0.063	106	74	87	192	28	107	6.706E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	7uel-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7uel-assembly1.cif.gz_L Genetic and structural basis for the human anti-alpha-galactosyl antibody response	0.051	127	89	69	195	113	207	8.383E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	5wkz-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5wkz-assembly1.cif.gz_L VH1-69 germline antibody predicted from CR6261	0.066	128	89	68	195	115	210	8.864E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	8gb5-assembly4.cif.gz_K	LOKIASV2_1517_ESMFold_hypothetical_protein	8gb5-assembly4.cif.gz_K Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 25F9	0.093	122	86	78	199	14	109	3.070E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	7cm4-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7cm4-assembly1.cif.gz_L Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59	0.066	128	89	68	195	116	211	9.911E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	6grz-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6grz-assembly1.cif.gz_B Crystal structure of the light chain dimer mH6	0.071	128	88	68	195	115	210	7.928E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	3pv6-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	3pv6-assembly1.cif.gz_A Crystal structure of NKp30 bound to its ligand B7-H6	0.097	109	77	88	196	129	214	9.373E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	5w6g-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5w6g-assembly1.cif.gz_L Human antibody 6649 in complex with influenza hemagglutinin H1 Solomon Islands	0.071	128	88	68	195	117	212	5.672E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	7jz1-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7jz1-assembly1.cif.gz_L Crystal structure of broadly Plasmodium RIFIN reactive LAIR1-inserted antibody MGC34	0.079	128	87	68	195	117	212	5.998E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	7ohi-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7ohi-assembly1.cif.gz_A FCHO1-peptide-AP2 alpha ear complex	0.076	129	98	65	193	21	127	7.196E-02	40
LOKIASV2_1517_ESMFold_hypothetical_protein	4grw-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	4grw-assembly2.cif.gz_D Structure of a complex of human IL-23 with 3 Nanobodies (Llama vHHs)	0.083	112	82	87	198	116	205	2.197E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	5njd-assembly3.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	5njd-assembly3.cif.gz_E Structure of Interleukin 23 in complex with Briakinumab FAb	0.103	127	104	72	198	91	207	1.064E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	3d87-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	3d87-assembly2.cif.gz_B Crystal structure of Interleukin-23	0.079	127	95	72	198	104	207	3.630E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	5mol-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5mol-assembly1.cif.gz_B Human IgE-Fc crystal structure	0.074	127	88	69	195	8	103	3.433E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	2wqr-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	2wqr-assembly1.cif.gz_B The high resolution crystal structure of IgE Fc	0.072	128	87	68	195	9	103	4.538E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	5fr0-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5fr0-assembly1.cif.gz_A The details of glycolipid glycan hydrolysis by the structural analysis of a family 123 glycoside hydrolase from Clostridium perfringens	0.077	128	112	80	201	33	160	2.597E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	1ggy-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	1ggy-assembly1.cif.gz_B HUMAN FACTOR XIII WITH YTTERBIUM BOUND IN THE ION SITE	0.065	129	88	69	197	610	704	5.073E-01	40
LOKIASV2_1517_ESMFold_hypothetical_protein	7lxz-assembly1.cif.gz_J	LOKIASV2_1517_ESMFold_hypothetical_protein	7lxz-assembly1.cif.gz_J SARS-CoV-2 S/S2M11/S2L28 Global Refinement	0.057	117	91	77	193	3	100	2.197E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	2avg-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	2avg-assembly1.cif.gz_A NMR structure of cC1 domain from Human Cardiac Myosin Binding Protein C	0.083	126	90	75	200	10	108	3.630E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	2h3n-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	2h3n-assembly1.cif.gz_B Crystal structure of a surrogate light chain (LAMBDA5 and VpreB) homodimer	0.065	127	88	69	195	21	115	8.383E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	5m2w-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5m2w-assembly1.cif.gz_A Structure of nanobody nb18 raised against TssK from E. coli T6SS	0.059	119	97	75	193	4	107	1.064E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	4bcx-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4bcx-assembly1.cif.gz_A gamma 2 adaptin EAR domain crystal structure	0.068	126	89	68	193	12	108	2.197E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	5mkd-assembly4.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	5mkd-assembly4.cif.gz_D Crystal structure of Bacillus subtilis Ywea	0.091	129	103	69	197	7	120	1.486E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	5fdy-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5fdy-assembly2.cif.gz_B Crystal structure of the Voltage-gated Sodium Channel Beta 2 subunit extracellular domain, C72A/C75A mutant	0.078	133	108	69	201	6	123	6.706E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	4b97-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4b97-assembly1.cif.gz_A Biomass sensing modules from putative Rsgi-like proteins of Clostridium thermocellum resemble family 3 carbohydrate-binding module of cellulosome	0.100	143	109	68	189	3	145	1.257E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	6dfx-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6dfx-assembly1.cif.gz_B human diabetogenic TCR T1D3 in complex with DQ8-p8E9E peptide	0.046	105	69	89	193	125	197	8.864E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	6kru-assembly2.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	6kru-assembly2.cif.gz_C Crystal structure of mouse IgG2b Fc	0.104	133	90	69	201	2	103	7.498E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	5zxv-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	5zxv-assembly2.cif.gz_D Structural definition of a unique neutralization epitope on the receptor-binding domain of MERS-CoV spike glycoprotein	0.071	128	88	68	195	110	205	7.498E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	5y56-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5y56-assembly1.cif.gz_B Fc mutant (K392D/K409D/D399K)	0.112	130	89	68	197	2	102	6.706E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	6b0w-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6b0w-assembly1.cif.gz_L Crystal structure of the anti-circumsporozoite protein 1710 antibody	0.086	128	87	68	195	111	206	7.091E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	7tr4-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	7tr4-assembly1.cif.gz_H MA2-MART1-HLAA0201	0.065	128	89	68	195	115	210	5.998E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	8gv2-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	8gv2-assembly1.cif.gz_B Crystal structure of anti-FX IgG fab without FAST-Ig mutations	0.071	128	88	68	195	113	208	8.864E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	6h5n-assembly2.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	6h5n-assembly2.cif.gz_E Plasmodium falciparum Pfs48/45 C-terminal domain bound to monoclonal antibody 85RF45.1	0.066	125	85	69	193	117	208	8.383E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	5hi5-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	5hi5-assembly1.cif.gz_D Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists	0.071	128	88	68	195	116	211	6.706E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	7jxc-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7jxc-assembly1.cif.gz_L Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology	0.082	125	98	75	199	2	109	5.073E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	6vtu-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6vtu-assembly1.cif.gz_L DH717.1 Fab monomer in complex with man9 glycan	0.064	104	79	88	191	17	101	3.630E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	6mg4-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6mg4-assembly1.cif.gz_B Structure of full-length human lambda-6A light chain JTO	0.071	128	88	68	195	116	211	7.928E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	4zso-assembly1.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	4zso-assembly1.cif.gz_E Crystal structure of a complex between B7-H6, a tumor cell ligand for natural cytotoxicity receptor NKp30, and an inhibitory antibody	0.097	129	85	68	196	122	216	9.373E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	6yjp-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	6yjp-assembly1.cif.gz_C Crystal structure of a complex between glycosylated NKp30 and its deglycosylated tumour ligand B7-H6	0.092	126	89	68	193	122	220	7.498E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	5njd-assembly5.cif.gz_I	LOKIASV2_1517_ESMFold_hypothetical_protein	5njd-assembly5.cif.gz_I Structure of Interleukin 23 in complex with Briakinumab FAb	0.104	125	102	74	198	93	207	1.257E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	5njd-assembly2.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	5njd-assembly2.cif.gz_C Structure of Interleukin 23 in complex with Briakinumab FAb	0.091	109	82	90	198	117	207	1.330E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	5njd-assembly6.cif.gz_K	LOKIASV2_1517_ESMFold_hypothetical_protein	5njd-assembly6.cif.gz_K Structure of Interleukin 23 in complex with Briakinumab FAb	0.104	125	102	74	198	93	207	1.330E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	5mj3-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5mj3-assembly1.cif.gz_A INTERLEUKIN-23 COMPLEX WITH AN ANTAGONISTIC ALPHABODY, CRYSTAL FORM 1	0.096	125	103	74	198	93	207	1.757E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	6efy-assembly1.cif.gz_A-2	LOKIASV2_1517_ESMFold_hypothetical_protein	6efy-assembly1.cif.gz_A-2 Crystal Structure of DIP-Alpha Ig1-3	0.093	125	80	69	193	207	295	3.838E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	7sht-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	7sht-assembly1.cif.gz_D Structure of a partially disrupted IgE high affinity receptor complex bound to an omalizumab variant	0.051	128	91	69	196	4	100	7.498E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	8g04-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	8g04-assembly1.cif.gz_B Structure of signaling thrombopoietin-MPL receptor complex	0.037	129	87	68	196	12	102	1.310E+00	39
LOKIASV2_1517_ESMFold_hypothetical_protein	8dfm-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	8dfm-assembly1.cif.gz_A Ectodomain of full-length wild-type KIT-SCF dimers	0.101	132	85	69	200	179	274	8.383E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	3vta-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	3vta-assembly2.cif.gz_B Crystal Structure of cucumisin, a subtilisin-like endoprotease from Cucumis melo L	0.085	121	82	79	199	504	594	1.965E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	8e72-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	8e72-assembly1.cif.gz_B Treponema lecithinolyticum beta-glucuronidase in complex with a ciprofloxacin-glucuronide conjugate	0.102	128	78	69	196	190	277	5.672E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	6kzb-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6kzb-assembly2.cif.gz_B Transglutaminase2 complexed with calcium	0.093	121	91	88	208	36	136	5.073E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	6nps-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6nps-assembly1.cif.gz_B Crystal structure of GH115 enzyme AxyAgu115A from Amphibacillus xylanus	0.108	114	71	86	199	687	767	2.197E-01	39
LOKIASV2_1517_ESMFold_hypothetical_protein	7ra8-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7ra8-assembly1.cif.gz_L SARS-CoV-2 S glycoprotein in complex with S2X259 Fab	0.115	119	81	75	193	1	93	1.662E-01	38
LOKIASV2_1517_ESMFold_hypothetical_protein	7l2e-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7l2e-assembly1.cif.gz_L Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein	0.093	117	86	77	193	6	101	2.078E-01	38
LOKIASV2_1517_ESMFold_hypothetical_protein	5e5m-assembly4.cif.gz_G	LOKIASV2_1517_ESMFold_hypothetical_protein	5e5m-assembly4.cif.gz_G Crystal structure of mouse CTLA-4 in complex with nanobody	0.071	106	84	88	193	16	106	4.058E-01	38
LOKIASV2_1517_ESMFold_hypothetical_protein	4kkn-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4kkn-assembly1.cif.gz_A Crystal structure of bovine CTLA-4, PSI-NYSGRC-012704	0.115	125	93	69	193	2	107	1.662E-01	38
LOKIASV2_1517_ESMFold_hypothetical_protein	6a69-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6a69-assembly1.cif.gz_B Cryo-EM structure of a P-type ATPase	0.075	129	87	69	197	3	97	7.928E-01	38
LOKIASV2_1517_ESMFold_hypothetical_protein	5ghu-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5ghu-assembly1.cif.gz_A Crystal structure of YadV chaperone at 1.63 Angstrom	0.091	132	95	68	199	2	107	2.746E-01	38
LOKIASV2_1517_ESMFold_hypothetical_protein	6nmv-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6nmv-assembly1.cif.gz_L Non-Blocking Fab 218 anti-SIRP-alpha antibody in complex with SIRP-alpha Variant 1	0.071	128	88	68	195	108	203	9.911E-01	38
LOKIASV2_1517_ESMFold_hypothetical_protein	7rxl-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	7rxl-assembly2.cif.gz_D Fab1488 in complex with the C-terminal alpha-TSR domain of P. falciparum	0.072	128	88	68	195	111	206	8.864E-01	38
LOKIASV2_1517_ESMFold_hypothetical_protein	6moi-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6moi-assembly1.cif.gz_B Dimeric DARPin C_angle_R5 complex with EpoR	0.045	125	88	72	196	14	106	9.373E-01	38
LOKIASV2_1517_ESMFold_hypothetical_protein	6q1k-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6q1k-assembly1.cif.gz_L Inferred intermediate I-7 of the human antibody lineage 652	0.071	129	89	68	196	113	209	7.498E-01	38
LOKIASV2_1517_ESMFold_hypothetical_protein	8x0t-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	8x0t-assembly1.cif.gz_L Frizzled8 CRD in complex with pF8_AC3 Fab	0.065	128	89	68	195	112	207	1.048E+00	38
LOKIASV2_1517_ESMFold_hypothetical_protein	8dfh-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	8dfh-assembly1.cif.gz_L Crystal structure of non-neutralizing / interfering human monoclonal antibody 42C3 Fab in complex with MSP1-19	0.068	125	99	75	199	2	108	5.672E-01	38
LOKIASV2_1517_ESMFold_hypothetical_protein	1ebp-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1ebp-assembly1.cif.gz_A COMPLEX BETWEEN THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP] AND AN AGONIST PEPTIDE [EMP1]	0.062	123	84	70	192	14	104	1.048E+00	38
LOKIASV2_1517_ESMFold_hypothetical_protein	3q6f-assembly4.cif.gz_G	LOKIASV2_1517_ESMFold_hypothetical_protein	3q6f-assembly4.cif.gz_G Crystal structure of Fab of human mAb 2909 specific for quaternary neutralizing epitope of HIV-1 gp120	0.079	128	87	68	195	113	208	1.048E+00	38
LOKIASV2_1517_ESMFold_hypothetical_protein	8dcc-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	8dcc-assembly1.cif.gz_L SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 3 Bound to P2B-2F6 Fab	0.051	131	101	68	198	3	109	8.383E-01	38
LOKIASV2_1517_ESMFold_hypothetical_protein	5m6a-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5m6a-assembly1.cif.gz_A Crystal structure of cardiotoxic Bence-Jones light chain dimer H9	0.077	125	98	75	199	3	109	6.706E-01	38
LOKIASV2_1517_ESMFold_hypothetical_protein	7jxe-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7jxe-assembly1.cif.gz_L Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology	0.082	134	92	68	201	116	216	5.073E-01	38
LOKIASV2_1517_ESMFold_hypothetical_protein	1t4k-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	1t4k-assembly1.cif.gz_B Crystal Structure of Unliganded Aldolase Antibody 93F3 Fab	0.133	130	100	70	199	1	116	5.365E-01	38
LOKIASV2_1517_ESMFold_hypothetical_protein	5mxa-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5mxa-assembly1.cif.gz_A Structure of unbound Interleukin-23	0.068	125	106	74	198	93	207	1.572E-01	38
LOKIASV2_1517_ESMFold_hypothetical_protein	5mzv-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5mzv-assembly1.cif.gz_A IL-23:IL-23R:Nb22E11 complex	0.081	131	104	68	198	94	207	5.365E-01	38
LOKIASV2_1517_ESMFold_hypothetical_protein	4yn3-assembly3.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4yn3-assembly3.cif.gz_A Crystal structure of Cucumisin complex with pro-peptide	0.091	113	74	88	200	515	596	1.572E-01	38
LOKIASV2_1517_ESMFold_hypothetical_protein	7y8i-assembly5.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	7y8i-assembly5.cif.gz_E Crystal structure of sDscam FNIII3 domain, isoform alpha7	0.044	129	81	69	197	9	94	6.342E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	7x4m-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7x4m-assembly1.cif.gz_L Cryo-EM structure of Coxsackievirus B1 mature virion in complex with nAb 8A10 (classified from CVB1 mature virion in complex with 8A10, 2E6 and 9A3)	0.077	113	81	87	199	17	105	7.091E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	3lrh-assembly6.cif.gz_K	LOKIASV2_1517_ESMFold_hypothetical_protein	3lrh-assembly6.cif.gz_K Structure of anti-huntingtin VL domain in complex with huntingtin peptide	0.056	104	79	88	191	16	100	5.672E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	7x96-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	7x96-assembly1.cif.gz_H The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab847	0.099	107	85	87	193	16	110	2.746E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	4h1l-assembly2.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	4h1l-assembly2.cif.gz_E TCR interaction with peptide mimics of nickel offers structural insights in nickel contact allergy	0.082	105	66	89	193	104	176	7.928E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	7rdv-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7rdv-assembly1.cif.gz_A TFH TCR bound to MHC Class II IAd presenting aggrecan epitope	0.089	148	105	48	195	64	179	8.383E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	1i8u-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1i8u-assembly1.cif.gz_A FAMILY 9 CARBOHYDRATE-BINDING MODULE FROM THERMOTOGA MARITIMA XYLANASE 10A	0.121	132	99	75	188	25	156	3.630E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	4k94-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	4k94-assembly1.cif.gz_C Crystal structure of KIT D4D5 fragment in complex with anti-Kit antibody Fab19	0.046	127	84	69	195	104	192	1.385E+00	37
LOKIASV2_1517_ESMFold_hypothetical_protein	5bq7-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5bq7-assembly1.cif.gz_B Crystal structure of chikungunya virus-human Fab 5F-10 fragment	0.057	128	90	68	195	103	198	1.048E+00	37
LOKIASV2_1517_ESMFold_hypothetical_protein	5d72-assembly2.cif.gz_N	LOKIASV2_1517_ESMFold_hypothetical_protein	5d72-assembly2.cif.gz_N Crystal structure of MOR04252, a neutralizing anti-human GM-CSF antibody Fab fragment in complex with human GM-CSF	0.066	128	89	68	195	105	200	1.385E+00	37
LOKIASV2_1517_ESMFold_hypothetical_protein	4uom-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4uom-assembly1.cif.gz_L Electron Cryo-microscopy of Venezuelan Equine Encephalitis Virus TC- 83 in complex with neutralizing antibody Fab F5	0.059	113	88	80	192	3	96	5.672E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	5fhc-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5fhc-assembly1.cif.gz_B Crystal Structure of Protective Human Antibodies 100 and 114 in Complex with Ebola Virus Fusion Glycoprotein (GP)	0.072	128	88	68	195	110	205	1.108E+00	37
LOKIASV2_1517_ESMFold_hypothetical_protein	7tqg-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7tqg-assembly1.cif.gz_L Crystal Structure of IOMA Fab inferred germline	0.073	128	88	68	195	112	207	1.172E+00	37
LOKIASV2_1517_ESMFold_hypothetical_protein	2ql1-assembly1.cif.gz_A-2	LOKIASV2_1517_ESMFold_hypothetical_protein	2ql1-assembly1.cif.gz_A-2 Structural Characterization of a Mutated, ADCC-Enhanced Human Fc Fragment	0.090	132	95	68	199	2	106	1.385E+00	37
LOKIASV2_1517_ESMFold_hypothetical_protein	6txz-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6txz-assembly1.cif.gz_L FAB PART OF M6903 IN COMPLEX WITH HUMAN TIM3	0.065	128	89	68	195	112	207	1.239E+00	37
LOKIASV2_1517_ESMFold_hypothetical_protein	5alc-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5alc-assembly1.cif.gz_L Ticagrelor antidote candidate Fab 72 in complex with ticagrelor	0.065	128	89	68	195	114	209	1.048E+00	37
LOKIASV2_1517_ESMFold_hypothetical_protein	7mfb-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7mfb-assembly1.cif.gz_L Crystal structure of antibody 10E8v4 Fab - light chain H31F variant	0.065	128	89	68	195	114	209	8.864E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	7yi6-assembly2.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	7yi6-assembly2.cif.gz_E bnAb 3D1 in complex with 6-mer HR1 peptide from HCoV-229E S protein	0.078	125	98	75	199	2	108	7.928E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	5c0s-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5c0s-assembly1.cif.gz_L Crystal structure of a generation 4 influenza hemagglutinin stabilized stem in complex with the broadly neutralizing antibody CR6261	0.071	128	88	68	195	114	209	9.373E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	4n0y-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4n0y-assembly1.cif.gz_L Structure of the Hepatitis C Envelope Glycoprotein E1 antigenic region 314-324 bound to the cross-neutralizing antibody IGH526	0.079	128	87	68	195	115	210	8.864E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	8hrd-assembly2.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	8hrd-assembly2.cif.gz_E Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant in complex with IMCAS74 Fab and W14 Fab	0.071	128	88	68	195	116	211	8.864E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	4utb-assembly2.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4utb-assembly2.cif.gz_L Crystal structure of dengue 2 virus envelope glycoprotein in complex with the Fab fragment of the broadly neutralizing human antibody EDE2 A11	0.079	128	87	68	195	116	211	8.864E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	7cko-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7cko-assembly1.cif.gz_B Cryo-EM structure of the human MCT1/Basigin-2 complex in the presence of anti-cancer drug candidate 7ACC2 in the inward-open conformation	0.061	109	74	88	196	99	178	7.091E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	6nis-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6nis-assembly1.cif.gz_L Crystal structure of a human anti-ZIKV-DENV neutralizing antibody MZ24 isolated following ZPIV vaccination	0.065	128	89	68	195	117	212	4.798E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	5mj4-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5mj4-assembly1.cif.gz_A INTERLEUKIN-23 COMPLEX WITH AN ANTAGONISTIC ALPHABODY, CRYSTAL FORM 2	0.085	125	99	74	198	93	201	1.006E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	3d85-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	3d85-assembly1.cif.gz_D Crystal structure of IL-23 in complex with neutralizing FAB	0.090	131	98	68	198	94	202	5.672E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	3duh-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	3duh-assembly2.cif.gz_B Structure of Interleukin-23	0.083	112	79	87	198	118	204	3.433E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	3qwr-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	3qwr-assembly1.cif.gz_A Crystal structure of IL-23 in complex with an adnectin	0.092	130	90	69	198	106	205	2.197E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	6smc-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	6smc-assembly2.cif.gz_D mouse Interleukin-12 subunit beta - p80 homodimer in space group P1	0.077	131	102	68	198	92	203	4.058E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	7r3n-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7r3n-assembly1.cif.gz_B mouse Interleukin-12 subunit beta - p80 homodimer in space group P21 crystal form 3	0.061	127	107	72	198	91	205	5.672E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	5e6w-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5e6w-assembly1.cif.gz_A Re-refinement of the Crystal Structure of the Plexin-Semaphorin-Integrin Domain/Hybrid Domain/I-EGF1 Segment from the Human Integrin b2 Subunit	0.118	110	81	88	197	86	178	1.125E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	8c1b-assembly1.cif.gz_X	LOKIASV2_1517_ESMFold_hypothetical_protein	8c1b-assembly1.cif.gz_X Focused map for structure of IgE bound to the ectodomain of FceRIa	0.066	127	87	69	195	7	100	5.998E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	5uwv-assembly2.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5uwv-assembly2.cif.gz_A Crystal structure of Mycobacterium abscessus L,D-transpeptidase 2	0.118	129	71	69	197	3	83	4.538E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	5mhl-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5mhl-assembly1.cif.gz_A FXIIIa in complex with the inhibitor Mi0621	0.066	128	85	69	196	600	691	4.058E-01	37
LOKIASV2_1517_ESMFold_hypothetical_protein	8ae2-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	8ae2-assembly1.cif.gz_B Cryo-EM structure of full-length human immunoglobulin M - F(ab')2 conformation 5	0.038	127	86	69	195	4	93	1.638E+00	36
LOKIASV2_1517_ESMFold_hypothetical_protein	5xwd-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	5xwd-assembly1.cif.gz_D Crystal structure of the complex of 059-152-Fv and EGFR-ECD	0.039	120	87	78	197	15	106	6.706E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	6cue-assembly1.cif.gz_4	LOKIASV2_1517_ESMFold_hypothetical_protein	6cue-assembly1.cif.gz_4 Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody vFP7.04 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122	0.068	123	101	75	197	2	110	8.383E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	6hhu-assembly1.cif.gz_G	LOKIASV2_1517_ESMFold_hypothetical_protein	6hhu-assembly1.cif.gz_G Structure of the Bacillus anthracis Sap S-layer assembly domain	0.107	124	96	70	193	1	109	1.858E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	6p62-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	6p62-assembly1.cif.gz_H HIV Env BG505 NFL TD+ in complex with antibody E70 fragment antigen binding	0.134	121	89	88	208	16	119	1.965E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	6qx4-assembly1.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	6qx4-assembly1.cif.gz_E Structure of the Bacillus anthracis Sap S-layer assembly domain	0.117	124	95	70	193	1	109	2.078E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	6cdi-assembly1.cif.gz_q	LOKIASV2_1517_ESMFold_hypothetical_protein	6cdi-assembly1.cif.gz_q Cryo-EM structure at 3.6 A resolution of vaccine-elicited antibody vFP16.02 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122	0.096	115	93	69	183	2	105	3.838E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	7cg1-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7cg1-assembly1.cif.gz_A Solution structure of the sensor domain of the anti-sigma factor RsgI4 in Pseudobacteroides cellulosolvens	0.072	125	94	75	199	2	103	2.746E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	3huj-assembly1.cif.gz_G	LOKIASV2_1517_ESMFold_hypothetical_protein	3huj-assembly1.cif.gz_G Crystal structure of human CD1d-alpha-Galactosylceramide in complex with semi-invariant NKT cell receptor	0.097	126	89	68	193	2	101	5.365E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	5d72-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5d72-assembly1.cif.gz_L Crystal structure of MOR04252, a neutralizing anti-human GM-CSF antibody Fab fragment in complex with human GM-CSF	0.065	128	89	68	195	110	205	1.310E+00	36
LOKIASV2_1517_ESMFold_hypothetical_protein	5dj8-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5dj8-assembly1.cif.gz_B Fc Heterodimer Design 7.7 D399M/Y407A + T366V/K409I	0.115	129	88	69	197	2	101	1.310E+00	36
LOKIASV2_1517_ESMFold_hypothetical_protein	5dvm-assembly1.cif.gz_A-2	LOKIASV2_1517_ESMFold_hypothetical_protein	5dvm-assembly1.cif.gz_A-2 Fc Design 20.8.37 B chain homodimer E357D/S364R/Y407A	0.129	129	86	69	197	2	101	9.911E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	5wdu-assembly1.cif.gz_I	LOKIASV2_1517_ESMFold_hypothetical_protein	5wdu-assembly1.cif.gz_I HIV-1 Env BG505 SOSIP.664 H72C-H564C trimer in complex with bNAbs PGT122 Fab, 35O22 Fab and NIH45-46 scFv	0.061	121	86	75	195	112	204	8.383E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	8f6i-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	8f6i-assembly1.cif.gz_D Cryo-EM structure of a Zinc-loaded symmetrical D70A mutant of the YiiP-Fab complex	0.105	109	83	75	183	4	97	5.672E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	3piq-assembly6.cif.gz_K	LOKIASV2_1517_ESMFold_hypothetical_protein	3piq-assembly6.cif.gz_K Crystal structure of human 2909 Fab, a quaternary structure-specific antibody against HIV-1	0.065	128	89	68	195	112	207	7.928E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	4wi3-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4wi3-assembly1.cif.gz_B Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation I253A	0.107	129	88	69	197	2	101	1.465E+00	36
LOKIASV2_1517_ESMFold_hypothetical_protein	4lly-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	4lly-assembly2.cif.gz_D Crystal structure of Pertuzumab Clambda Fab with variable and constant domain redesigns (VRD2 and CRD2) at 1.6A	0.065	128	89	68	195	113	208	5.672E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	4n0u-assembly1.cif.gz_E-2	LOKIASV2_1517_ESMFold_hypothetical_protein	4n0u-assembly1.cif.gz_E-2 Ternary complex between Neonatal Fc receptor, serum albumin and Fc	0.115	130	89	68	197	2	102	1.048E+00	36
LOKIASV2_1517_ESMFold_hypothetical_protein	3g6d-assembly2.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	3g6d-assembly2.cif.gz_L Crystal structure of the complex between CNTO607 Fab and IL-13	0.079	128	87	68	195	113	208	1.048E+00	36
LOKIASV2_1517_ESMFold_hypothetical_protein	6vy4-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6vy4-assembly1.cif.gz_L Crystal structure of Hendra receptor binding protein head domain in complex with human neutralizing antibody HENV-32	0.072	127	87	69	195	115	209	1.048E+00	36
LOKIASV2_1517_ESMFold_hypothetical_protein	4hqq-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4hqq-assembly1.cif.gz_L Crystal structure of RV144-elicited antibody CH58	0.074	125	99	75	199	3	110	6.706E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	6ktr-assembly2.cif.gz_G	LOKIASV2_1517_ESMFold_hypothetical_protein	6ktr-assembly2.cif.gz_G Crystal structure of fibroblast growth factor 19 in complex with Fab	0.072	128	88	68	195	115	210	1.172E+00	36
LOKIASV2_1517_ESMFold_hypothetical_protein	5m6i-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5m6i-assembly1.cif.gz_B Crystal structure of non-cardiotoxic Bence-Jones light chain dimer M8	0.072	127	87	69	195	116	210	8.864E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	5w08-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	5w08-assembly1.cif.gz_H A/Texas/50/2012(H3N2) Influenza hemagglutinin in complex with K03.12 Fab	0.065	128	89	68	195	113	208	1.385E+00	36
LOKIASV2_1517_ESMFold_hypothetical_protein	5w4l-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	5w4l-assembly1.cif.gz_H Crystal structure of the non-neutralizing and ADCC-potent C11-like antibody N12-i3 in complex with HIV-1 clade A/E gp120, the CD4 mimetic M48U1, and the antibody N5-i5.	0.124	128	79	70	197	121	211	3.630E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	6ii8-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6ii8-assembly1.cif.gz_L Crystal structure of H7 hemagglutinin from A/Anhui/1/2013 in complex with a human neutralizing antibody L4B-18	0.075	127	98	77	203	6	112	8.864E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	7kkh-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7kkh-assembly1.cif.gz_A P1A4 Fab in complex with ARS1620	0.058	128	89	68	195	114	209	1.465E+00	36
LOKIASV2_1517_ESMFold_hypothetical_protein	6xlz-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6xlz-assembly1.cif.gz_L Structure of NHP D11A.F2 Fab in complex with 16055 V2b peptide	0.065	128	89	68	195	117	212	1.638E+00	36
LOKIASV2_1517_ESMFold_hypothetical_protein	6bp2-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6bp2-assembly1.cif.gz_L Therapeutic human monoclonal antibody MR191 bound to a marburgvirus glycoprotein	0.079	128	87	68	195	116	211	9.911E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	2w59-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	2w59-assembly1.cif.gz_A STRUCTURE OF AN AVIAN IGY-FC 3-4 FRAGMENT	0.079	131	93	69	199	2	103	1.732E+00	36
LOKIASV2_1517_ESMFold_hypothetical_protein	7xlt-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7xlt-assembly1.cif.gz_L Cryo-EM Structure of R-loop monoclonal antibody S9.6 in recognizing RNA:DNA hybrids	0.079	128	90	68	195	117	215	1.310E+00	36
LOKIASV2_1517_ESMFold_hypothetical_protein	6iea-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6iea-assembly1.cif.gz_L Structure of RVFV Gn and human monoclonal antibody R13	0.065	128	89	68	195	121	216	1.172E+00	36
LOKIASV2_1517_ESMFold_hypothetical_protein	6kn9-assembly3.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	6kn9-assembly3.cif.gz_C Crystal structure of human interleukin 18 receptor beta extracellular domain in complex with an antagonistic scFv	0.028	123	101	74	196	153	257	7.498E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	5njd-assembly4.cif.gz_G	LOKIASV2_1517_ESMFold_hypothetical_protein	5njd-assembly4.cif.gz_G Structure of Interleukin 23 in complex with Briakinumab FAb	0.104	125	102	74	198	93	207	2.197E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	3hmx-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	3hmx-assembly1.cif.gz_A Crystal structure of ustekinumab FAB/IL-12 complex	0.071	125	106	74	198	93	207	3.247E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	5g64-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5g64-assembly1.cif.gz_B The complex between human IgE-Fc and two anti-IgE Fab fragments	0.065	128	90	69	196	3	99	1.732E+00	36
LOKIASV2_1517_ESMFold_hypothetical_protein	4y61-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4y61-assembly1.cif.gz_A Crystal structure of the complex between Slitrk2 LRR1 and PTP delta Ig1-Fn1	0.057	134	97	68	201	105	208	9.911E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	5l7u-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5l7u-assembly1.cif.gz_B Crystal structure of BvGH123 with bound GalNAc	0.064	154	116	69	193	28	181	1.125E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	7vt9-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7vt9-assembly1.cif.gz_B CRYSTAL STRUCTURE AT 3.4 ANGSTROMS RESOLUTION OF Maltodextrin glucosidase, MalZ, FROM Escherichia coli	0.106	121	73	69	189	7	89	5.365E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	5b68-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5b68-assembly1.cif.gz_A Crystal structure of apo amylomaltase from Corynebacterium glutamicum	0.074	107	69	90	196	83	158	7.928E-01	36
LOKIASV2_1517_ESMFold_hypothetical_protein	1tnm-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1tnm-assembly1.cif.gz_A TERTIARY STRUCTURE OF AN IMMUNOGLOBULIN-LIKE DOMAIN FROM THE GIANT MUSCLE PROTEIN TITIN: A NEW MEMBER OF THE I SET	0.075	120	73	79	198	10	89	4.058E-01	35
LOKIASV2_1517_ESMFold_hypothetical_protein	3ie4-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	3ie4-assembly2.cif.gz_B b-glucan binding domain of Drosophila GNBP3 defines a novel family of pattern recognition receptor	0.048	132	90	70	201	5	100	1.239E+00	35
LOKIASV2_1517_ESMFold_hypothetical_protein	1i85-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	1i85-assembly1.cif.gz_D CRYSTAL STRUCTURE OF THE CTLA-4/B7-2 COMPLEX	0.122	128	91	74	201	7	111	4.058E-01	35
LOKIASV2_1517_ESMFold_hypothetical_protein	7su1-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	7su1-assembly1.cif.gz_C Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.106 in complex with CTLA-4	0.109	126	92	68	193	1	104	2.904E-01	35
LOKIASV2_1517_ESMFold_hypothetical_protein	2edn-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	2edn-assembly1.cif.gz_A Solution structure of the first ig-like domain from human Myosin-binding protein C, fast-type	0.086	110	77	88	197	29	113	3.070E-01	35
LOKIASV2_1517_ESMFold_hypothetical_protein	8dpm-assembly1.cif.gz_N	LOKIASV2_1517_ESMFold_hypothetical_protein	8dpm-assembly1.cif.gz_N Structure of EBOV GP lacking the mucin-like domain with 9.20.1A2 Fab and 6D6 scFv bound	0.057	125	102	69	193	3	111	4.538E-01	35
LOKIASV2_1517_ESMFold_hypothetical_protein	7q9m-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	7q9m-assembly1.cif.gz_H Beta-53 fab in complex with SARS-CoV-2 beta-Spike glycoprotein	0.104	122	94	78	199	14	119	2.904E-01	35
LOKIASV2_1517_ESMFold_hypothetical_protein	8fif-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	8fif-assembly1.cif.gz_C A2.3 Nanobody In Complex With Microcystin-LR	0.065	125	98	69	193	3	108	4.058E-01	35
LOKIASV2_1517_ESMFold_hypothetical_protein	2x1w-assembly2.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	2x1w-assembly2.cif.gz_L Crystal Structure of VEGF-C in Complex with Domains 2 and 3 of VEGFR2	0.090	121	77	77	197	108	193	7.091E-01	35
LOKIASV2_1517_ESMFold_hypothetical_protein	5w0d-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	5w0d-assembly1.cif.gz_C Inferred precursor (UCA) of the human antibody lineage K03.12 in complex with influenza hemagglutinin H1 Solomon Islands/03/2006	0.079	128	87	68	195	105	200	1.048E+00	35
LOKIASV2_1517_ESMFold_hypothetical_protein	6avn-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6avn-assembly1.cif.gz_L Crystal structure of unbound anti-HIV antibody Fab PGV19 at 2.5 A	0.064	128	91	68	195	106	203	1.048E+00	35
LOKIASV2_1517_ESMFold_hypothetical_protein	4d2n-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	4d2n-assembly1.cif.gz_C Crystal structure of deglycosylated serum-derived human IgG4 Fc	0.083	131	93	69	199	2	103	1.732E+00	35
LOKIASV2_1517_ESMFold_hypothetical_protein	6w3h-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6w3h-assembly1.cif.gz_A Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys	0.127	129	86	69	197	2	101	1.549E+00	35
LOKIASV2_1517_ESMFold_hypothetical_protein	5w5l-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5w5l-assembly1.cif.gz_A Crystal structure of human IgG1-Sigma Fc fragment	0.090	130	93	66	195	2	104	8.864E-01	35
LOKIASV2_1517_ESMFold_hypothetical_protein	4bsw-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4bsw-assembly1.cif.gz_A Heterodimeric Fc Antibody Azymetric Variant 2	0.127	130	87	68	197	2	102	1.549E+00	35
LOKIASV2_1517_ESMFold_hypothetical_protein	5hvw-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5hvw-assembly1.cif.gz_A Monomeric IgG4 Fc	0.100	130	90	68	197	3	103	1.732E+00	35
LOKIASV2_1517_ESMFold_hypothetical_protein	5m76-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5m76-assembly1.cif.gz_B Crystal structure of cardiotoxic Bence-Jones light chain dimer H10	0.095	136	98	68	203	2	110	6.342E-01	35
LOKIASV2_1517_ESMFold_hypothetical_protein	7u0e-assembly2.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7u0e-assembly2.cif.gz_L Crystal Structure of C13C9 Fab in complex with SARS-CoV-2 S fusion peptide	0.058	127	89	69	195	113	207	1.549E+00	35
LOKIASV2_1517_ESMFold_hypothetical_protein	7dc8-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	7dc8-assembly2.cif.gz_D Crystal structure of Switch Ab Fab and hIL6R in complex with ATP	0.065	128	89	68	195	116	211	1.108E+00	35
LOKIASV2_1517_ESMFold_hypothetical_protein	5wcd-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5wcd-assembly1.cif.gz_L Crystal structure of the broadly neutralizing Influenza A antibody VRC 315 04-1D02 Fab.	0.059	127	87	69	195	118	210	1.172E+00	35
LOKIASV2_1517_ESMFold_hypothetical_protein	7zff-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7zff-assembly1.cif.gz_L Omi-42 Fab	0.028	104	81	88	191	16	99	7.498E-01	35
LOKIASV2_1517_ESMFold_hypothetical_protein	7dc7-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7dc7-assembly1.cif.gz_B Crystal structure of D12 Fab-ATP complex	0.064	132	100	68	199	3	110	1.239E+00	35
LOKIASV2_1517_ESMFold_hypothetical_protein	5njd-assembly2.cif.gz_Q	LOKIASV2_1517_ESMFold_hypothetical_protein	5njd-assembly2.cif.gz_Q Structure of Interleukin 23 in complex with Briakinumab FAb	0.076	111	86	88	198	16	109	8.383E-01	35
LOKIASV2_1517_ESMFold_hypothetical_protein	5xaj-assembly3.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	5xaj-assembly3.cif.gz_D Structural mimicry of the dengue virus envelope glycoprotein revealed by the crystallographic study of an idiotype-anti-idiotype Fab complex.	0.065	128	89	68	195	115	210	1.310E+00	35
LOKIASV2_1517_ESMFold_hypothetical_protein	7rkv-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7rkv-assembly1.cif.gz_L Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C118 (State 1)	0.071	128	88	68	195	117	212	1.172E+00	35
LOKIASV2_1517_ESMFold_hypothetical_protein	8aom-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	8aom-assembly1.cif.gz_A Complex of PD-L1 with VHH1	0.067	127	87	71	197	115	208	1.172E+00	35
LOKIASV2_1517_ESMFold_hypothetical_protein	5kg9-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5kg9-assembly2.cif.gz_B Crystal structure of the gp120 v2 antibody RE505-22 Fab from IGH- and IGK-humanized mouse	0.071	128	88	68	195	121	216	1.310E+00	35
LOKIASV2_1517_ESMFold_hypothetical_protein	7t6v-assembly1.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	7t6v-assembly1.cif.gz_E Structure of the human FPR2-Gi complex with fMLFII	0.084	112	82	69	180	125	215	5.998E-01	35
LOKIASV2_1517_ESMFold_hypothetical_protein	5fqe-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5fqe-assembly2.cif.gz_B The details of glycolipid glycan hydrolysis by the structural analysis of a family 123 glycoside hydrolase from Clostridium perfringens	0.074	120	105	80	193	34	153	4.291E-01	35
LOKIASV2_1517_ESMFold_hypothetical_protein	3vta-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	3vta-assembly1.cif.gz_A Crystal Structure of cucumisin, a subtilisin-like endoprotease from Cucumis melo L	0.075	112	74	88	199	511	591	2.597E-01	35
LOKIASV2_1517_ESMFold_hypothetical_protein	1ggt-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	1ggt-assembly1.cif.gz_B THREE-DIMENSIONAL STRUCTURE OF A TRANSGLUTAMINASE: HUMAN BLOOD COAGULATION FACTOR XIII	0.086	128	112	69	192	26	153	8.864E-01	35
LOKIASV2_1517_ESMFold_hypothetical_protein	6nps-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6nps-assembly1.cif.gz_A Crystal structure of GH115 enzyme AxyAgu115A from Amphibacillus xylanus	0.108	114	71	86	199	697	777	4.798E-01	35
LOKIASV2_1517_ESMFold_hypothetical_protein	4ofk-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4ofk-assembly1.cif.gz_A Crystal Structure of SYG-2 D4	0.109	134	83	69	202	10	103	1.310E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	2e9g-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	2e9g-assembly1.cif.gz_A Solution structure of the alpha adaptinC2 domain from human Adapter-related protein complex 1 gamma 2 subunit	0.067	126	91	68	193	23	121	2.456E-01	34
LOKIASV2_1517_ESMFold_hypothetical_protein	5ktb-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5ktb-assembly1.cif.gz_A Structure of a complex between S. cerevisiae Csm1 and Mam1	0.159	94	68	6	99	6	87	6.608E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	1wic-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1wic-assembly1.cif.gz_A Solution structure of the MSP domain of RIKEN cDNA 6030424E15	0.134	122	86	69	190	11	110	1.757E-01	34
LOKIASV2_1517_ESMFold_hypothetical_protein	7cea-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7cea-assembly1.cif.gz_A Crystal structure of HUTS-4 Fv-clasp fragment	0.110	130	105	69	198	3	121	3.433E-01	34
LOKIASV2_1517_ESMFold_hypothetical_protein	5v43-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5v43-assembly1.cif.gz_B Engineered human IgG Fc domain aglyco801	0.129	130	81	69	198	3	96	1.239E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	4ydj-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4ydj-assembly2.cif.gz_B Crystal structure of broadly and potently neutralizing antibody 44-VRC13.01 in complex with HIV-1 clade AE strain 93TH057 gp120	0.059	127	88	69	195	107	201	2.047E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	8fo3-assembly5.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	8fo3-assembly5.cif.gz_E Structure of full-length amyloidogenic immunoglobulin light chain H9 in complex with (E)-3-nitro-4-(2-(2-phenylpropylidene)hydrazineyl)benzenesulfonamide	0.078	112	84	73	184	1	92	5.998E-01	34
LOKIASV2_1517_ESMFold_hypothetical_protein	4of8-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4of8-assembly2.cif.gz_B Crystal Structure of Rst D1-D2	0.102	130	88	68	197	109	207	1.732E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	6phd-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6phd-assembly1.cif.gz_L Pfs25 in complex with the human transmission blocking antibody 2586	0.071	128	88	68	195	112	207	1.465E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	6b08-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6b08-assembly1.cif.gz_B Crystal structure of Pfs25 in complex with the transmission blocking antibody 1276	0.079	128	87	68	195	113	208	1.549E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	4r2g-assembly1.cif.gz_P	LOKIASV2_1517_ESMFold_hypothetical_protein	4r2g-assembly1.cif.gz_P Crystal Structure of PGT124 Fab bound to HIV-1 JRCSF gp120 core and to CD4	0.078	128	88	68	195	113	208	5.672E-01	34
LOKIASV2_1517_ESMFold_hypothetical_protein	4r90-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4r90-assembly1.cif.gz_L Anti CD70 Llama glama Fab 27B3	0.071	128	88	68	195	114	209	1.549E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	4yc2-assembly2.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	4yc2-assembly2.cif.gz_C Crystal structure of the stabilized inner domain of clade A/E HIV-1 gp120 from E. coli in complex with the antibody A32.	0.050	112	88	88	199	15	108	9.373E-01	34
LOKIASV2_1517_ESMFold_hypothetical_protein	7jmp-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7jmp-assembly1.cif.gz_L Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39	0.068	125	99	75	199	2	108	9.911E-01	34
LOKIASV2_1517_ESMFold_hypothetical_protein	6ss0-assembly2.cif.gz_MMM	LOKIASV2_1517_ESMFold_hypothetical_protein	6ss0-assembly2.cif.gz_MMM Structure of the arginase-2-inhibitory human antigen-binding fragment Fab C0021181	0.096	132	97	68	199	2	109	1.385E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	5t29-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5t29-assembly1.cif.gz_L Crystal structure of 10E8 Fab light chain mutant3, against the MPER region of the HIV-1 Env, in complex with the MPER epitope scaffold T117v2	0.065	128	89	68	195	114	209	1.936E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	6c5v-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6c5v-assembly1.cif.gz_L An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus	0.064	127	88	69	195	116	210	1.385E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	7cho-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7cho-assembly1.cif.gz_L Crystal structure of SARS-CoV-2 antibody P5A-1D2 with RBD	0.065	128	89	68	195	116	211	1.831E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	7lfa-assembly2.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7lfa-assembly2.cif.gz_L Fab 3B6 bound to ApoL1 NTD	0.073	128	88	68	195	115	210	1.831E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	6p95-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6p95-assembly1.cif.gz_L Structure of Lassa virus glycoprotein in complex with Fab 25.6A	0.065	128	89	68	195	115	210	1.385E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	6s5a-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6s5a-assembly1.cif.gz_L CRYSTAL STRUCTURE OF FC P329G LALA WITH ANTI FC P329G FAB	0.073	128	88	68	195	115	210	1.732E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	6e64-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6e64-assembly2.cif.gz_B Crystal structure of malaria transmission-blocking antibody 85RF45.1	0.084	125	98	75	199	3	110	1.239E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	3ixx-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	3ixx-assembly1.cif.gz_H The pseudo-atomic structure of West Nile immature virus in complex with Fab fragments of the anti-fusion loop antibody E53	0.066	127	95	70	196	1	103	5.365E-01	34
LOKIASV2_1517_ESMFold_hypothetical_protein	3mlz-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	3mlz-assembly1.cif.gz_L Crystal structure of anti-HIV-1 V3 Fab 3074 in complex with a VI191 V3 peptide	0.071	128	88	68	195	115	210	1.549E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	6wh9-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	6wh9-assembly1.cif.gz_C Ketoreductase from module 1 of the 6-deoxyerythronolide B synthase (KR1) in complex with antibody fragment (Fab) 1D10	0.094	128	86	68	195	116	211	1.239E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	7so7-assembly2.cif.gz_Y	LOKIASV2_1517_ESMFold_hypothetical_protein	7so7-assembly2.cif.gz_Y Novel structural insights for a pair of monoclonal antibodies recognizing non-overlapping epitopes of the glucosyltransferase domain of Clostridium difficile toxin B	0.090	126	103	74	199	2	115	7.091E-01	34
LOKIASV2_1517_ESMFold_hypothetical_protein	1ky7-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1ky7-assembly1.cif.gz_A THE AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH AMPHIPHYSIN FXDXF	0.086	135	102	59	193	12	124	8.508E-02	34
LOKIASV2_1517_ESMFold_hypothetical_protein	4grw-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4grw-assembly1.cif.gz_B Structure of a complex of human IL-23 with 3 Nanobodies (Llama vHHs)	0.058	112	81	87	198	116	202	5.073E-01	34
LOKIASV2_1517_ESMFold_hypothetical_protein	5lgj-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5lgj-assembly2.cif.gz_B THE CRYSTAL STRUCTURE OF IGE FC MUTANT - P333C	0.045	127	85	69	195	4	93	1.048E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	7n6g-assembly1.cif.gz_3K	LOKIASV2_1517_ESMFold_hypothetical_protein	7n6g-assembly1.cif.gz_3K C1 of central pair	0.125	131	86	68	198	23	121	9.911E-01	34
LOKIASV2_1517_ESMFold_hypothetical_protein	7rno-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	7rno-assembly1.cif.gz_C Model of the Ac-6-FP/hpMR1/bB2m/TAPBPR complex from integrated docking, NMR and restrained MD	0.080	129	87	69	197	283	378	1.310E+00	34
LOKIASV2_1517_ESMFold_hypothetical_protein	6xt9-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6xt9-assembly1.cif.gz_A Subunits BBS 1,4,8,9,18 of the human BBSome complex	0.090	185	127	1	185	408	548	3.838E-01	34
LOKIASV2_1517_ESMFold_hypothetical_protein	7wdu-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7wdu-assembly1.cif.gz_A 6-sulfo-beta-D-N-acetylglucosaminidase from Bifidobacterium bifidum in complex with PUGNAc-6S	0.123	117	96	77	193	708	818	7.928E-01	34
LOKIASV2_1517_ESMFold_hypothetical_protein	6jcs-assembly1.cif.gz_R	LOKIASV2_1517_ESMFold_hypothetical_protein	6jcs-assembly1.cif.gz_R AAV5 in complex with AAVR	0.084	123	82	75	197	6	95	2.597E-01	33
LOKIASV2_1517_ESMFold_hypothetical_protein	3j9f-assembly1.cif.gz_8	LOKIASV2_1517_ESMFold_hypothetical_protein	3j9f-assembly1.cif.gz_8 Poliovirus complexed with soluble, deglycosylated poliovirus receptor (Pvr) at 4 degrees C	0.050	130	90	68	197	3	98	3.025E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	5cn1-assembly5.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	5cn1-assembly5.cif.gz_C Crystal structure of yeast GGA1_GAE domain-P21	0.060	143	98	66	208	8	112	7.498E-01	33
LOKIASV2_1517_ESMFold_hypothetical_protein	4r0l-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	4r0l-assembly1.cif.gz_C Anti-canine CD28 antibody, 1C6, bound canine CD28	0.100	123	93	69	191	2	105	5.365E-01	33
LOKIASV2_1517_ESMFold_hypothetical_protein	4pir-assembly1.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	4pir-assembly1.cif.gz_F X-ray structure of the mouse serotonin 5-HT3 receptor	0.077	135	110	69	203	2	121	2.597E-01	33
LOKIASV2_1517_ESMFold_hypothetical_protein	4bhu-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	4bhu-assembly1.cif.gz_C Crystal structure of BslA - A bacterial hydrophobin	0.075	140	107	69	208	10	126	3.070E-01	33
LOKIASV2_1517_ESMFold_hypothetical_protein	4k9e-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	4k9e-assembly1.cif.gz_C Crystal structure of KIT D4D5 fragment in complex with anti-Kit antibodies Fab79D	0.078	127	79	69	195	103	189	1.831E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	5muh-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5muh-assembly1.cif.gz_A Crystal structure of an amyloidogenic light chain dimer H7	0.079	128	87	68	195	98	193	1.108E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	7ugm-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7ugm-assembly1.cif.gz_L Crystal Structure of BG24-iGL CDR3mat Fab	0.079	128	87	68	195	103	198	1.549E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	4lsu-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4lsu-assembly1.cif.gz_L Crystal structure of broadly and potently neutralizing antibody VRC-PG20 in complex with HIV-1 clade A/E 93TH057 gp120	0.059	128	89	68	195	104	199	1.936E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	7fab-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7fab-assembly1.cif.gz_L CRYSTAL STRUCTURE OF HUMAN IMMUNOGLOBULIN FRAGMENT FAB NEW REFINED AT 2.0 ANGSTROMS RESOLUTION	0.086	111	77	88	198	17	101	1.465E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	1gsm-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1gsm-assembly1.cif.gz_A A reassessment of the MAdCAM-1 structure and its role in integrin recognition.	0.145	132	91	69	200	96	203	8.383E-01	33
LOKIASV2_1517_ESMFold_hypothetical_protein	6uqc-assembly2.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	6uqc-assembly2.cif.gz_F Mouse IgG2a Bispecific Fc	0.111	117	77	83	199	18	105	1.638E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	7zf4-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7zf4-assembly1.cif.gz_L SARS-CoV-2 Omicron RBD in complex with Omi-9 Fab and nanobody F2	0.082	112	82	88	199	16	105	8.864E-01	33
LOKIASV2_1517_ESMFold_hypothetical_protein	6d4e-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6d4e-assembly1.cif.gz_A Crystal Structure of a Fc Fragment of Rhesus macaque (Macaca mulatta) IgG1.	0.092	127	90	69	195	2	101	2.289E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	7ktx-assembly1.cif.gz_J	LOKIASV2_1517_ESMFold_hypothetical_protein	7ktx-assembly1.cif.gz_J Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent	0.106	137	81	70	206	114	205	1.465E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	8dgw-assembly4.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	8dgw-assembly4.cif.gz_F Crystal structure of HCoV-HKU1 spike stem helix peptide in complex with Fab of broadly neutralizing antibody CC95.108 isolated from a vaccinated COVID-19 convalescent	0.072	127	89	69	195	113	209	2.047E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	6q1g-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6q1g-assembly1.cif.gz_L Human antibody H1244 of the human antibody lineage 652	0.071	128	88	68	195	113	208	2.047E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	7rxi-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7rxi-assembly1.cif.gz_L Fab234 in complex with the C-terminal alpha-TSR domain of P. falciparum	0.093	128	86	68	195	114	209	8.864E-01	33
LOKIASV2_1517_ESMFold_hypothetical_protein	6wit-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6wit-assembly1.cif.gz_B Crystal structure of NHP D15.SD7 Fab in complex with 16055 V1V2 1FD6 scaffold	0.105	110	81	88	197	15	105	1.310E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	6fy1-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6fy1-assembly1.cif.gz_L Crystal structure of a V2p-reactive RV144 vaccine-like antibody, CAP228-16H, in complex with a scaffolded autologous V1V2	0.079	128	87	68	195	112	207	1.048E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	3t2n-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	3t2n-assembly1.cif.gz_L Human hepsin protease in complex with the Fab fragment of an inhibitory antibody	0.079	128	87	68	195	115	210	1.936E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	7beh-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7beh-assembly1.cif.gz_L Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab	0.060	125	101	75	199	2	109	1.108E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	8d36-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	8d36-assembly1.cif.gz_L Crystal structure of SARS-CoV-2 fusion peptide in complex with neutralizing antibody COV44-62	0.073	128	88	68	195	116	211	1.936E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	5gzn-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5gzn-assembly1.cif.gz_L Structure of neutralizing antibody bound to Zika envelope protein	0.065	128	89	68	195	116	211	1.831E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	4ris-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4ris-assembly1.cif.gz_L Structural Analysis of the Unmutated Ancestor of the HIV-1 Envelope V2 Region Antibody CH58 Isolated From an RV144 HIV-1 Vaccine Efficacy Trial Vaccinee and Associated with Decreased Transmission Risk	0.100	124	95	75	198	3	109	1.385E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	6fy3-assembly2.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6fy3-assembly2.cif.gz_L Crystal structure of a V2-directed, RV144 vaccine-like antibody from HIV-1 infection, CAP228-3D, bound to a heterologous V2 peptide	0.079	128	87	68	195	118	213	9.911E-01	33
LOKIASV2_1517_ESMFold_hypothetical_protein	7jxd-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	7jxd-assembly2.cif.gz_D Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology	0.065	128	89	68	195	117	212	1.638E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	2w59-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	2w59-assembly1.cif.gz_B STRUCTURE OF AN AVIAN IGY-FC 3-4 FRAGMENT	0.076	131	91	69	199	2	101	1.108E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	5wcc-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5wcc-assembly2.cif.gz_B Crystal structure of the broadly neutralizing Influenza A antibody VRC 315 02-1F07 Fab.	0.085	122	88	78	199	13	109	1.172E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	7m7w-assembly2.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	7m7w-assembly2.cif.gz_F Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape	0.058	128	89	68	195	117	212	2.047E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	6oo0-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6oo0-assembly1.cif.gz_L Crystal structure of bovine Fab NC-Cow1	0.066	127	88	69	195	116	210	2.047E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	6w7s-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6w7s-assembly1.cif.gz_L Ketoreductase from module 1 of the 6-deoxyerythronolide B synthase (KR1) in complex with antibody fragment (Fab) 2G10	0.073	127	87	69	195	120	214	7.928E-01	33
LOKIASV2_1517_ESMFold_hypothetical_protein	5tud-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	5tud-assembly1.cif.gz_C Structural Insights into the Extracellular Recognition of the Human Serotonin 2B Receptor by an Antibody	0.082	115	103	87	201	16	128	9.373E-01	33
LOKIASV2_1517_ESMFold_hypothetical_protein	7wg3-assembly1.cif.gz_I	LOKIASV2_1517_ESMFold_hypothetical_protein	7wg3-assembly1.cif.gz_I Structural basis of interleukin-17B receptor in complex with a neutralizing antibody D9 for guiding humanization and affinity maturation for cancer therapy	0.096	130	99	68	197	30	139	3.630E-01	33
LOKIASV2_1517_ESMFold_hypothetical_protein	7pur-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7pur-assembly1.cif.gz_A mouse Interleukin-12 subunit beta - p80 homodimer in space group P21 crystal form 2	0.054	131	105	68	198	94	205	4.058E-01	33
LOKIASV2_1517_ESMFold_hypothetical_protein	4b60-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4b60-assembly1.cif.gz_A Structure of rFnBPA(189-505) in complex with fibrinogen gamma chain C- terminal peptide	0.142	139	112	66	197	4	142	2.904E-01	33
LOKIASV2_1517_ESMFold_hypothetical_protein	5g64-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5g64-assembly1.cif.gz_A The complex between human IgE-Fc and two anti-IgE Fab fragments	0.083	127	87	69	195	4	99	1.172E+00	33
LOKIASV2_1517_ESMFold_hypothetical_protein	6lxh-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	6lxh-assembly1.cif.gz_C Staphylococcus aureus surface protein-sdrc	0.095	151	120	66	199	5	155	3.070E-01	33
LOKIASV2_1517_ESMFold_hypothetical_protein	5fqh-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5fqh-assembly1.cif.gz_A The details of glycolipid glycan hydrolysis by the structural analysis of a family 123 glycoside hydrolase from Clostridium perfringens	0.077	128	112	80	201	34	161	9.911E-01	33
LOKIASV2_1517_ESMFold_hypothetical_protein	3mnm-assembly3.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	3mnm-assembly3.cif.gz_C Crystal structure of GAE domain of GGA2p from Saccharomyces cerevisiae	0.107	125	79	69	193	14	102	5.365E-01	32
LOKIASV2_1517_ESMFold_hypothetical_protein	5jqh-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	5jqh-assembly2.cif.gz_D Structure of beta2 adrenoceptor bound to carazolol and inactive-state stabilizing nanobody, Nb60	0.091	125	97	69	193	2	109	6.342E-01	32
LOKIASV2_1517_ESMFold_hypothetical_protein	8e6k-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	8e6k-assembly1.cif.gz_H 2H08 Fab in complex with influenza virus neuraminidase from A/Brevig Mission/1/1918 (H1N1)	0.046	103	87	88	190	17	108	5.073E-01	32
LOKIASV2_1517_ESMFold_hypothetical_protein	6oil-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6oil-assembly1.cif.gz_A Crystal structure of human VISTA extracellular domain	0.100	143	123	69	206	3	145	3.433E-01	32
LOKIASV2_1517_ESMFold_hypothetical_protein	3n4x-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	3n4x-assembly1.cif.gz_A Structure of Csm1 full-length	0.166	90	64	6	95	9	86	9.235E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	3v6b-assembly1.cif.gz_R-2	LOKIASV2_1517_ESMFold_hypothetical_protein	3v6b-assembly1.cif.gz_R-2 VEGFR-2/VEGF-E complex structure	0.094	133	81	69	201	96	185	1.108E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	2wv3-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	2wv3-assembly1.cif.gz_A Neuroplastin-55 binds to and signals through the fibroblast growth factor receptor	0.079	133	90	68	200	90	188	1.239E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	5mtl-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5mtl-assembly1.cif.gz_B Crystal structure of an amyloidogenic light chain	0.072	128	88	68	195	102	197	1.465E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	2ykl-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	2ykl-assembly1.cif.gz_L Structure of human anti-nicotine Fab fragment in complex with nicotine-11-yl-methyl-(4-ethylamino-4-oxo)-butanoate	0.080	120	75	76	195	117	199	1.385E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	8fab-assembly2.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	8fab-assembly2.cif.gz_C CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE HUMAN MYELOMA IMMUNOGLOBULIN IGG HIL AT 1.8 ANGSTROMS RESOLUTION	0.085	125	86	75	199	10	104	1.549E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	5cex-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5cex-assembly1.cif.gz_A Crystal Structure of Fab 32H+109L, a putative precursor of the PGT121 family of potent HIV-1 antibodies	0.065	128	89	68	195	110	205	1.732E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	7aj6-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7aj6-assembly1.cif.gz_L LN02 Fab	0.066	128	89	68	195	113	208	2.559E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	7x8p-assembly2.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	7x8p-assembly2.cif.gz_E Frizzled 2 CRD in complex with pF7_A5 Fab	0.065	128	89	68	195	112	207	1.172E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	8fo4-assembly2.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	8fo4-assembly2.cif.gz_C Structure of full-length amyloidogenic immunoglobulin light chain H9 in complex with 6-methyl-2-(2-((1E,2E)-3-(2-nitrophenyl)allylidene)hydrazineyl)pyrimidin-4-ol	0.079	128	87	68	195	113	208	1.048E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	4hk0-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	4hk0-assembly2.cif.gz_D UCA Fab (unbound) from CH65-CH67 Lineage	0.073	128	88	68	195	114	209	2.706E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	4qf1-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4qf1-assembly2.cif.gz_B Crystal structure of unliganded CH59UA, the inferred unmutated ancestor of the RV144 anti-HIV antibody lineage producing CH59	0.079	128	87	68	195	114	209	1.936E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	7s5p-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7s5p-assembly1.cif.gz_L Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibody CS23	0.071	128	88	68	195	113	208	1.831E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	6fg2-assembly2.cif.gz_G	LOKIASV2_1517_ESMFold_hypothetical_protein	6fg2-assembly2.cif.gz_G CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84.	0.071	128	90	68	195	112	209	1.172E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	4npy-assembly2.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4npy-assembly2.cif.gz_A Crystal structure of germline Fab PGT121, a putative precursor of the broadly reactive and potent HIV-1 neutralizing antibody	0.071	128	88	68	195	115	210	2.165E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	5ukn-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5ukn-assembly1.cif.gz_L Structure of unliganded anti-gp120 CD4bs antibody DH522UCA Fab	0.058	128	89	68	195	114	209	2.559E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	5d1x-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5d1x-assembly1.cif.gz_B IsdB NEAT2 bound by D4-30	0.114	129	78	68	196	122	210	1.310E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	8ek6-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	8ek6-assembly1.cif.gz_L UCA Y35N (unbound) Fab from CH65-CH67 lineage	0.071	128	88	68	195	114	209	1.831E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	5iq7-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5iq7-assembly1.cif.gz_L Crystal structure of 10E8-S74W Fab in complex with an HIV-1 gp41 peptide.	0.066	128	89	68	195	114	209	2.420E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	5mud-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5mud-assembly1.cif.gz_B Crystal structure of an amyloidogenic light chain dimer H6	0.079	128	87	68	195	115	210	1.172E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	4rnr-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	4rnr-assembly2.cif.gz_D Crystal structure of broadly neutralizing anti-HIV antibody PGT130	0.073	128	88	68	195	114	209	2.861E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	6j6y-assembly2.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	6j6y-assembly2.cif.gz_F FGFR4 D2 - Fab complex	0.075	116	81	78	193	13	101	5.672E-01	32
LOKIASV2_1517_ESMFold_hypothetical_protein	7myt-assembly2.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7myt-assembly2.cif.gz_L Crystal Structure of HPV L1-directed B25.M05 Fab	0.086	112	85	88	199	17	110	1.732E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	3ghe-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	3ghe-assembly1.cif.gz_L Crystal structure of anti-HIV-1 Fab 537-10D in complex with V3 peptide MN	0.071	128	88	68	195	117	212	2.165E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	4gxv-assembly2.cif.gz_M	LOKIASV2_1517_ESMFold_hypothetical_protein	4gxv-assembly2.cif.gz_M Crystal structure of anti-influenza virus antibody 1F1	0.051	127	87	69	195	120	212	1.549E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	6mty-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6mty-assembly1.cif.gz_L Crystal structure of a human anti-ZIKV-DENV neutralizing antibody MZ4 isolated following ZPIV vaccination	0.090	127	98	75	201	3	111	7.498E-01	32
LOKIASV2_1517_ESMFold_hypothetical_protein	5oca-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5oca-assembly1.cif.gz_L PCSK9:Fab Complex with Dextran Sulfate	0.065	128	89	68	195	117	212	2.047E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	3omz-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	3omz-assembly1.cif.gz_A Crystal structure of MICA-specific human gamma delta T cell receptor	0.114	106	77	88	193	118	205	5.073E-01	32
LOKIASV2_1517_ESMFold_hypothetical_protein	7czt-assembly1.cif.gz_M	LOKIASV2_1517_ESMFold_hypothetical_protein	7czt-assembly1.cif.gz_M S protein of SARS-CoV-2 in complex bound with P5A-2G9	0.139	125	97	75	199	3	116	1.048E+00	32
LOKIASV2_1517_ESMFold_hypothetical_protein	1hxm-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	1hxm-assembly1.cif.gz_B Crystal Structure of a Human Vgamma9/Vdelta2 T Cell Receptor	0.101	126	101	68	193	1	113	6.342E-01	32
LOKIASV2_1517_ESMFold_hypothetical_protein	4dkd-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	4dkd-assembly1.cif.gz_C Crystal Structure of Human Interleukin-34 Bound to Human CSF-1R	0.068	126	80	68	193	181	267	9.911E-01	32
LOKIASV2_1517_ESMFold_hypothetical_protein	5vl3-assembly1.cif.gz_Q	LOKIASV2_1517_ESMFold_hypothetical_protein	5vl3-assembly1.cif.gz_Q CD22 d1-d3 in complex with therapeutic Fab Epratuzumab	0.051	128	88	69	196	119	212	5.672E-01	32
LOKIASV2_1517_ESMFold_hypothetical_protein	6lxs-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6lxs-assembly1.cif.gz_A CWA protein-SdrC	0.090	151	121	66	199	5	155	4.538E-01	32
LOKIASV2_1517_ESMFold_hypothetical_protein	6leb-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6leb-assembly1.cif.gz_B Staphylococcus aureus surface protein SdrC mutant-P366H	0.073	135	103	84	195	166	300	5.672E-01	32
LOKIASV2_1517_ESMFold_hypothetical_protein	5lgj-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5lgj-assembly1.cif.gz_A THE CRYSTAL STRUCTURE OF IGE FC MUTANT - P333C	0.086	127	85	69	195	7	100	7.498E-01	32
LOKIASV2_1517_ESMFold_hypothetical_protein	7tfo-assembly1.cif.gz_J	LOKIASV2_1517_ESMFold_hypothetical_protein	7tfo-assembly1.cif.gz_J Cryo-EM structure of HIV-1 Env trimer BG505 SOSIP.664 in complex with CD4bs antibody Ab1573	0.109	106	75	88	193	16	100	4.291E-01	31
LOKIASV2_1517_ESMFold_hypothetical_protein	3mnm-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	3mnm-assembly1.cif.gz_A Crystal structure of GAE domain of GGA2p from Saccharomyces cerevisiae	0.116	141	96	68	208	1	110	3.070E-01	31
LOKIASV2_1517_ESMFold_hypothetical_protein	6dbd-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6dbd-assembly2.cif.gz_B Crystal Structure of VHH R326	0.074	129	101	69	197	4	113	1.465E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	5tru-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	5tru-assembly1.cif.gz_C Structure of the first-in-class checkpoint inhibitor Ipilimumab bound to human CTLA-4	0.103	125	91	69	193	4	105	7.091E-01	31
LOKIASV2_1517_ESMFold_hypothetical_protein	7q9j-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	7q9j-assembly1.cif.gz_H Beta-26 fab in complex with SARS-CoV-2 beta-Spike glycoprotein	0.061	135	110	69	203	2	119	7.928E-01	31
LOKIASV2_1517_ESMFold_hypothetical_protein	4pgz-assembly1.cif.gz_C-2	LOKIASV2_1517_ESMFold_hypothetical_protein	4pgz-assembly1.cif.gz_C-2 Structural basis of KIT activation by oncogenic mutations in the extracellular region reveals a zipper-like mechanism for ligand-dependent or oncogenic receptor tyrosine kinase activation	0.057	129	88	69	197	7	100	1.172E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	8dc0-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	8dc0-assembly1.cif.gz_A Rat Betaglycan Zona Pellucida Domain (ZPC) in complex with mini monomer TGFb2 (mmTGF-b2-7M2R)	0.077	99	87	88	186	28	122	7.498E-01	31
LOKIASV2_1517_ESMFold_hypothetical_protein	3sdx-assembly2.cif.gz_G	LOKIASV2_1517_ESMFold_hypothetical_protein	3sdx-assembly2.cif.gz_G Crystal structure of human autoreactive-Valpha24 NKT TCR in complex with CD1d-beta-galactosylceramide	0.080	106	79	88	193	17	103	1.465E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	4pgz-assembly2.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4pgz-assembly2.cif.gz_A Structural basis of KIT activation by oncogenic mutations in the extracellular region reveals a zipper-like mechanism for ligand-dependent or oncogenic receptor tyrosine kinase activation	0.072	125	82	69	193	106	194	1.465E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	3pxh-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	3pxh-assembly1.cif.gz_A Tandem Ig domains of tyrosine phosphatase LAR	0.044	110	71	88	197	20	94	1.108E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	6d7g-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	6d7g-assembly1.cif.gz_D Structure of 5F3 TCR in complex with HLA-A2/MART-1	0.067	126	97	68	193	1	105	8.864E-01	31
LOKIASV2_1517_ESMFold_hypothetical_protein	5c7x-assembly2.cif.gz_N	LOKIASV2_1517_ESMFold_hypothetical_protein	5c7x-assembly2.cif.gz_N Crystal structure of MOR04357, a neutralizing anti-human GM-CSF antibody Fab fragment in complex with human GM-CSF	0.071	128	88	68	195	105	200	2.420E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	4hkx-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4hkx-assembly1.cif.gz_B Influenza hemagglutinin in complex with CH67 Fab	0.071	128	88	68	195	104	199	2.559E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	5jik-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5jik-assembly1.cif.gz_B Crystal structure of HER2 binding IgG1-Fc (Fcab H10-03-6)	0.128	129	86	69	197	2	101	2.706E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	5gkr-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	5gkr-assembly2.cif.gz_D Crystal structure of SLE patient-derived anti-DNA antibody in complex with oligonucleotide	0.080	127	86	69	195	111	205	2.420E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	6bz4-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6bz4-assembly1.cif.gz_A Human IgG1 lacking complement-dependent cytotoxicity: hu3S193 Fc mutant K322A	0.086	127	90	69	195	2	101	3.782E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	7q3p-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	7q3p-assembly1.cif.gz_C Crystal structure of IgG1-Fc-MST-HN (efgartigimod)	0.090	131	94	69	199	2	105	3.782E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	3uji-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	3uji-assembly1.cif.gz_L Crystal structure of anti-HIV-1 V3 Fab 2558 in complex with MN peptide	0.071	128	88	68	195	112	207	2.047E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	4x98-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4x98-assembly1.cif.gz_A Immunoglobulin Fc heterodimer variant	0.115	129	88	69	197	2	101	2.420E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	5y2k-assembly4.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	5y2k-assembly4.cif.gz_H A human antibody AF4H1L1	0.079	128	87	68	195	111	206	2.047E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	5mvg-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5mvg-assembly1.cif.gz_B Crystal structure of non-amyloidogenic light chain dimer M7	0.079	128	87	68	195	112	207	2.420E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	3omz-assembly2.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	3omz-assembly2.cif.gz_C Crystal structure of MICA-specific human gamma delta T cell receptor	0.078	106	80	88	193	112	199	5.365E-01	31
LOKIASV2_1517_ESMFold_hypothetical_protein	6wtu-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	6wtu-assembly1.cif.gz_C Plasmodium vivax reticulocyte binding protein 2b (PvRBP2b) bound to human monoclonal antibody 273264	0.071	128	88	68	195	113	208	2.289E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	5y9k-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5y9k-assembly1.cif.gz_L Structure of the belimumab Fab fragment	0.071	128	88	68	195	112	207	2.047E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	5alb-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5alb-assembly1.cif.gz_L Ticagrelor antidote candidate MEDI2452 in complex with ticagrelor	0.105	124	94	75	198	2	107	1.310E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	5cck-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5cck-assembly1.cif.gz_L Crystal structure of Human anti-HIV-1 broadly neutralizing antibody 3BC315 Fab	0.061	125	100	75	199	2	108	1.465E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	6d2p-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6d2p-assembly1.cif.gz_L Crystal structure of IOMA-class CLK31 Fab from an HIV-1 naive donor in complex with a germline-targeting gp120 engineered outer domain eOD-GT8 at 2.6 A	0.065	128	89	68	195	112	207	2.289E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	6dla-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6dla-assembly1.cif.gz_L Crystal structures of an influenza A hemagglutinin antibody Fab CH65:7969d2	0.066	127	88	69	195	114	208	3.025E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	8fo3-assembly6.cif.gz_K	LOKIASV2_1517_ESMFold_hypothetical_protein	8fo3-assembly6.cif.gz_K Structure of full-length amyloidogenic immunoglobulin light chain H9 in complex with (E)-3-nitro-4-(2-(2-phenylpropylidene)hydrazineyl)benzenesulfonamide	0.085	126	96	74	199	2	107	1.638E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	3wn5-assembly2.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	3wn5-assembly2.cif.gz_E Crystal structure of asymmetrically engineered Fc variant in complex with FcgRIIIa	0.118	131	89	69	199	4	105	1.936E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	6blh-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6blh-assembly1.cif.gz_L RSV G central conserved region bound to Fab CB017.5	0.073	128	88	68	195	114	209	2.706E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	5n4j-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5n4j-assembly1.cif.gz_L human Fab fragment 10C3 against NHBA from Neisseria meningitidis	0.079	128	87	68	195	115	210	2.861E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	7sjs-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7sjs-assembly1.cif.gz_L Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CC40.8	0.073	128	88	68	195	114	209	3.577E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	5whj-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5whj-assembly1.cif.gz_L Crystal structure of Fab fragment of anti-FcRn antibody DX-2507	0.066	127	88	69	195	116	210	2.047E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	5wl2-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5wl2-assembly2.cif.gz_B VH1-69 germline antibody with CDR H3 sequence of CR9114	0.065	128	89	68	195	114	209	2.706E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	6azz-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6azz-assembly2.cif.gz_B Crystal structure of Pfs25 in complex with the transmission blocking antibody 1190	0.072	128	88	68	195	115	210	1.831E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	8f2j-assembly4.cif.gz_J	LOKIASV2_1517_ESMFold_hypothetical_protein	8f2j-assembly4.cif.gz_J Crystal structure of antibody WRAIR-2134 in complex with SARS-CoV-2 receptor binding domain	0.065	128	89	68	195	114	209	2.559E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	4ocs-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4ocs-assembly1.cif.gz_L Crystal structure of human Fab CAP256-VRC26.10, a potent V1V2-directed HIV-1 neutralizing antibody	0.057	127	87	69	195	118	210	1.831E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	4hpy-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4hpy-assembly1.cif.gz_L Crystal structure of RV144-elicited antibody CH59 in complex with V2 peptide	0.079	128	87	68	195	115	210	1.936E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	6mol-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6mol-assembly1.cif.gz_B Monoextended DARPin M_R12 complex with EpoR	0.040	119	83	74	192	17	103	2.559E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	1rzf-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	1rzf-assembly1.cif.gz_L Crystal structure of Human anti-HIV-1 GP120-reactive antibody E51	0.078	132	100	68	199	3	111	1.831E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	8d3a-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	8d3a-assembly1.cif.gz_L Crystal Structure of DH475 Fab in complex with Man9	0.065	128	89	68	195	117	212	3.025E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	6m3b-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6m3b-assembly1.cif.gz_B hAPC-c25k23 Fab complex	0.083	132	99	68	199	2	110	1.936E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	5m6a-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5m6a-assembly1.cif.gz_B Crystal structure of cardiotoxic Bence-Jones light chain dimer H9	0.052	111	87	88	198	16	108	2.047E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	7mzh-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7mzh-assembly1.cif.gz_L SARS-CoV-2 receptor binding domain bound to Fab WCSL 119	0.058	127	87	69	195	118	210	1.385E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	4ot1-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4ot1-assembly1.cif.gz_L Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by the Neutralizing Human Antibody SM5-1	0.059	128	89	68	195	115	210	3.577E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	3ay4-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	3ay4-assembly1.cif.gz_B Crystal structure of nonfucosylated Fc complexed with bis-glycosylated soluble form of Fc gamma receptor IIIa	0.121	131	89	67	197	8	109	2.559E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	1dcl-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	1dcl-assembly1.cif.gz_B MCG, A LAMBDA V TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN), CRYSTALLIZED FROM AMMONIUM SULFATE	0.059	128	89	68	195	116	211	1.831E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	3ffd-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	3ffd-assembly1.cif.gz_B Structure of parathyroid hormone-related protein complexed to a neutralizing monoclonal antibody	0.066	128	88	68	195	121	215	3.199E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	4fmk-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4fmk-assembly1.cif.gz_A Crystal structure of mouse nectin-2 extracellular fragment D1-D2	0.090	119	76	79	197	131	215	1.385E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	5t6l-assembly2.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5t6l-assembly2.cif.gz_A Crystal structure of 10E8 Fab in complex with the MPER epitope scaffold T117v2	0.107	128	79	70	197	133	221	9.373E-01	31
LOKIASV2_1517_ESMFold_hypothetical_protein	3lrs-assembly3.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	3lrs-assembly3.cif.gz_C Structure of PG16, an antibody with broad and potent neutralization of HIV-1	0.152	136	85	64	199	128	228	5.672E-01	31
LOKIASV2_1517_ESMFold_hypothetical_protein	2vj0-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	2vj0-assembly1.cif.gz_A Crystal structure of the alpha-adaptin appendage domain, from the AP2 adaptor complex, in complex with an FXDNF peptide from amphiphysin1 and a WVXF peptide from synaptojanin P170	0.089	141	107	58	198	10	128	2.078E-01	31
LOKIASV2_1517_ESMFold_hypothetical_protein	5vkj-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5vkj-assembly1.cif.gz_A Crystal structure of human CD22 Ig domains 1-3	0.043	128	89	69	196	129	222	7.928E-01	31
LOKIASV2_1517_ESMFold_hypothetical_protein	8dfm-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	8dfm-assembly1.cif.gz_B Ectodomain of full-length wild-type KIT-SCF dimers	0.101	126	76	78	203	192	276	2.559E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	6tn6-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6tn6-assembly1.cif.gz_A X-ray structure of the endo-beta-1,4-mannanase from Thermotoga petrophila	0.065	106	64	88	193	389	457	1.385E+00	31
LOKIASV2_1517_ESMFold_hypothetical_protein	7xj9-assembly1.cif.gz_K	LOKIASV2_1517_ESMFold_hypothetical_protein	7xj9-assembly1.cif.gz_K Local refinement of the SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab	0.117	108	84	88	195	17	112	9.373E-01	30
LOKIASV2_1517_ESMFold_hypothetical_protein	2dwy-assembly3.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	2dwy-assembly3.cif.gz_C Crystal Structure Analysis of GGA1-GAE	0.058	141	102	68	208	15	123	9.911E-01	30
LOKIASV2_1517_ESMFold_hypothetical_protein	3s4s-assembly1.cif.gz_G	LOKIASV2_1517_ESMFold_hypothetical_protein	3s4s-assembly1.cif.gz_G Crystal structure of CD4 mutant bound to HLA-DR1	0.090	133	69	69	201	100	176	1.310E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	6v19-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6v19-assembly1.cif.gz_B immune receptor complex	0.083	106	65	88	193	106	177	2.420E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	5cus-assembly4.cif.gz_O	LOKIASV2_1517_ESMFold_hypothetical_protein	5cus-assembly4.cif.gz_O Crystal Structure of sErbB3-Fab3379 Complex	0.061	106	79	88	193	16	100	8.383E-01	30
LOKIASV2_1517_ESMFold_hypothetical_protein	4qgt-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4qgt-assembly1.cif.gz_A The Crystal Structure of Human IgG Fc Domain with Enhanced Aromatic Sequon	0.086	127	89	69	195	2	99	2.289E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	1h3u-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	1h3u-assembly1.cif.gz_B CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (M3N2F)2	0.065	127	91	69	195	3	100	3.383E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	7rew-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7rew-assembly1.cif.gz_L Crystal Structure of IL-13 in complex with MMAb3 Fab	0.050	111	84	88	198	17	105	1.638E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	5vaa-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5vaa-assembly1.cif.gz_B Crystal structure of mouse IgG2a Fc T370K mutant	0.104	131	92	69	199	2	105	3.782E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	7lur-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7lur-assembly1.cif.gz_B Stable Effector Functionless 2 (SEFL2) IgG1 Fc Scaffold Bound to a Minimized Version of the B-domain (Mini-Z) from Protein A Called Z34C	0.076	131	95	69	199	2	105	4.728E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	3gbm-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	3gbm-assembly1.cif.gz_L Crystal Structure of Fab CR6261 in Complex with a H5N1 influenza virus hemagglutinin.	0.069	125	89	69	193	2	98	1.385E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	4jy6-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4jy6-assembly1.cif.gz_A Crystal structure of human Fab PGT123, a broadly reactive and potent HIV-1 neutralizing antibody	0.066	128	89	68	195	111	206	3.025E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	7kq7-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7kq7-assembly1.cif.gz_B Crystal structure of IL21R in complex with an antibody Fab fragment	0.072	133	86	75	207	2	95	1.172E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	7mlh-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7mlh-assembly1.cif.gz_A Crystal structure of human IgE (2F10) in complex with Der p 2.0103	0.072	128	88	68	195	112	207	3.782E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	7ox2-assembly4.cif.gz_K	LOKIASV2_1517_ESMFold_hypothetical_protein	7ox2-assembly4.cif.gz_K Fab 6E2: hIL-9 complex	0.064	128	89	68	195	112	207	2.706E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	6x3i-assembly1.cif.gz_A-2	LOKIASV2_1517_ESMFold_hypothetical_protein	6x3i-assembly1.cif.gz_A-2 NNAS Fc mutant	0.114	129	88	69	197	3	102	3.383E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	7lyw-assembly3.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7lyw-assembly3.cif.gz_L Crystal structure of the HCMV pentamer-specific antibody 2-25	0.068	111	82	88	198	17	105	2.047E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	6q1e-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6q1e-assembly1.cif.gz_L Inferred precursor (UCA) of the human antibody lineage 652	0.086	122	87	78	199	13	108	1.108E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	6wib-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6wib-assembly1.cif.gz_A Next generation monomeric IgG4 Fc	0.071	127	92	69	195	4	103	3.999E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	6b5p-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6b5p-assembly1.cif.gz_L Structure of PfCSP peptide 20 with human antibody CIS42	0.079	128	87	68	195	115	210	1.549E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	6db5-assembly2.cif.gz_M	LOKIASV2_1517_ESMFold_hypothetical_protein	6db5-assembly2.cif.gz_M Crystal structure of anti-HIV-1 V3 Fab TA6 in complex with a HIV-1 gp120 V3 peptide from NY5 strain	0.051	128	90	68	195	114	209	3.199E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	7kn4-assembly2.cif.gz_N	LOKIASV2_1517_ESMFold_hypothetical_protein	7kn4-assembly2.cif.gz_N Crystal structure of SARS-CoV-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody S-E6 Fab	0.102	131	95	68	198	2	108	2.420E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	4ocw-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4ocw-assembly1.cif.gz_L Crystal structure of human Fab CAP256-VRC26.06, a potent V1V2-directed HIV-1 neutralizing antibody	0.072	128	90	68	195	112	209	2.289E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	7tp4-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7tp4-assembly1.cif.gz_L Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K398.22	0.042	112	87	88	199	17	108	2.420E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	7x08-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7x08-assembly1.cif.gz_L S protein of SARS-CoV-2 in complex with 2G1	0.067	110	89	90	199	15	110	1.385E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	7bxa-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7bxa-assembly1.cif.gz_B Crystal structure of PD-1 in complex with tislelizumab Fab	0.091	128	105	70	197	1	117	1.108E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	4dix-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4dix-assembly2.cif.gz_B Crystal structure of the Ig-PH domain of actin-binding protein SCAB1	0.115	128	75	75	202	4	89	1.638E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	6oc7-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6oc7-assembly1.cif.gz_L HMP42 Fab in complex with Protein G	0.079	128	87	68	195	112	207	1.638E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	6be4-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6be4-assembly1.cif.gz_L Crystal structure of a polysaccharide-binding human Fab (F598) in complex with nona-N-acetyl-D-glucosamine (9NAc)	0.066	128	89	68	195	117	212	2.559E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	6dc3-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6dc3-assembly1.cif.gz_L RSV prefusion F bound to RSD5 Fab	0.069	126	93	78	203	12	112	1.936E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	4f57-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4f57-assembly1.cif.gz_L Fab structure of a neutralizing antibody L1 from an early subtype A HIV-1 infected patient	0.065	128	89	68	195	116	211	2.861E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	3tje-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	3tje-assembly1.cif.gz_L Crystal structure of Fas receptor extracellular domain in complex with Fab E09	0.065	128	89	68	195	116	211	2.559E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	4odw-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4odw-assembly1.cif.gz_L Unliganded Fab structure of lipid A-specific antibody A6	0.081	131	96	69	199	4	108	2.420E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	2b1h-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	2b1h-assembly1.cif.gz_L Crystal structure analysis of anti-HIV-1 V3 Fab 2219 in complex with UG29 peptide	0.079	128	87	68	195	118	213	2.706E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	7z0x-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7z0x-assembly1.cif.gz_L THSC20.HVTR26 Fab bound to SARS-CoV-2 Receptor Binding Domain	0.079	128	87	68	195	116	211	2.861E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	1a8j-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	1a8j-assembly1.cif.gz_L IMMUNOGLOBULIN LAMBDA LIGHT CHAIN DIMER (MCG) COMPLEX WITH ASPARTAME	0.059	127	88	69	195	117	211	2.706E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	6xkp-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	6xkp-assembly1.cif.gz_H Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-270	0.094	130	117	70	199	1	130	1.465E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	8gsx-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	8gsx-assembly1.cif.gz_A X-ray structure of Clostridium perfringens pili protein B collagen-binding domains	0.089	144	113	69	193	108	251	3.070E-01	30
LOKIASV2_1517_ESMFold_hypothetical_protein	6sff-assembly1.cif.gz_A-2	LOKIASV2_1517_ESMFold_hypothetical_protein	6sff-assembly1.cif.gz_A-2 mouse Interleukin-12 subunit beta - p80 homodimer in space group I41	0.075	131	101	68	198	94	203	7.091E-01	30
LOKIASV2_1517_ESMFold_hypothetical_protein	5njd-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5njd-assembly1.cif.gz_A Structure of Interleukin 23 in complex with Briakinumab FAb	0.104	125	102	74	198	93	207	7.091E-01	30
LOKIASV2_1517_ESMFold_hypothetical_protein	3qs9-assembly2.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	3qs9-assembly2.cif.gz_F Crystal structure of a human Flt3 ligand-receptor ternary complex	0.053	129	80	69	197	169	253	3.782E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	7t0r-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	7t0r-assembly2.cif.gz_D Crystal structure of the anti-CD4 adnectin 6940_B01 as a complex with the extracellular domains of CD4 and ibalizumab fAb	0.069	129	64	69	197	100	169	8.864E-01	30
LOKIASV2_1517_ESMFold_hypothetical_protein	3qs9-assembly1.cif.gz_G	LOKIASV2_1517_ESMFold_hypothetical_protein	3qs9-assembly1.cif.gz_G Crystal structure of a human Flt3 ligand-receptor ternary complex	0.053	129	80	69	197	245	329	3.782E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	8ayh-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	8ayh-assembly1.cif.gz_A Structure of Complement C5 in Complex with small molecule inhibitor and CVF	0.051	130	90	68	197	145	240	2.165E+00	30
LOKIASV2_1517_ESMFold_hypothetical_protein	6v8i-assembly1.cif.gz_BN	LOKIASV2_1517_ESMFold_hypothetical_protein	6v8i-assembly1.cif.gz_BN Composite atomic model of the Staphylococcus aureus phage 80alpha baseplate	0.105	102	69	90	191	34	111	1.239E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	7rq6-assembly1.cif.gz_J	LOKIASV2_1517_ESMFold_hypothetical_protein	7rq6-assembly1.cif.gz_J Cryo-EM structure of SARS-CoV-2 spike in complex with non-neutralizing NTD-directed CV3-13 Fab isolated from convalescent individual	0.088	119	93	88	206	17	119	6.342E-01	29
LOKIASV2_1517_ESMFold_hypothetical_protein	6u6v-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6u6v-assembly1.cif.gz_A Crystal structure of human PD-1H / VISTA	0.071	132	122	75	206	11	142	4.538E-01	29
LOKIASV2_1517_ESMFold_hypothetical_protein	5anm-assembly2.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5anm-assembly2.cif.gz_L Crystal structure of IgE Fc in complex with a neutralizing antibody	0.055	104	80	88	191	15	100	2.047E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	7shu-assembly1.cif.gz_B-2	LOKIASV2_1517_ESMFold_hypothetical_protein	7shu-assembly1.cif.gz_B-2 IgE-Fc in complex with omalizumab variant C02	0.094	113	72	87	199	17	97	2.289E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	4fqc-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4fqc-assembly1.cif.gz_L Crystal Structure of PGT121 Fab Bound to a complex-type sialylated N-glycan	0.065	128	89	68	195	110	205	3.025E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	4glr-assembly2.cif.gz_K	LOKIASV2_1517_ESMFold_hypothetical_protein	4glr-assembly2.cif.gz_K Structure of the anti-ptau Fab (pT231/pS235_1) in complex with phosphoepitope pT231/pS235	0.071	128	88	68	195	110	205	3.199E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	5dvk-assembly1.cif.gz_A-2	LOKIASV2_1517_ESMFold_hypothetical_protein	5dvk-assembly1.cif.gz_A-2 Fc Design 7.7 B chain homodimer T366V/K409I	0.126	129	87	69	197	2	101	2.861E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	6lxj-assembly1.cif.gz_N	LOKIASV2_1517_ESMFold_hypothetical_protein	6lxj-assembly1.cif.gz_N Crystal structure of human Z2B3 Fab in complex with influenza virus neuraminidase from A/Anhui/1/2013 (H7N9)	0.081	117	87	75	191	2	97	1.732E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	5nsc-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5nsc-assembly1.cif.gz_A Fc DEKK heterodimer variant	0.115	129	88	69	197	3	102	3.782E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	6mtr-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6mtr-assembly1.cif.gz_L Crystal structure of VRC43.01 Fab	0.079	128	87	68	195	114	209	2.706E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	6p9j-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6p9j-assembly1.cif.gz_L crystal structure of human anti staphylococcus aureus antibody STAU-229 Fab	0.065	128	89	68	195	114	209	3.782E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	7y0v-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7y0v-assembly1.cif.gz_L The co-crystal structure of BA.1-RBD with Fab-5549	0.065	128	89	68	195	112	207	3.025E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	4zs7-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4zs7-assembly1.cif.gz_L Structural mimicry of receptor interaction by antagonistic IL-6 antibodies	0.081	105	80	87	191	12	99	8.864E-01	29
LOKIASV2_1517_ESMFold_hypothetical_protein	8ecv-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	8ecv-assembly1.cif.gz_L Bovine Fab 2F12	0.079	128	87	68	195	114	209	3.025E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	7epx-assembly1.cif.gz_M	LOKIASV2_1517_ESMFold_hypothetical_protein	7epx-assembly1.cif.gz_M S protein of SARS-CoV-2 in complex with GW01	0.071	128	88	68	195	114	209	3.025E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	7qny-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7qny-assembly1.cif.gz_B The receptor binding domain of SARS-CoV-2 spike glycoprotein in complex with COVOX-58 and COVOX-158 Fabs	0.073	128	88	68	195	114	209	4.228E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	6whk-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6whk-assembly1.cif.gz_B Minimally mutated anti-influenza broadly neutralizing antibody	0.082	124	98	75	198	1	108	1.638E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	6wn1-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	6wn1-assembly1.cif.gz_C Plasmodium vivax reticulocyte binding protein 2b (PvRBP2b) bound to human monoclonal antibody 241242	0.071	128	88	68	195	113	208	3.025E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	6a67-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	6a67-assembly2.cif.gz_D Crystal structure of influenza A virus H5 hemagglutinin globular head in complex with the Fab of antibody FLD21.140	0.093	131	98	69	199	2	110	1.549E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	5awn-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5awn-assembly1.cif.gz_L Crystal structure of Human anti-HIV-1 broadly neutralizing antibody 3BC176 Fab	0.086	128	87	68	195	115	210	3.025E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	8hes-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	8hes-assembly1.cif.gz_L Crystal structure of SARS-CoV-2 RBD and NIV-10 complex	0.079	128	87	68	195	115	210	2.706E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	3muh-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	3muh-assembly1.cif.gz_L Crystal structure of PG9 light chain	0.055	120	88	78	197	14	107	1.831E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	6p9i-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6p9i-assembly1.cif.gz_B crystal structure of human anti staphylococcus aureus antibody STAU-399 Fab	0.079	127	87	69	195	117	211	1.732E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	8e1g-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	8e1g-assembly1.cif.gz_H SARS-CoV-2 RBD in complex with Omicron-neutralizing antibody 2A10	0.093	116	87	70	185	1	97	1.936E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	4f58-assembly4.cif.gz_O	LOKIASV2_1517_ESMFold_hypothetical_protein	4f58-assembly4.cif.gz_O Fab structure of a neutralizing antibody L3 from an early subtype A HIV-1 infected patient	0.068	125	100	75	199	3	110	2.165E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	6glx-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6glx-assembly1.cif.gz_L Structure of galectin-10 in complex with the Fab fragment of a Charcot-Leyden crystal solubilizing antibody, 4E8	0.071	122	85	78	199	15	107	2.165E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	4dqo-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4dqo-assembly1.cif.gz_L Crystal Structure of PG16 Fab in Complex with V1V2 Region from HIV-1 strain ZM109	0.073	125	99	75	199	3	110	1.936E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	7n3e-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7n3e-assembly1.cif.gz_L Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment C032	0.065	127	86	69	195	119	211	2.420E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	3thm-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	3thm-assembly1.cif.gz_L Crystal structure of Fas receptor extracellular domain in complex with Fab EP6b_B01	0.071	128	88	68	195	116	211	3.025E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	8tfq-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	8tfq-assembly1.cif.gz_B Fab from C10-S66K antibody in complex with fentanyl	0.099	124	95	69	192	4	109	1.465E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	7vzt-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	7vzt-assembly1.cif.gz_C A human neutralizing antibody targeting SARS-CoV-2 RBD	0.072	128	88	68	195	117	212	2.289E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	6x1v-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6x1v-assembly1.cif.gz_L Structure of pHis Fab (SC44-8) in complex with pHis mimetic peptide	0.098	126	91	68	193	2	103	1.831E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	6jp7-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6jp7-assembly1.cif.gz_L Human antibody 32D6 Fab in complex with PEG	0.079	128	87	68	195	116	211	3.025E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	3mlt-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	3mlt-assembly1.cif.gz_L Crystal structure of anti-HIV-1 V3 Fab 2557 in complex with a UG1033 V3 peptide	0.079	128	87	68	195	119	214	2.047E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	7r8u-assembly1.cif.gz_LLL	LOKIASV2_1517_ESMFold_hypothetical_protein	7r8u-assembly1.cif.gz_LLL LOX-1 - Structural and Functional Studies of a Receptor Implicated in Atherosclerosis	0.078	130	102	74	203	2	113	1.638E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	3bae-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	3bae-assembly1.cif.gz_H Crystal structure of Fab WO2 bound to the N terminal domain of Amyloid beta peptide (1-28)	0.093	117	86	69	185	5	100	1.385E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	6sni-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	6sni-assembly1.cif.gz_H Cryo-EM structure of nanodisc reconstituted yeast ALG6 in complex with 6AG9 Fab	0.141	129	81	69	197	128	222	8.864E-01	29
LOKIASV2_1517_ESMFold_hypothetical_protein	3mj6-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	3mj6-assembly1.cif.gz_A Crystal structure of the gammadelta T cell costimulatory receptor Junctional Adhesion Molecule-Like Protein, JAML	0.134	112	87	90	201	124	225	9.911E-01	29
LOKIASV2_1517_ESMFold_hypothetical_protein	8dfw-assembly1.cif.gz_G	LOKIASV2_1517_ESMFold_hypothetical_protein	8dfw-assembly1.cif.gz_G Crystal Structure of Human BTN2A1 in Complex With Vgamma9-Vdelta2 T Cell Receptor	0.099	116	99	88	203	17	127	6.342E-01	29
LOKIASV2_1517_ESMFold_hypothetical_protein	4dep-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4dep-assembly1.cif.gz_B Structure of the IL-1b signaling complex	0.068	126	90	68	193	196	293	3.383E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	8dfq-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	8dfq-assembly1.cif.gz_A Ectodomain of full-length KIT(T417I,delta418-419)-SCF dimers	0.099	134	86	69	202	179	274	3.199E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	4liq-assembly1.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	4liq-assembly1.cif.gz_E Structure of the extracellular domain of human CSF-1 receptor in complex with the Fab fragment of RG7155	0.078	129	90	69	197	371	469	2.420E+00	29
LOKIASV2_1517_ESMFold_hypothetical_protein	8jmw-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	8jmw-assembly1.cif.gz_A Fibril form of serine peptidase Vpr	0.074	130	98	68	197	309	415	4.291E-01	29
LOKIASV2_1517_ESMFold_hypothetical_protein	8ae2-assembly1.cif.gz_I	LOKIASV2_1517_ESMFold_hypothetical_protein	8ae2-assembly1.cif.gz_I Cryo-EM structure of full-length human immunoglobulin M - F(ab')2 conformation 5	0.062	127	91	69	195	6	103	2.706E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	2otu-assembly4.cif.gz_G	LOKIASV2_1517_ESMFold_hypothetical_protein	2otu-assembly4.cif.gz_G Crystal structure of Fv polyglutamine complex	0.122	124	92	70	193	2	107	8.383E-01	28
LOKIASV2_1517_ESMFold_hypothetical_protein	2cde-assembly3.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	2cde-assembly3.cif.gz_E Structure and binding kinetics of three different human CD1d-alpha- Galactosylceramide specific T cell receptors - iNKT-TCR	0.118	106	74	88	193	17	101	2.289E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	4pbv-assembly3.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	4pbv-assembly3.cif.gz_E Crystal structure of chicken receptor protein tyrosine phosphatase sigma in complex with TrkC	0.052	110	64	88	197	20	88	1.239E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	5d7s-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5d7s-assembly1.cif.gz_L Crystal structure of MOR04357, a neutralizing anti-human GM-CSF antibody Fab fragment	0.073	128	88	68	195	108	203	4.228E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	5anm-assembly2.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	5anm-assembly2.cif.gz_E Crystal structure of IgE Fc in complex with a neutralizing antibody	0.096	108	73	88	195	18	99	1.831E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	8btb-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	8btb-assembly1.cif.gz_D Hexameric human IgG3 Fc complex	0.128	129	86	69	197	2	101	4.228E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	7x8t-assembly2.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	7x8t-assembly2.cif.gz_E Frizzled 10 CRD in complex with hB9L9.3 Fab	0.071	128	88	68	195	112	207	4.471E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	4llu-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4llu-assembly1.cif.gz_B Structure of Pertuzumab Fab with light chain Clambda at 2.16A	0.079	128	87	68	195	113	208	2.047E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	7ly3-assembly2.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	7ly3-assembly2.cif.gz_E Crystal structure of SARS-CoV-2 S NTD bound to S2M28 Fab	0.058	128	89	68	195	112	207	4.999E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	6mol-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	6mol-assembly1.cif.gz_C Monoextended DARPin M_R12 complex with EpoR	0.053	106	73	87	192	25	102	3.199E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	7ryv-assembly3.cif.gz_J	LOKIASV2_1517_ESMFold_hypothetical_protein	7ryv-assembly3.cif.gz_J Anti-HIV neutralizing antibody Ab1573 Fab isolated from sequentially immunized macaques	0.113	126	87	68	193	2	100	1.239E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	5u15-assembly2.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5u15-assembly2.cif.gz_L Crystal Structure of DH270.UCA3 (unliganded) from the DH270 Broadly Neutralizing N332-glycan Dependent Lineage	0.055	104	79	88	191	15	99	2.420E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	6xca-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6xca-assembly1.cif.gz_L Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C105	0.078	126	91	68	193	1	100	2.289E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	5zmj-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5zmj-assembly1.cif.gz_L Crystal structure of the Fab region of a neutralizing fully human antibody against GM-CSF	0.083	125	98	75	199	2	109	2.706E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	7dm1-assembly2.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	7dm1-assembly2.cif.gz_C crystal structure of the M.tuberculosis phosphate ABC transport receptor PstS-1 in complex with Fab p4-36	0.072	128	88	68	195	116	211	2.706E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	5dur-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	5dur-assembly1.cif.gz_D Influenza A virus H5 hemagglutinin globular head in complex with antibody 100F4	0.066	127	86	69	195	119	211	3.782E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	3lzf-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	3lzf-assembly1.cif.gz_L Crystal Structure of Fab 2D1 in Complex with the 1918 Influenza Virus Hemagglutinin	0.084	116	80	78	193	14	101	1.732E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	5t33-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5t33-assembly1.cif.gz_L Crystal structure of strain-specific glycan-dependent CD4 binding site-directed neutralizing antibody CAP257-RH1, in complex with HIV-1 strain RHPA gp120 core with an oligomannose N276 glycan.	0.064	128	89	68	195	113	208	4.228E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	5w4l-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5w4l-assembly1.cif.gz_L Crystal structure of the non-neutralizing and ADCC-potent C11-like antibody N12-i3 in complex with HIV-1 clade A/E gp120, the CD4 mimetic M48U1, and the antibody N5-i5.	0.071	128	88	68	195	116	211	3.999E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	7ps0-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7ps0-assembly1.cif.gz_L Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with beta-24 Fabs	0.069	110	85	88	197	17	108	2.289E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	6srv-assembly2.cif.gz_MMM	LOKIASV2_1517_ESMFold_hypothetical_protein	6srv-assembly2.cif.gz_MMM Structure of the arginase-2-inhibitory human antigen-binding fragment Fab C0021144	0.072	128	88	68	195	116	211	2.861E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	4d9l-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4d9l-assembly1.cif.gz_L Fab structure of anti-HIV-1 gp120 V2 mAb 697	0.066	127	88	69	195	118	212	4.471E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	1lhz-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1lhz-assembly1.cif.gz_A Structure of a Human Bence-Jones Dimer Crystallized in U.S. Space Shuttle Mission STS-95: 293K	0.079	128	87	68	195	117	212	1.638E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	7mf1-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7mf1-assembly1.cif.gz_L Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1	0.074	124	98	75	198	2	108	2.047E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	6yjp-assembly2.cif.gz_D-2	LOKIASV2_1517_ESMFold_hypothetical_protein	6yjp-assembly2.cif.gz_D-2 Crystal structure of a complex between glycosylated NKp30 and its deglycosylated tumour ligand B7-H6	0.091	105	74	89	193	130	211	3.782E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	5dt1-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5dt1-assembly1.cif.gz_L Crystal structure of human Fab CAP256-VRC26.25, a potent V1V2-directed HIV-1 broadly neutralizing antibody	0.064	127	88	69	195	118	212	3.577E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	8g1c-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	8g1c-assembly1.cif.gz_A Crystal structure of polyreactive 3B03 human Fab	0.105	130	79	68	197	126	214	1.048E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	6rco-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	6rco-assembly2.cif.gz_D PfRH5-binding monoclonal antibody R5.004	0.066	113	88	87	199	16	110	2.706E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	4fs0-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4fs0-assembly1.cif.gz_A Crystal structure of mutant F136D of mouse nectin-2 extracellular fragment D1-D2	0.069	131	106	67	197	2	116	2.559E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	3mlv-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	3mlv-assembly1.cif.gz_L Crystal structure of anti-HIV-1 V3 Fab 2557 in complex with an NOF V3 peptide	0.073	128	88	68	195	121	216	5.589E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	6fab-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	6fab-assembly1.cif.gz_H THREE-DIMENSIONAL STRUCTURE OF MURINE ANTI-P-AZOPHENYLARSONATE FAB 36-71. 1. X-RAY CRYSTALLOGRAPHY, SITE-DIRECTED MUTAGENESIS, AND MODELING OF THE COMPLEX WITH HAPTEN	0.115	130	82	68	197	126	219	1.549E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	7a3u-assembly1.cif.gz_H-2	LOKIASV2_1517_ESMFold_hypothetical_protein	7a3u-assembly1.cif.gz_H-2 Crystal structure of Zika virus envelope glycoprotein in complex with the divalent F(ab')2 fragment of the broadly neutralizing human antibody EDE1 C10	0.099	126	79	76	201	136	224	1.239E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	7zf6-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	7zf6-assembly1.cif.gz_H Omi-12 Fab	0.078	109	89	87	195	16	112	1.638E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	8ezm-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	8ezm-assembly1.cif.gz_H Pfs25 in complex with transmission-reducing antibody AS01-63	0.079	128	98	68	195	122	228	1.549E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	6e9u-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6e9u-assembly1.cif.gz_A The crystal structure of bovine ultralong antibody BOV-7	0.085	127	75	68	194	176	258	1.638E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	6eg1-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6eg1-assembly1.cif.gz_B Crystal structure of Dpr2 Ig1-Ig2 in complex with DIP-Theta Ig1-Ig3	0.060	129	85	69	197	203	293	2.706E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	5vkm-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5vkm-assembly1.cif.gz_A Crystal structure of human CD22 Ig domains 1-3 in complex with alpha 2-6 sialyllactose	0.043	128	89	69	196	121	214	1.239E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	5opi-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	5opi-assembly1.cif.gz_C Crystal structure of the TAPBPR-MHC I peptide editing complex	0.051	125	88	68	192	237	330	1.385E+00	28
LOKIASV2_1517_ESMFold_hypothetical_protein	7som-assembly1.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	7som-assembly1.cif.gz_E Ciliary C2 central pair apparatus isolated from Chlamydomonas reinhardtii	0.118	129	89	69	197	212	313	6.706E-01	28
LOKIASV2_1517_ESMFold_hypothetical_protein	7zg0-assembly1.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	7zg0-assembly1.cif.gz_E Murine IL-27 in complex with IL-27Ra and a non-competing Nb	0.101	128	78	69	196	2	89	5.365E-01	27
LOKIASV2_1517_ESMFold_hypothetical_protein	5d70-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5d70-assembly1.cif.gz_L Crystal structure of MOR03929, a neutralizing anti-human GM-CSF antibody Fab fragment in complex with human GM-CSF	0.071	128	88	68	195	100	195	4.228E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	3tyf-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	3tyf-assembly1.cif.gz_A Crystal structure of a CD1d-lysophosphatidylcholine reactive iNKT TCR	0.072	128	96	68	195	2	105	2.289E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	3t2n-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	3t2n-assembly1.cif.gz_H Human hepsin protease in complex with the Fab fragment of an inhibitory antibody	0.099	128	78	70	197	115	202	1.172E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	6wmh-assembly2.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6wmh-assembly2.cif.gz_A Next generation monomeric IgG4 Fc	0.103	123	87	75	197	3	100	3.199E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	5anm-assembly2.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	5anm-assembly2.cif.gz_F Crystal structure of IgE Fc in complex with a neutralizing antibody	0.090	132	91	68	199	106	206	1.936E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	4jy4-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4jy4-assembly1.cif.gz_A Crystal structure of human Fab PGT121, a broadly reactive and potent HIV-1 neutralizing antibody	0.065	128	89	68	195	110	205	3.383E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	2fl5-assembly4.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	2fl5-assembly4.cif.gz_E Cofactor-containing antibodies: Crystal structure of the original yellow antibody	0.070	130	90	66	195	110	207	4.728E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	3go1-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	3go1-assembly1.cif.gz_L Crystal structure of anti-HIV-1 Fab 268-D in complex with V3 peptide MN	0.065	127	86	69	195	116	208	3.199E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	4qhl-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	4qhl-assembly2.cif.gz_D I3.2 (unbound) from CH103 Lineage	0.076	124	95	75	198	2	105	2.289E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	7rxj-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7rxj-assembly1.cif.gz_B Fab236 in complex with the C-terminal alpha-TSR domain of P. falciparum	0.080	110	80	88	197	17	104	2.559E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	5wcc-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5wcc-assembly1.cif.gz_L Crystal structure of the broadly neutralizing Influenza A antibody VRC 315 02-1F07 Fab.	0.066	127	88	69	195	111	205	4.471E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	5tpl-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5tpl-assembly1.cif.gz_L Crystal Structure of DH270.3 (unliganded) from the DH270 Broadly Neutralizing N332-glycan Dependent Lineage	0.071	110	85	88	197	15	106	3.025E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	7u0k-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7u0k-assembly1.cif.gz_L IOMA class antibody Fab ACS124	0.044	127	87	69	195	116	207	4.228E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	6xkp-assembly2.cif.gz_N	LOKIASV2_1517_ESMFold_hypothetical_protein	6xkp-assembly2.cif.gz_N Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-270	0.059	111	87	88	198	15	107	3.577E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	3sqo-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	3sqo-assembly1.cif.gz_H PCSK9 J16 Fab complex	0.117	130	102	70	199	1	117	3.199E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	6xkp-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6xkp-assembly1.cif.gz_L Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-270	0.050	110	86	88	197	15	106	3.025E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	5bv7-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5bv7-assembly1.cif.gz_B Crystal structure of human LCAT (L4F, N5D) in complex with Fab of an agonistic antibody	0.051	127	87	69	195	116	208	3.383E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	6vca-assembly2.cif.gz_J	LOKIASV2_1517_ESMFold_hypothetical_protein	6vca-assembly2.cif.gz_J TB38 complex	0.078	130	89	66	195	114	211	3.199E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	7d85-assembly2.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	7d85-assembly2.cif.gz_F Crystal structure of anti-ErbB3 Fab ISU104 in complex with human ErbB3 extracellular domain 3	0.059	112	88	88	199	16	109	3.999E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	7lq7-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7lq7-assembly1.cif.gz_L Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16	0.070	132	100	68	199	2	110	2.559E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	3mlt-assembly4.cif.gz_G	LOKIASV2_1517_ESMFold_hypothetical_protein	3mlt-assembly4.cif.gz_G Crystal structure of anti-HIV-1 V3 Fab 2557 in complex with a UG1033 V3 peptide	0.064	128	89	68	195	116	211	4.728E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	7s0d-assembly1.cif.gz_P	LOKIASV2_1517_ESMFold_hypothetical_protein	7s0d-assembly1.cif.gz_P Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014	0.108	128	87	68	195	112	210	4.999E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	3u4e-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	3u4e-assembly1.cif.gz_L Crystal Structure of PG9 Fab in Complex with V1V2 Region from HIV-1 strain CAP45	0.066	128	89	68	195	116	211	4.999E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	6umh-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6umh-assembly1.cif.gz_L Crystal structure of erenumab Fab-a	0.098	132	97	68	199	3	110	3.577E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	7mu4-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7mu4-assembly1.cif.gz_L Crystal Structure of HPV L1-directed D24.M01Fab	0.065	128	89	68	195	116	211	3.782E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	6wh9-assembly2.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	6wh9-assembly2.cif.gz_F Ketoreductase from module 1 of the 6-deoxyerythronolide B synthase (KR1) in complex with antibody fragment (Fab) 1D10	0.072	128	87	68	195	118	212	4.471E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	2old-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	2old-assembly1.cif.gz_B Bence Jones KWR Protein- Immunoglobulin Light Chain Dimer, P3(2)21 Crystal Form	0.065	128	89	68	195	117	212	5.589E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	3mls-assembly4.cif.gz_O	LOKIASV2_1517_ESMFold_hypothetical_protein	3mls-assembly4.cif.gz_O Crystal structure of anti-HIV-1 V3 mAb 2557 Fab in complex with a HIV-1 gp120 V3 mimotope	0.071	128	88	68	195	122	217	4.228E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	5f89-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5f89-assembly1.cif.gz_L Structure of the Unliganded Fab from HIV-1 Neutralising Antibody CAP248-2B that Binds to the gp120 C-terminus - gp41 Interface	0.058	127	89	69	195	125	219	3.383E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	6urm-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	6urm-assembly1.cif.gz_D Crystal structure of vaccine-elicited receptor-binding site targeting antibody LPAF-a.01 in complex with Hemagglutinin H1 A/California/04/2009	0.081	110	96	88	197	17	121	2.706E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	7wso-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7wso-assembly1.cif.gz_B Structure of a membrane protein G	0.142	129	85	69	197	2	101	4.471E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	5vl3-assembly2.cif.gz_R	LOKIASV2_1517_ESMFold_hypothetical_protein	5vl3-assembly2.cif.gz_R CD22 d1-d3 in complex with therapeutic Fab Epratuzumab	0.043	128	89	69	196	110	203	1.465E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	6arq-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	6arq-assembly1.cif.gz_D Crystal structure of CD96 (D1) bound to CD155/necl-5 (D1-3)	0.062	130	89	68	197	114	209	2.289E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	6sp3-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6sp3-assembly1.cif.gz_A mouse Interleukin-12 subunit beta - p80 homodimer in space group P21 crystal form 1	0.053	131	105	68	198	94	205	1.108E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	4gaf-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4gaf-assembly1.cif.gz_B Crystal structure of EBI-005, a chimera of human IL-1beta and IL-1Ra, bound to human Interleukin-1 receptor type 1	0.094	128	92	69	196	202	303	3.199E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	6eyo-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6eyo-assembly1.cif.gz_B Structure of extended IgE-Fc in complex with two anti-IgE Fabs	0.061	127	84	69	195	2	91	2.706E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	6mvg-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6mvg-assembly1.cif.gz_A Crystal structure of FMN-binding beta-glucuronidase from Ruminococcus gnavus	0.088	121	83	75	195	165	256	1.549E+00	27
LOKIASV2_1517_ESMFold_hypothetical_protein	5tru-assembly2.cif.gz_c	LOKIASV2_1517_ESMFold_hypothetical_protein	5tru-assembly2.cif.gz_c Structure of the first-in-class checkpoint inhibitor Ipilimumab bound to human CTLA-4	0.120	115	83	79	193	11	105	1.239E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	7mxe-assembly1.cif.gz_W	LOKIASV2_1517_ESMFold_hypothetical_protein	7mxe-assembly1.cif.gz_W Ab1245 Fab in complex with BG505 SOSIP.664 and 8ANC195 Fab	0.070	107	85	87	193	16	107	2.420E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	4hf5-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4hf5-assembly1.cif.gz_L Crystal structure of Fab 8F8 in complex a H2N2 influenza virus hemagglutinin	0.104	116	79	78	193	13	101	7.091E-01	26
LOKIASV2_1517_ESMFold_hypothetical_protein	5moj-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5moj-assembly1.cif.gz_A Crystal structure of IgE-Fc epsilon 3-4	0.085	112	72	88	199	18	97	3.025E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	6chb-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6chb-assembly1.cif.gz_L Crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and IOMA	0.066	128	89	68	195	106	201	6.608E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	8ent-assembly2.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	8ent-assembly2.cif.gz_E Interleukin-21 signaling complex with IL-21R and IL-2Rg	0.067	128	83	69	196	4	93	2.289E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	6g1e-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6g1e-assembly1.cif.gz_B BEAT Fc with improved heterodimerization (Q3A-D84.4Q)	0.112	131	88	69	199	4	103	3.383E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	6lxj-assembly1.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	6lxj-assembly1.cif.gz_F Crystal structure of human Z2B3 Fab in complex with influenza virus neuraminidase from A/Anhui/1/2013 (H7N9)	0.067	114	77	78	191	15	98	3.025E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	7zfc-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7zfc-assembly1.cif.gz_B SARS-CoV-2 Beta RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs	0.064	127	88	69	195	111	205	4.228E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	8a48-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	8a48-assembly1.cif.gz_A Less crystallisable" IgG1 Fc fragment (E382S variant)	0.128	131	88	69	199	2	103	4.471E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	4l4j-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4l4j-assembly1.cif.gz_A Crystal structure of fc-fragment of human IgG2-Sigma antibody	0.119	130	88	68	197	1	101	4.471E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	7lsi-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	7lsi-assembly2.cif.gz_D Structure of KD035, a VEGFR2 monoclonal antibody	0.093	104	73	88	191	15	95	2.559E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	7ox3-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7ox3-assembly1.cif.gz_B Fab 6D3: hIL-9 complex	0.065	128	89	68	195	112	207	5.589E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	6pbv-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6pbv-assembly1.cif.gz_A Crystal structure of Fab668 complex	0.071	128	88	68	195	114	209	3.199E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	3lrs-assembly3.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	3lrs-assembly3.cif.gz_D Structure of PG16, an antibody with broad and potent neutralization of HIV-1	0.051	127	87	69	195	117	209	3.782E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	5jo5-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5jo5-assembly2.cif.gz_B Crystal structure of 10E8 gHV-gLV antigen-binding fragment.	0.059	128	89	68	195	114	209	6.249E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	4bsj-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4bsj-assembly1.cif.gz_A Crystal structure of VEGFR-3 extracellular domains D4-5	0.079	133	109	69	201	95	213	3.383E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	7czw-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7czw-assembly1.cif.gz_L S protein of SARS-CoV-2 in complex bound with P5A-2G7	0.071	128	88	68	195	117	212	4.728E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	4tsc-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4tsc-assembly1.cif.gz_L Structure of a lysozyme antibody complex	0.059	110	87	88	197	17	109	3.383E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	4frw-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4frw-assembly1.cif.gz_A Crystal structure of human nectin-4 extracellular fragment D1-D2	0.073	129	82	69	197	122	210	1.732E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	5ihz-assembly4.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5ihz-assembly4.cif.gz_L Crystal structure of anti-gliadin 1002-1E01 Fab fragment	0.071	128	88	68	195	117	212	4.999E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	7pqz-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7pqz-assembly1.cif.gz_B Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with FI-3A and FD-11A Fabs	0.071	128	88	68	195	118	213	6.249E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	7r6w-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7r6w-assembly1.cif.gz_L SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2X35 Fab and S309 Fab	0.064	106	81	88	193	16	103	2.289E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	7n3f-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7n3f-assembly1.cif.gz_L Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment C080	0.076	124	100	75	198	3	111	3.577E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	6pi7-assembly2.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	6pi7-assembly2.cif.gz_F Crystal structure of the TDRD2 extended Tudor domain in complex with an antibody fragment and the PIWIL1 peptide	0.097	130	79	68	197	129	217	2.861E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	7mf9-assembly2.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	7mf9-assembly2.cif.gz_C Crystal structure of antibody 10E8v4-P100fA Fab in space group C2	0.078	126	106	69	194	4	119	1.936E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	7mf9-assembly5.cif.gz_Q	LOKIASV2_1517_ESMFold_hypothetical_protein	7mf9-assembly5.cif.gz_Q Crystal structure of antibody 10E8v4-P100fA Fab in space group C2	0.093	122	73	76	197	139	220	1.048E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	6mef-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	6mef-assembly1.cif.gz_H Crystal structure of broadly neutralizing antibody AR3C	0.103	128	83	70	197	128	221	7.091E-01	26
LOKIASV2_1517_ESMFold_hypothetical_protein	6ffj-assembly3.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	6ffj-assembly3.cif.gz_E Anti-tumor antibody 14F7-derived single chain fragment variable (scFv)	0.080	115	90	70	184	1	99	1.831E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	6sp3-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6sp3-assembly1.cif.gz_B mouse Interleukin-12 subunit beta - p80 homodimer in space group P21 crystal form 1	0.048	121	105	78	198	95	205	7.928E-01	26
LOKIASV2_1517_ESMFold_hypothetical_protein	7tug-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	7tug-assembly1.cif.gz_D Crystal structure of Tapasin in complex with PaSta2-Fab	0.098	120	94	78	197	108	212	2.861E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	7tuf-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	7tuf-assembly1.cif.gz_D Crystal structure of Tapasin in complex with PaSta1-Fab	0.097	120	98	78	197	115	224	2.420E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	2e9w-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	2e9w-assembly1.cif.gz_A Crystal structure of the extracellular domain of Kit in complex with stem cell factor (SCF)	0.037	129	90	69	197	283	376	3.782E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	6u7i-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	6u7i-assembly1.cif.gz_C Faecalibacterium prausnitzii Beta-glucuronidase	0.059	128	79	69	196	199	283	1.936E+00	26
LOKIASV2_1517_ESMFold_hypothetical_protein	1wwc-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1wwc-assembly1.cif.gz_A NT3 BINDING DOMAIN OF HUMAN TRKC RECEPTOR	0.072	106	67	88	193	19	91	2.047E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	3iy4-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	3iy4-assembly1.cif.gz_A Variable domains of the computer generated model (WAM) of Fab 15 fitted into the cryoEM reconstruction of the virus-Fab 15 complex	0.099	125	88	69	193	2	100	4.471E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	6pnq-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6pnq-assembly1.cif.gz_B Crystal structure of the SS2A splice insert-containing neurexin-1 LNS2 domain in complex with neurexophilin-1	0.130	125	100	78	193	2	126	1.064E-01	25
LOKIASV2_1517_ESMFold_hypothetical_protein	1na8-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	1na8-assembly1.cif.gz_B Crystal structure of ADP-ribosylation factor binding protein GGA1	0.053	142	118	67	208	11	136	9.373E-01	25
LOKIASV2_1517_ESMFold_hypothetical_protein	3s5l-assembly2.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	3s5l-assembly2.cif.gz_H Crystal structure of CD4 mutant bound to HLA-DR1	0.077	129	67	69	197	101	174	2.861E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	5cus-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5cus-assembly1.cif.gz_L Crystal Structure of sErbB3-Fab3379 Complex	0.063	106	79	88	193	16	100	2.420E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	4pgz-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4pgz-assembly2.cif.gz_B Structural basis of KIT activation by oncogenic mutations in the extracellular region reveals a zipper-like mechanism for ligand-dependent or oncogenic receptor tyrosine kinase activation	0.022	129	91	69	197	7	100	5.910E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	3tzv-assembly1.cif.gz_G	LOKIASV2_1517_ESMFold_hypothetical_protein	3tzv-assembly1.cif.gz_G Crystal structure of an iNKT TCR in complex with CD1d-lysophosphatidylcholine	0.090	126	90	68	193	2	101	3.782E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	2x1x-assembly1.cif.gz_R-2	LOKIASV2_1517_ESMFold_hypothetical_protein	2x1x-assembly1.cif.gz_R-2 CRYSTAL STRUCTURE OF VEGF-C IN COMPLEX WITH DOMAINS 2 AND 3 OF VEGFR2 IN A TETRAGONAL CRYSTAL FORM	0.090	129	93	69	197	96	198	1.048E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	6e8v-assembly5.cif.gz_P	LOKIASV2_1517_ESMFold_hypothetical_protein	6e8v-assembly5.cif.gz_P The crystal structure of bovine ultralong antibody BOV-1	0.131	117	85	75	191	2	100	1.638E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	4wi5-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4wi5-assembly1.cif.gz_B Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation H310A	0.097	131	91	69	199	4	105	6.249E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	5v43-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5v43-assembly1.cif.gz_A Engineered human IgG Fc domain aglyco801	0.142	129	85	69	197	3	102	3.999E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	2h32-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	2h32-assembly1.cif.gz_H Crystal structure of the pre-B cell receptor	0.090	121	76	77	197	127	211	4.228E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	2dd8-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	2dd8-assembly1.cif.gz_L Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody	0.042	112	87	88	199	17	108	3.999E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	5t5b-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5t5b-assembly1.cif.gz_L CRYSTAL STRUCTURE OF THE COMPLEX OF 10E8 FAB LIGHT CHAIN MUTANT5 AND T117V2 HIV-1 MPER SCAFFOLD	0.065	128	89	68	195	114	209	5.910E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	7zfb-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7zfb-assembly1.cif.gz_B SARS-CoV-2 Omicron RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs	0.072	117	91	75	191	2	100	3.199E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	7cr5-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7cr5-assembly1.cif.gz_L Complex structure of a human monoclonal antibody with SARS-CoV-2 nucleocapsid protein NTD	0.065	128	89	68	195	117	212	5.286E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	7fcq-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7fcq-assembly1.cif.gz_L Crystallographic structure of neutralizing antibody P14-44 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD)	0.059	128	89	68	195	116	211	6.987E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	6srx-assembly1.cif.gz_LLL	LOKIASV2_1517_ESMFold_hypothetical_protein	6srx-assembly1.cif.gz_LLL Structure of the arginase-2-inhibitory human antigen-binding fragment Fab C0021158	0.072	128	88	68	195	115	210	3.999E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	6ev1-assembly2.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	6ev1-assembly2.cif.gz_C Crystal structure of antibody against schizophyllan	0.125	128	80	70	197	119	210	1.831E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	3mlw-assembly2.cif.gz_M	LOKIASV2_1517_ESMFold_hypothetical_protein	3mlw-assembly2.cif.gz_M Crystal structure of anti-HIV-1 V3 Fab 1006-15D in complex with an MN V3 peptide	0.073	116	82	78	193	15	103	2.559E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	5nhw-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5nhw-assembly1.cif.gz_L CRYSTAL STRUCTURE OF THE BIMAGRUMAB Fab	0.059	127	87	69	195	119	211	4.999E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	4ocr-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4ocr-assembly1.cif.gz_L Crystal structure of human Fab CAP256-VRC26.01, a potent V1V2-directed HIV-1 neutralizing antibody	0.057	127	87	69	195	119	211	4.999E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	6jhr-assembly1.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	6jhr-assembly1.cif.gz_E The cryo-EM structure of HAV bound to a neutralizing antibody-F6	0.077	128	108	70	197	1	118	2.559E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	7rd9-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7rd9-assembly1.cif.gz_L Crystal structure of PfCSP peptide 21 with vaccine-elicited human anti-malaria antibody m43.159	0.112	126	90	68	193	3	104	4.728E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	6mnr-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	6mnr-assembly1.cif.gz_H Rhesus macaque anti-HIV V3 antibody DH753 with gp120 V3 ZAM18 peptide	0.096	131	109	69	199	2	123	1.638E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	5jo4-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5jo4-assembly1.cif.gz_A Antibody Fab Fragment Complex	0.084	115	93	70	184	1	102	1.638E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	7uce-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	7uce-assembly1.cif.gz_H Structure of the anti-HIV-1 neutralizing antibody BG24 Fab fragment	0.142	123	78	75	197	131	222	1.831E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	6w4m-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	6w4m-assembly1.cif.gz_H CRYSTAL STRUCTURE OF THE ADCC-POTENT, WEAKLY NEUTRALIZING HIV ENV CO-RECEPTOR BINDING SITE ANTIBODY N12-I2 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48U1	0.103	128	80	70	197	133	222	2.047E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	6pph-assembly1.cif.gz_k	LOKIASV2_1517_ESMFold_hypothetical_protein	6pph-assembly1.cif.gz_k Kaposi's sarcoma-associated herpesvirus (KSHV), C1 penton vertex register, CATC-binding structure	0.071	89	66	106	194	36	107	3.782E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	4u4j-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4u4j-assembly1.cif.gz_A Crystal structure of Salmonella alpha-2-macroglobulin mutant Y1175G	0.124	131	105	69	199	413	533	2.559E+00	25
LOKIASV2_1517_ESMFold_hypothetical_protein	8cw9-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	8cw9-assembly1.cif.gz_C Prefusion-stabilized hMPV fusion protein bound to ADI-61026 and MPE8 Fabs	0.080	116	96	88	203	16	120	2.706E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	4or1-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4or1-assembly1.cif.gz_A Structure and mechanism of fibronectin binding and biofilm formation of enteroaggregative Escherischia coli AAF fimbriae	0.078	140	113	69	208	6	129	8.383E-01	24
LOKIASV2_1517_ESMFold_hypothetical_protein	1om9-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1om9-assembly1.cif.gz_A Structure of the GGA1-appendage in complex with the p56 binding peptide	0.038	127	114	67	193	8	127	8.864E-01	24
LOKIASV2_1517_ESMFold_hypothetical_protein	1na8-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1na8-assembly1.cif.gz_A Crystal structure of ADP-ribosylation factor binding protein GGA1	0.045	127	114	67	193	17	136	7.928E-01	24
LOKIASV2_1517_ESMFold_hypothetical_protein	4adf-assembly1.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	4adf-assembly1.cif.gz_F CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (hCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1	0.066	110	86	88	197	8	100	4.471E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	2x1w-assembly1.cif.gz_N	LOKIASV2_1517_ESMFold_hypothetical_protein	2x1w-assembly1.cif.gz_N Crystal Structure of VEGF-C in Complex with Domains 2 and 3 of VEGFR2	0.100	110	68	88	197	115	191	4.471E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	4jy5-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4jy5-assembly1.cif.gz_L Crystal structure of human Fab PGT122, a broadly reactive and potent HIV-1 neutralizing antibody	0.058	128	85	68	195	109	199	8.734E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	6p9j-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6p9j-assembly2.cif.gz_B crystal structure of human anti staphylococcus aureus antibody STAU-229 Fab	0.072	128	88	68	195	107	202	5.286E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	6lxj-assembly1.cif.gz_K	LOKIASV2_1517_ESMFold_hypothetical_protein	6lxj-assembly1.cif.gz_K Crystal structure of human Z2B3 Fab in complex with influenza virus neuraminidase from A/Anhui/1/2013 (H7N9)	0.089	117	87	75	191	2	97	3.025E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	6f2z-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6f2z-assembly1.cif.gz_B Structure of a Fc mutant	0.125	129	83	69	197	6	101	3.199E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	6umx-assembly1.cif.gz_l	LOKIASV2_1517_ESMFold_hypothetical_protein	6umx-assembly1.cif.gz_l Structural basis for specific inhibition of extracellular activation of pro/latent myostatin by SRK-015	0.076	111	84	88	198	15	106	5.286E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	8dw9-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	8dw9-assembly2.cif.gz_D Crystal structure of neutralizing antibody D29 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD)	0.065	127	86	69	195	117	209	4.228E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	7u5g-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7u5g-assembly1.cif.gz_L ACS122 Fab	0.084	111	82	88	198	16	106	2.559E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	6xkq-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6xkq-assembly1.cif.gz_L Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-250	0.079	128	87	68	195	114	209	4.471E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	8el2-assembly2.cif.gz_K	LOKIASV2_1517_ESMFold_hypothetical_protein	8el2-assembly2.cif.gz_K SARS-CoV-2 RBD bound to neutralizing antibody Fab ICO-hu23	0.065	128	89	68	195	116	211	6.249E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	7ps6-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	7ps6-assembly1.cif.gz_D Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-44 and Beta-54 Fabs	0.058	112	89	88	199	16	110	3.782E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	1mcj-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1mcj-assembly1.cif.gz_A PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS	0.054	121	87	75	195	119	211	5.589E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	5occ-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5occ-assembly1.cif.gz_L Crystal structure of CD32b (Fc Gamma Receptor IIb) in complex with Human IgG1 Fab fragment (6G08)	0.066	127	88	69	195	118	212	6.987E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	2ny1-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	2ny1-assembly1.cif.gz_D HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b	0.114	112	68	88	199	146	223	1.638E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	6wj1-assembly1.cif.gz_G	LOKIASV2_1517_ESMFold_hypothetical_protein	6wj1-assembly1.cif.gz_G Crystal structure of Fab 54-4H03 bound to H1 influenza hemagglutinin	0.119	129	80	69	197	135	226	2.861E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	4od3-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	4od3-assembly1.cif.gz_H Crystal structure of human Fab CAP256-VRC26.07, a potent V1V2-directed HIV-1 neutralizing antibody	0.155	125	79	75	199	140	233	1.831E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	5u3m-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	5u3m-assembly1.cif.gz_H Crystal Structure of DH511.11P Fab in Complex with HIV-1 gp41 MPER Peptide	0.110	134	87	68	201	137	235	3.199E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	7ram-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	7ram-assembly1.cif.gz_D Cryo-EM Structure of the HCMV gHgLgO Trimer Derived from AD169 and TR strains in complex with PDGFRalpha	0.096	133	87	69	201	193	289	3.383E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	6o3o-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	6o3o-assembly1.cif.gz_D Structure of human DNAM-1 (CD226) bound to nectin-like protein-5 (necl-5)	0.070	118	82	76	193	118	206	2.559E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	3u82-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	3u82-assembly1.cif.gz_B Binding of herpes simplex virus glycoprotein D to nectin-1 exploits host cell adhesion	0.101	129	85	69	197	113	207	2.559E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	5dza-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5dza-assembly1.cif.gz_A Streptococcus agalactiae AgI/II polypeptide BspA C terminal domain (WT)	0.083	143	105	77	191	4	146	1.638E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	2wqs-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	2wqs-assembly1.cif.gz_A Crystal structure of the C-terminal domain of Streptococcus gordonii surface protein SspB	0.101	157	114	68	195	176	332	5.672E-01	24
LOKIASV2_1517_ESMFold_hypothetical_protein	4qrb-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4qrb-assembly1.cif.gz_A Structure and specificity of L-D-Transpeptidase from Mycobacterium tuberculosis and antibiotic resistance: Calcium binding promotes dimer formation	0.067	132	79	69	200	6	91	3.577E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	6t0q-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6t0q-assembly1.cif.gz_A Pleurotus Ostreatus Lectin (POL), apo form	0.084	121	99	73	193	184	292	1.108E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	5xau-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	5xau-assembly2.cif.gz_D Crystal structure of integrin binding fragment of laminin-511	0.112	190	154	19	208	12	185	2.420E+00	24
LOKIASV2_1517_ESMFold_hypothetical_protein	7tj9-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7tj9-assembly1.cif.gz_B Cryo-EM structure of the human Nax channel in complex with beta3 solved in GDN	0.120	114	93	88	201	16	122	1.172E+00	23
LOKIASV2_1517_ESMFold_hypothetical_protein	6bck-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6bck-assembly1.cif.gz_L Crystal Structure of Broadly Neutralizing Antibody N49P7 in Complex with HIV-1 Clade AE strain 93TH057 gp120 core.	0.094	128	86	68	195	103	198	3.577E+00	23
LOKIASV2_1517_ESMFold_hypothetical_protein	6oz3-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6oz3-assembly1.cif.gz_L Crystal structure of broadly neutralizing antibody N49P9.1 Fab in complex with HIV-1 Clade A/E strain 93TH057 gp120 core	0.072	127	89	69	195	102	198	4.999E+00	23
LOKIASV2_1517_ESMFold_hypothetical_protein	6ieb-assembly2.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	6ieb-assembly2.cif.gz_F Structure of RVFV Gn and human monoclonal antibody R15	0.065	128	89	68	195	108	203	5.910E+00	23
LOKIASV2_1517_ESMFold_hypothetical_protein	4jy6-assembly2.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	4jy6-assembly2.cif.gz_C Crystal structure of human Fab PGT123, a broadly reactive and potent HIV-1 neutralizing antibody	0.085	128	85	68	195	111	204	5.910E+00	23
LOKIASV2_1517_ESMFold_hypothetical_protein	4gsd-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4gsd-assembly1.cif.gz_L H5.3 Fab Structure	0.072	127	87	69	195	110	204	8.260E+00	23
LOKIASV2_1517_ESMFold_hypothetical_protein	7u04-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7u04-assembly1.cif.gz_L IOMA class antibody ACS101	0.073	128	88	68	195	110	205	8.734E+00	23
LOKIASV2_1517_ESMFold_hypothetical_protein	5gks-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	5gks-assembly2.cif.gz_D Crystal structure of SLE patient-derived anti-DNA antibody	0.067	125	100	75	199	2	109	5.286E+00	23
LOKIASV2_1517_ESMFold_hypothetical_protein	5bw7-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5bw7-assembly1.cif.gz_A Crystal structure of nonfucosylated Fc Y296W mutant complexed with bis-glycosylated soluble form of Fc gamma receptor IIIa	0.141	132	88	68	199	5	107	6.249E+00	23
LOKIASV2_1517_ESMFold_hypothetical_protein	6iuv-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	6iuv-assembly2.cif.gz_D Crystal structure of influenza A virus H5 hemagglutinin globular head in complex with the Fab of antibody 3C11	0.070	108	75	88	195	133	214	6.249E+00	23
LOKIASV2_1517_ESMFold_hypothetical_protein	6jhs-assembly1.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	6jhs-assembly1.cif.gz_E The cryo-EM structure of HAV bound to a neutralizing antibody-F7	0.068	123	101	70	192	1	109	3.025E+00	23
LOKIASV2_1517_ESMFold_hypothetical_protein	6jbt-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6jbt-assembly1.cif.gz_L Complex structure of toripalimab-Fab and PD-1	0.068	124	93	68	191	3	103	6.608E+00	23
LOKIASV2_1517_ESMFold_hypothetical_protein	5jor-assembly2.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5jor-assembly2.cif.gz_A Crystal structure of unbound anti-glycan antibody Fab14.22 at 2.2 A	0.083	123	91	69	191	4	103	7.388E+00	23
LOKIASV2_1517_ESMFold_hypothetical_protein	2qhr-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	2qhr-assembly1.cif.gz_L Crystal structure of the 13F6-1-2 Fab fragment bound to its Ebola virus glycoprotein peptide epitope.	0.058	128	89	68	195	121	215	8.734E+00	23
LOKIASV2_1517_ESMFold_hypothetical_protein	6rqm-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6rqm-assembly1.cif.gz_A A blocking anti-CTLA-4 Nanobody (KN044) complexed with CTLA-4	0.075	132	95	75	206	2	105	2.047E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	2dwx-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	2dwx-assembly1.cif.gz_A Co-crystal Structure Analysis of GGA1-GAE with the WNSF motif	0.042	125	105	69	193	4	114	1.732E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	6pnp-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6pnp-assembly1.cif.gz_B Crystal structure of the splice insert-free neurexin-1 LNS2 domain in complex with neurexophilin-1	0.110	115	97	84	193	9	123	2.746E-01	22
LOKIASV2_1517_ESMFold_hypothetical_protein	1p4u-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1p4u-assembly1.cif.gz_A CRYSTAL STRUCTURE OF GGA3 GAE DOMAIN IN COMPLEX WITH RABAPTIN-5 PEPTIDE	0.056	134	110	75	208	20	136	5.365E-01	22
LOKIASV2_1517_ESMFold_hypothetical_protein	3twc-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	3twc-assembly1.cif.gz_L Crystal structure of broad and potent HIV-1 neutralizing antibody PGT127 in complex with Man9	0.058	132	96	68	199	1	103	4.728E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	3ha0-assembly3.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	3ha0-assembly3.cif.gz_F Crystal structure of the IgE-Fc3-4 domains	0.125	112	74	88	199	18	103	3.025E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	6nb5-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6nb5-assembly1.cif.gz_L Crystal structure of anti- MERS-CoV human neutralizing LCA60 antibody Fab fragment	0.064	104	80	90	193	15	100	3.025E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	7ps7-assembly2.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7ps7-assembly2.cif.gz_L Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-40 Fab	0.101	134	92	75	208	3	105	4.728E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	5sy8-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5sy8-assembly1.cif.gz_L Crystal structure of the complex of 10E8 Fab light chain mutant1 and T117v2 HIV-1 MPER scaffold	0.071	128	88	68	195	113	208	8.734E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	6db6-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6db6-assembly1.cif.gz_L Crystal structure of anti-HIV-1 V3 Fab 311-11D in complex with a HIV-1 gp120 V3 peptide from MN strain	0.057	112	87	88	199	16	108	4.471E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	6glw-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	6glw-assembly2.cif.gz_D Structure of galectin-10 in complex with the Fab fragment of a Charcot-Leyden crystal solubilizing antibody, 1D11	0.071	128	88	68	195	115	210	5.910E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	4isv-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4isv-assembly1.cif.gz_A Crystal structure of the Fab FRAGMENT OF 1C2, A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE	0.058	128	89	68	195	121	215	9.765E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	1iai-assembly1.cif.gz_H-2	LOKIASV2_1517_ESMFold_hypothetical_protein	1iai-assembly1.cif.gz_H-2 IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX	0.096	130	109	70	199	1	122	5.589E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	6vry-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	6vry-assembly1.cif.gz_H Structure of NCI09 fab in complex with SIV V2 peptide	0.112	129	81	69	197	132	223	2.559E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	5k9k-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	5k9k-assembly1.cif.gz_A Crystal structure of multidonor HV6-1-class broadly neutralizing Influenza A antibody 56.a.09 in complex with Hemagglutinin Hong Kong 1968.	0.112	128	84	70	197	128	223	3.782E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	5ijv-assembly3.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	5ijv-assembly3.cif.gz_D Crystal structure of bovine Fab E03	0.096	130	80	68	197	156	244	4.471E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	3lb6-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	3lb6-assembly1.cif.gz_C The structure of IL-13 in complex with IL-13Ralpha2	0.053	119	82	78	196	96	183	7.388E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	5lgk-assembly2.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	5lgk-assembly2.cif.gz_C Crystal structure of the human IgE-Fc bound to its B cell receptor derCD23	0.098	119	79	75	193	2	90	3.999E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	3opu-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	3opu-assembly2.cif.gz_B Crystal structure of the C-terminal domain of Streptococcus mutans surface protein SpaP	0.102	150	110	69	191	181	330	1.048E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	8a1m-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	8a1m-assembly1.cif.gz_A Crystal structure of the transpeptidase LdtMt2 from Mycobacterium tuberculosis in complex with maleimide analogue 4	0.098	129	87	69	197	100	196	5.589E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	7paw-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7paw-assembly1.cif.gz_B MALT1 in complex with compound 1	0.088	132	102	76	207	245	357	2.420E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	6gfe-assembly1.cif.gz_K	LOKIASV2_1517_ESMFold_hypothetical_protein	6gfe-assembly1.cif.gz_K High-resolution Structure of a therapeutic full-length anti-NPRA Antibody with exceptional Conformational Diversity	0.118	129	87	69	197	220	319	7.812E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	6qgr-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6qgr-assembly1.cif.gz_A The F420-reducing [NiFe] hydrogenase complex from Methanosarcina barkeri at the Nia-S state	0.071	42	38	166	207	358	399	7.388E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	6u7j-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	6u7j-assembly1.cif.gz_D Uncultured Clostridium sp. Beta-glucuronidase	0.053	122	76	75	196	184	264	3.782E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	6mvh-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	6mvh-assembly1.cif.gz_C Crystal structure of FMN-binding beta-glucuronidase from Roseburia hominis	0.048	129	89	68	196	163	257	3.199E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	6dms-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6dms-assembly1.cif.gz_A Endo-fucoidan hydrolase MfFcnA4_H294Q from glycoside hydrolase family 107	0.121	128	86	66	193	596	694	1.172E+00	22
LOKIASV2_1517_ESMFold_hypothetical_protein	2dwx-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	2dwx-assembly2.cif.gz_B Co-crystal Structure Analysis of GGA1-GAE with the WNSF motif	0.063	132	93	68	199	11	110	4.471E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	4adf-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	4adf-assembly1.cif.gz_C CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (hCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1	0.066	110	86	88	197	8	100	7.388E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	4adf-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4adf-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (hCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1	0.066	110	86	88	197	8	100	6.608E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	4ay0-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4ay0-assembly1.cif.gz_A High resolution crystal structure of the monomeric subunit-free Caf1M chaperone	0.076	120	89	78	197	5	101	3.782E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	7lf9-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7lf9-assembly1.cif.gz_B Structure of Hyperglycosylated Human IgG1 Fc (Fc329)	0.080	127	83	69	195	2	92	4.228E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	5dja-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	5dja-assembly1.cif.gz_B Fc Heterodimer Design 9.1 Y407M + T366I	0.129	129	86	69	197	2	101	9.765E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	7e7y-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	7e7y-assembly2.cif.gz_D Crystal structure of the SARS-CoV-2 S RBD in complex with BD-623 Fab	0.072	128	88	68	195	113	208	8.260E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	8tfq-assembly2.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	8tfq-assembly2.cif.gz_L Fab from C10-S66K antibody in complex with fentanyl	0.065	128	89	68	195	112	207	4.471E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	6mek-assembly1.cif.gz_G	LOKIASV2_1517_ESMFold_hypothetical_protein	6mek-assembly1.cif.gz_G Crystal structure of Hepatitis C virus envelope glycoprotein E2 core in complex with human antibodies HEPC3 and HEPC46	0.050	128	88	68	195	118	211	6.608E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	7q0i-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7q0i-assembly1.cif.gz_B Crystal structure of the N-terminal domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-43	0.058	127	89	69	195	115	209	7.812E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	4o5i-assembly2.cif.gz_X	LOKIASV2_1517_ESMFold_hypothetical_protein	4o5i-assembly2.cif.gz_X Crystal structure of broadly neutralizing antibody F045-092 in complex with A/Victoria/361/2011 (H3N2) influenza hemagglutinin	0.079	128	87	68	195	116	211	6.608E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	7mzh-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	7mzh-assembly1.cif.gz_H SARS-CoV-2 receptor binding domain bound to Fab WCSL 119	0.121	122	78	76	197	122	211	1.936E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	7u2d-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7u2d-assembly1.cif.gz_L Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADG20	0.084	112	87	88	199	17	112	7.812E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	6wtv-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6wtv-assembly1.cif.gz_B Plasmodium vivax reticulocyte binding protein 2b (PvRBP2b) bound to human monoclonal antibody 258259	0.120	122	72	76	197	131	213	3.999E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	7n4j-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	7n4j-assembly1.cif.gz_L Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2173.	0.077	120	92	74	193	3	103	4.228E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	5eor-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5eor-assembly1.cif.gz_L Structure of the murine antibody Fab 8E3 bound to the vaccinia virus A27 peptide 101-110	0.057	128	89	68	195	121	215	9.235E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	5k8a-assembly3.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	5k8a-assembly3.cif.gz_F NIST FAB	0.091	132	107	68	199	3	121	4.999E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	7mf9-assembly4.cif.gz_M	LOKIASV2_1517_ESMFold_hypothetical_protein	7mf9-assembly4.cif.gz_M Crystal structure of antibody 10E8v4-P100fA Fab in space group C2	0.129	128	78	70	197	133	222	2.861E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	7jkb-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	7jkb-assembly1.cif.gz_B 2xVH Fab	0.110	130	84	68	197	130	224	7.812E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	7ad6-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7ad6-assembly1.cif.gz_A Crystal structure of human complement C5 in complex with the K92 bovine knob domain peptide.	0.072	129	88	69	197	142	237	5.910E+00	21
LOKIASV2_1517_ESMFold_hypothetical_protein	6anw-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6anw-assembly1.cif.gz_A Crystal structure of anti-CRISPR protein AcrF10	0.105	19	16	177	195	18	36	7.388E+00	20
LOKIASV2_1517_ESMFold_hypothetical_protein	7r8o-assembly1.cif.gz_P	LOKIASV2_1517_ESMFold_hypothetical_protein	7r8o-assembly1.cif.gz_P Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C548	0.060	119	98	75	193	2	106	2.861E+00	20
LOKIASV2_1517_ESMFold_hypothetical_protein	4adf-assembly2.cif.gz_N	LOKIASV2_1517_ESMFold_hypothetical_protein	4adf-assembly2.cif.gz_N CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (hCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1	0.064	114	87	84	197	7	100	7.388E+00	20
LOKIASV2_1517_ESMFold_hypothetical_protein	7nwo-assembly1.cif.gz_AAA	LOKIASV2_1517_ESMFold_hypothetical_protein	7nwo-assembly1.cif.gz_AAA A carbohydrate binding module family 9 (CBM9) from Caldicellulosiruptor kristjanssonii in complex with glucose	0.093	144	128	66	207	20	163	3.025E+00	20
LOKIASV2_1517_ESMFold_hypothetical_protein	6lir-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6lir-assembly1.cif.gz_A crystal structure of chicken TCR for 2.0	0.078	107	78	87	193	14	99	6.608E+00	20
LOKIASV2_1517_ESMFold_hypothetical_protein	4wi9-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4wi9-assembly1.cif.gz_B Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation I253A/H310A	0.142	129	85	69	197	2	101	8.734E+00	20
LOKIASV2_1517_ESMFold_hypothetical_protein	8ent-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	8ent-assembly1.cif.gz_B Interleukin-21 signaling complex with IL-21R and IL-2Rg	0.078	139	84	69	207	4	95	3.999E+00	20
LOKIASV2_1517_ESMFold_hypothetical_protein	6nb5-assembly2.cif.gz_M	LOKIASV2_1517_ESMFold_hypothetical_protein	6nb5-assembly2.cif.gz_M Crystal structure of anti- MERS-CoV human neutralizing LCA60 antibody Fab fragment	0.081	106	78	88	193	15	100	5.910E+00	20
LOKIASV2_1517_ESMFold_hypothetical_protein	6wtv-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	6wtv-assembly1.cif.gz_C Plasmodium vivax reticulocyte binding protein 2b (PvRBP2b) bound to human monoclonal antibody 258259	0.072	128	88	68	195	113	208	5.910E+00	20
LOKIASV2_1517_ESMFold_hypothetical_protein	2jb6-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	2jb6-assembly1.cif.gz_A Fab fragment in complex with small molecule hapten, crystal form-2	0.066	106	79	88	193	15	100	7.388E+00	20
LOKIASV2_1517_ESMFold_hypothetical_protein	5tfw-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	5tfw-assembly1.cif.gz_L Crystal structure of 10E8 Fab light chain mutant2 against the MPER region of the HIV-1 Env, in complex with T117v2 epitope scaffold	0.079	128	87	68	195	113	208	9.765E+00	20
LOKIASV2_1517_ESMFold_hypothetical_protein	4d9l-assembly4.cif.gz_K	LOKIASV2_1517_ESMFold_hypothetical_protein	4d9l-assembly4.cif.gz_K Fab structure of anti-HIV-1 gp120 V2 mAb 697	0.129	123	75	75	197	129	215	3.383E+00	20
LOKIASV2_1517_ESMFold_hypothetical_protein	7ps2-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	7ps2-assembly1.cif.gz_H Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-29 and Beta-53 Fabs	0.141	129	76	69	197	128	216	3.025E+00	20
LOKIASV2_1517_ESMFold_hypothetical_protein	8d48-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	8d48-assembly1.cif.gz_L sd1.040 Fab in complex with SARS-CoV-2 Spike 2P glycoprotein	0.081	139	90	68	206	118	216	9.765E+00	20
LOKIASV2_1517_ESMFold_hypothetical_protein	5ijv-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	5ijv-assembly1.cif.gz_H Crystal structure of bovine Fab E03	0.087	130	81	68	197	156	245	3.999E+00	20
LOKIASV2_1517_ESMFold_hypothetical_protein	3wo3-assembly2.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	3wo3-assembly2.cif.gz_D Crystal structure of IL-18 in complex with IL-18 receptor alpha	0.072	130	93	68	197	188	288	9.235E+00	20
LOKIASV2_1517_ESMFold_hypothetical_protein	4z23-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4z23-assembly1.cif.gz_A BspA_C_WT	0.080	148	112	69	191	154	301	1.936E+00	20
LOKIASV2_1517_ESMFold_hypothetical_protein	2wza-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	2wza-assembly1.cif.gz_A Two intramolecular isopeptide bonds are identified in the crystal structure of the Streptococcus gordonii SspB C-terminal domain	0.101	157	114	68	195	181	337	1.385E+00	20
LOKIASV2_1517_ESMFold_hypothetical_protein	4ofd-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4ofd-assembly1.cif.gz_A Crystal Structure of mouse Neph1 D1-D2	0.082	129	83	69	197	2	92	7.388E+00	19
LOKIASV2_1517_ESMFold_hypothetical_protein	8dps-assembly1.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	8dps-assembly1.cif.gz_F The structure of the interleukin 11 signalling complex, truncated gp130	0.087	121	78	75	195	8	93	3.383E+00	19
LOKIASV2_1517_ESMFold_hypothetical_protein	4odh-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4odh-assembly1.cif.gz_L Crystal structure of human Fab CAP256-VRC26.UCA, a potent V1V2-directed HIV-1 neutralizing antibody	0.074	125	96	75	199	2	106	9.765E+00	19
LOKIASV2_1517_ESMFold_hypothetical_protein	6vu2-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6vu2-assembly1.cif.gz_L M1214_N1 Fab structure	0.035	106	82	88	193	16	101	6.987E+00	19
LOKIASV2_1517_ESMFold_hypothetical_protein	6tke-assembly1.cif.gz_HHH	LOKIASV2_1517_ESMFold_hypothetical_protein	6tke-assembly1.cif.gz_HHH ChiLob 7/4 H2 HC-C224S Kappa LC-C214S F(ab')2	0.121	121	74	76	196	127	211	3.577E+00	19
LOKIASV2_1517_ESMFold_hypothetical_protein	6ym0-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	6ym0-assembly1.cif.gz_H Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab (crystal form 1)	0.110	130	81	68	197	122	213	4.999E+00	19
LOKIASV2_1517_ESMFold_hypothetical_protein	7rlw-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7rlw-assembly1.cif.gz_A Antibody 2F2 in complex with P. vivax CSP peptide GDRAAGQPAGDRAAGQPA	0.088	113	97	87	199	14	120	7.388E+00	19
LOKIASV2_1517_ESMFold_hypothetical_protein	5oyj-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	5oyj-assembly1.cif.gz_C Crystal structure of VEGFR-2 domains 4-5 in complex with DARPin D4b	0.038	133	116	69	201	100	221	6.249E+00	19
LOKIASV2_1517_ESMFold_hypothetical_protein	6bft-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6bft-assembly1.cif.gz_A Structure of Bevacizumab Fab mutant in complex with VEGF	0.117	128	81	70	197	125	217	4.228E+00	19
LOKIASV2_1517_ESMFold_hypothetical_protein	3bes-assembly1.cif.gz_R	LOKIASV2_1517_ESMFold_hypothetical_protein	3bes-assembly1.cif.gz_R Structure of a Poxvirus ifngbp/ifng Complex	0.088	126	98	75	200	89	197	3.999E+00	19
LOKIASV2_1517_ESMFold_hypothetical_protein	4r6u-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	4r6u-assembly1.cif.gz_C IL-18 receptor complex	0.041	130	90	68	197	177	271	9.765E+00	19
LOKIASV2_1517_ESMFold_hypothetical_protein	6h3j-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	6h3j-assembly1.cif.gz_C Structural snapshots of the Type 9 protein translocon Plug-complex	0.101	125	111	69	193	5	129	2.289E+00	19
LOKIASV2_1517_ESMFold_hypothetical_protein	7ko8-assembly1.cif.gz_B-60	LOKIASV2_1517_ESMFold_hypothetical_protein	7ko8-assembly1.cif.gz_B-60 Cryo-EM structure of the mature and infective Mayaro virus	0.074	144	117	69	195	4	147	1.965E-01	19
LOKIASV2_1517_ESMFold_hypothetical_protein	6mvh-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6mvh-assembly1.cif.gz_A Crystal structure of FMN-binding beta-glucuronidase from Roseburia hominis	0.048	129	89	68	196	163	257	5.286E+00	19
LOKIASV2_1517_ESMFold_hypothetical_protein	4ddx-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4ddx-assembly2.cif.gz_B Thermotoga maritima reverse gyrase, primitive monoclinic form	0.171	33	27	172	204	935	967	7.388E+00	19
LOKIASV2_1517_ESMFold_hypothetical_protein	6e8v-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6e8v-assembly1.cif.gz_B The crystal structure of bovine ultralong antibody BOV-1	0.119	104	74	88	191	16	100	7.812E+00	18
LOKIASV2_1517_ESMFold_hypothetical_protein	7pr0-assembly3.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	7pr0-assembly3.cif.gz_F Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with FD-5D Fab	0.111	114	79	78	191	16	105	9.765E+00	18
LOKIASV2_1517_ESMFold_hypothetical_protein	4k3d-assembly2.cif.gz_I	LOKIASV2_1517_ESMFold_hypothetical_protein	4k3d-assembly2.cif.gz_I Crystal structure of bovine antibody BLV1H12 with ultralong CDR H3	0.136	135	104	69	203	2	122	6.987E+00	18
LOKIASV2_1517_ESMFold_hypothetical_protein	6db7-assembly2.cif.gz_I	LOKIASV2_1517_ESMFold_hypothetical_protein	6db7-assembly2.cif.gz_I Crystal structure of anti-HIV-1 V3 Fab 1334 in complex with a HIV-1 gp120 V3 peptide from MN strain	0.094	130	90	70	199	133	232	8.260E+00	18
LOKIASV2_1517_ESMFold_hypothetical_protein	2ijr-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	2ijr-assembly1.cif.gz_A Crystal structure of a protein api92 from Yersinia pseudotuberculosis, Pfam DUF1281	0.115	89	68	129	206	188	276	8.383E-01	18
LOKIASV2_1517_ESMFold_hypothetical_protein	7ok5-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7ok5-assembly1.cif.gz_A Crystal structure of mouse neurofascin 155 immunoglobulin domains	0.043	130	83	68	197	491	578	8.260E+00	18
LOKIASV2_1517_ESMFold_hypothetical_protein	6fpy-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6fpy-assembly1.cif.gz_A Inter-alpha-inhibitor heavy chain 1, wild type	0.100	58	45	143	193	438	495	3.383E+00	18
LOKIASV2_1517_ESMFold_hypothetical_protein	4jj5-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4jj5-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE Fab FRAGMENT OF 1C2, A MONOCLONAL ANTIBODY SPECIFIC for POLY-GLUTAMINE	0.103	124	94	70	193	1	106	5.286E+00	17
LOKIASV2_1517_ESMFold_hypothetical_protein	8w85-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	8w85-assembly1.cif.gz_D HLA-DQ2.5-gamma2 gliadin peptide in complex with DQN0385AE01	0.015	125	76	69	193	108	185	7.388E+00	17
LOKIASV2_1517_ESMFold_hypothetical_protein	6lir-assembly2.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	6lir-assembly2.cif.gz_C crystal structure of chicken TCR for 2.0	0.075	124	90	70	193	1	98	9.765E+00	17
LOKIASV2_1517_ESMFold_hypothetical_protein	5tez-assembly1.cif.gz_I	LOKIASV2_1517_ESMFold_hypothetical_protein	5tez-assembly1.cif.gz_I TCR F50 recgonizing M1-HLA-A2	0.058	125	94	69	193	2	102	8.260E+00	17
LOKIASV2_1517_ESMFold_hypothetical_protein	6peh-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	6peh-assembly1.cif.gz_L Crystal structure of rabbit monoclonal anti-HIV antibody 1C2	0.100	106	76	88	193	17	101	6.987E+00	17
LOKIASV2_1517_ESMFold_hypothetical_protein	4m6n-assembly1.cif.gz_L	LOKIASV2_1517_ESMFold_hypothetical_protein	4m6n-assembly1.cif.gz_L Crystal structure of anti-IL-23 antibody CNTO1959 at pH 6.5	0.109	124	90	70	193	1	102	9.765E+00	17
LOKIASV2_1517_ESMFold_hypothetical_protein	6u9u-assembly1.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	6u9u-assembly1.cif.gz_H Structure of GM9_TH8seq732127 FAB	0.134	128	79	70	197	123	214	5.286E+00	17
LOKIASV2_1517_ESMFold_hypothetical_protein	8tfq-assembly2.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	8tfq-assembly2.cif.gz_H Fab from C10-S66K antibody in complex with fentanyl	0.124	123	80	75	197	127	218	5.589E+00	17
LOKIASV2_1517_ESMFold_hypothetical_protein	4wk2-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4wk2-assembly1.cif.gz_B Metal Ion and Ligand Binding of Integrin	0.100	100	70	100	199	348	426	3.782E+00	17
LOKIASV2_1517_ESMFold_hypothetical_protein	8hey-assembly1.cif.gz_M	LOKIASV2_1517_ESMFold_hypothetical_protein	8hey-assembly1.cif.gz_M One CVSC-binding penton vertex in HCMV B-capsid	0.120	132	114	63	194	34	163	1.831E+00	17
LOKIASV2_1517_ESMFold_hypothetical_protein	6mvg-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	6mvg-assembly2.cif.gz_B Crystal structure of FMN-binding beta-glucuronidase from Ruminococcus gnavus	0.068	128	98	68	195	149	254	7.388E+00	17
LOKIASV2_1517_ESMFold_hypothetical_protein	7eha-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	7eha-assembly1.cif.gz_C Crystal structure of the flagellar hook cap from Salmonella enterica serovar Typhimurium	0.097	161	117	33	193	3	133	8.734E+00	16
LOKIASV2_1517_ESMFold_hypothetical_protein	4z1p-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4z1p-assembly1.cif.gz_A BspA_C_mut	0.080	148	110	71	191	179	326	2.165E+00	16
LOKIASV2_1517_ESMFold_hypothetical_protein	4o8j-assembly2.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4o8j-assembly2.cif.gz_B Crystal structure of RtcA, the RNA 3'-terminal phosphate cyclase from Pyrococcus horikoshii, in complex with rACAAA3'phosphate and adenine.	0.050	119	61	130	194	133	251	3.025E+00	16
LOKIASV2_1517_ESMFold_hypothetical_protein	7ol4-assembly1.cif.gz_C	LOKIASV2_1517_ESMFold_hypothetical_protein	7ol4-assembly1.cif.gz_C Mouse contactin-1 neurofascin-155 immunoglobulin domains adhesion complex	0.037	129	83	69	197	497	583	9.235E+00	16
LOKIASV2_1517_ESMFold_hypothetical_protein	7ol4-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	7ol4-assembly1.cif.gz_D Mouse contactin-1 neurofascin-155 immunoglobulin domains adhesion complex	0.037	129	83	69	197	500	586	8.734E+00	16
LOKIASV2_1517_ESMFold_hypothetical_protein	7tfq-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7tfq-assembly1.cif.gz_A Crystal Structure of the Pirin Family Protein Redox-sensitive Bicupin YhaK Bound to Copper Ion from Yersinia pestis	0.112	140	107	67	206	147	267	1.239E+00	15
LOKIASV2_1517_ESMFold_hypothetical_protein	1wio-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1wio-assembly1.cif.gz_A STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, TETRAGONAL CRYSTAL FORM	0.085	106	85	88	193	193	286	8.260E+00	15
LOKIASV2_1517_ESMFold_hypothetical_protein	4um9-assembly1.cif.gz_D	LOKIASV2_1517_ESMFold_hypothetical_protein	4um9-assembly1.cif.gz_D Crystal structure of alpha V beta 6 with peptide	0.058	95	67	105	199	353	424	6.608E+00	15
LOKIASV2_1517_ESMFold_hypothetical_protein	6q2n-assembly1.cif.gz_F	LOKIASV2_1517_ESMFold_hypothetical_protein	6q2n-assembly1.cif.gz_F Cryo-EM structure of RET/GFRa1/GDNF extracellular complex	0.097	116	92	84	199	250	352	2.420E+00	15
LOKIASV2_1517_ESMFold_hypothetical_protein	3wo4-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	3wo4-assembly1.cif.gz_B Crystal structure of the IL-18 signaling ternary complex	0.091	113	92	81	193	192	293	6.249E+00	14
LOKIASV2_1517_ESMFold_hypothetical_protein	7cym-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7cym-assembly1.cif.gz_A Crystal structure of LI-Cadherin EC1-4	0.062	124	97	70	193	306	409	8.734E+00	14
LOKIASV2_1517_ESMFold_hypothetical_protein	4wjk-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4wjk-assembly1.cif.gz_B Metal Ion and Ligand Binding of Integrin	0.127	94	61	100	193	344	414	4.728E+00	14
LOKIASV2_1517_ESMFold_hypothetical_protein	6bxf-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6bxf-assembly1.cif.gz_A Crystal structure of an extended b3 integrin L33	0.086	100	69	100	199	295	371	3.383E+00	14
LOKIASV2_1517_ESMFold_hypothetical_protein	7et3-assembly1.cif.gz_M	LOKIASV2_1517_ESMFold_hypothetical_protein	7et3-assembly1.cif.gz_M C5 portal vertex in the enveloped virion capsid	0.113	133	115	63	195	34	164	4.228E+00	14
LOKIASV2_1517_ESMFold_hypothetical_protein	2o8q-assembly1.cif.gz_B-2	LOKIASV2_1517_ESMFold_hypothetical_protein	2o8q-assembly1.cif.gz_B-2 CRYSTAL STRUCTURE OF A PROTEIN WITH A CUPIN-LIKE FOLD AND UNKNOWN FUNCTION (BXE_C0505) FROM BURKHOLDERIA XENOVORANS LB400 AT 1.55 A RESOLUTION	0.092	107	75	87	193	36	119	2.165E+00	13
LOKIASV2_1517_ESMFold_hypothetical_protein	5bob-assembly5.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	5bob-assembly5.cif.gz_E Crystal Structure of the Meningitis Pathogen Streptococcus suis adhesion Fhb	0.059	167	113	73	193	24	190	4.728E+00	13
LOKIASV2_1517_ESMFold_hypothetical_protein	6rpy-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6rpy-assembly1.cif.gz_A Cytokine receptor-like factor 3 C-terminus residues 174-442: Hg-SAD derivative	0.077	133	120	69	199	93	225	3.999E+00	13
LOKIASV2_1517_ESMFold_hypothetical_protein	4weu-assembly2.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	4weu-assembly2.cif.gz_A Co-complex structure of the F4 fimbrial adhesin FaeG variant ad with llama single domain antibody V3	0.062	173	119	68	195	72	244	3.025E+00	13
LOKIASV2_1517_ESMFold_hypothetical_protein	6dns-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6dns-assembly1.cif.gz_A Endo-fucoidan hydrolase MfFcnA9 from glycoside hydrolase family 107	0.099	156	112	69	193	430	585	1.732E+00	13
LOKIASV2_1517_ESMFold_hypothetical_protein	3wst-assembly8.cif.gz_H	LOKIASV2_1517_ESMFold_hypothetical_protein	3wst-assembly8.cif.gz_H Crystal structure of C.elegans PRMT7 in complex with SAH(P31)	0.091	125	75	69	193	554	636	7.812E+00	13
LOKIASV2_1517_ESMFold_hypothetical_protein	6u1m-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	6u1m-assembly1.cif.gz_A Resting state of rat cysteine dioxygenase R60E variant	0.107	133	114	72	200	51	183	3.999E+00	12
LOKIASV2_1517_ESMFold_hypothetical_protein	4weu-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	4weu-assembly1.cif.gz_B Co-complex structure of the F4 fimbrial adhesin FaeG variant ad with llama single domain antibody V3	0.085	171	118	68	197	52	222	2.559E+00	12
LOKIASV2_1517_ESMFold_hypothetical_protein	3wst-assembly6.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	3wst-assembly6.cif.gz_E Crystal structure of C.elegans PRMT7 in complex with SAH(P31)	0.091	125	75	69	193	551	633	8.260E+00	12
LOKIASV2_1517_ESMFold_hypothetical_protein	7e4s-assembly1.cif.gz_E	LOKIASV2_1517_ESMFold_hypothetical_protein	7e4s-assembly1.cif.gz_E Crystal structure of Lactobacillus rhamnosus 4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase KduI complexed with HEPES	0.091	122	105	69	190	150	265	7.388E+00	11
LOKIASV2_1517_ESMFold_hypothetical_protein	1umk-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	1umk-assembly1.cif.gz_A The Structure of Human Erythrocyte NADH-cytochrome b5 Reductase	0.103	128	107	76	195	14	141	3.025E+00	11
LOKIASV2_1517_ESMFold_hypothetical_protein	2cnd-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	2cnd-assembly1.cif.gz_A STRUCTURAL STUDIES ON CORN NITRATE REDUCTASE: REFINED STRUCTURE OF THE CYTOCHROME B REDUCTASE FRAGMENT AT 2.5 ANGSTROMS, ITS ADP COMPLEX AND AN ACTIVE SITE MUTANT AND MODELING OF THE CYTOCHROME B DOMAIN	0.082	122	105	76	190	3	124	8.260E+00	10
LOKIASV2_1517_ESMFold_hypothetical_protein	7uk7-assembly1.cif.gz_A	LOKIASV2_1517_ESMFold_hypothetical_protein	7uk7-assembly1.cif.gz_A YjfC from Escherichia coli K-12 in complex with ADP, Mg2+ and SO4	0.061	96	82	100	195	285	372	9.765E+00	10
LOKIASV2_1517_ESMFold_hypothetical_protein	1qx4-assembly1.cif.gz_B	LOKIASV2_1517_ESMFold_hypothetical_protein	1qx4-assembly1.cif.gz_B Structrue of S127P mutant of cytochrome b5 reductase	0.071	120	107	76	191	13	132	9.765E+00	9
LOKIASV2_1517_ESMFold_hypothetical_protein	6rhv-assembly1.cif.gz_G	LOKIASV2_1517_ESMFold_hypothetical_protein	6rhv-assembly1.cif.gz_G Crystal structure of mouse CD11b I-domain (CD11b-I) in complex with Staphylococcus aureus octameric bi-component leukocidin LukGH (LukH K319A mutant)	0.072	218	116	69	194	48	265	3.999E+00	9
